Crown (CCK) 10-K 3 Mar 25 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2024	Feb. 27, 2025	Jun. 30, 2024
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2024
Document Transition Report	false
Entity File Number	001-41550
Entity Registrant Name	CROWN HOLDINGS, INC.
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	75-3099507
Entity Address, Address Line One	14025 Riveredge Drive, Suite 300
Entity Address, City or Town	Tampa
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33637-2015
City Area Code	215
Local Phone Number	698-5100
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Document Financial Statement Error Correction	false
Entity Public Float			$ 8,940,581,920
Entity Common Stock, Shares Outstanding		117,552,541
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Document Parts Into Which Incorporated Proxy Statement for the Annual Meeting of Shareholders to be held May 1, 2025 Part III to the extent described therein
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Central Index Key	0001219601
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock $5.00 Par Value
Trading Symbol	CCK
Security Exchange Name	NYSE
7 3/8% Debentures Due 2026
Document Information [Line Items]
Title of 12(b) Security	7 3/8% Debentures Due 2026
Trading Symbol	CCK26
Security Exchange Name	NYSE
7 1/2% Debentures Due 2096
Document Information [Line Items]
Title of 12(b) Security	7 1/2% Debentures Due 2096
Trading Symbol	CCK96
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2024
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Philadelphia, PA
Auditor Firm ID	238

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 11,801	$ 12,010	$ 12,943
Cost of products sold, excluding depreciation and amortization	9,262	9,546	10,643
Depreciation and amortization	448	499	460
Selling and administrative expense	597	582	556
Restructuring and other, net	75	114	(52)
Income from operations	1,419	1,269	1,336
Loss from early extinguishments of debt	1	1	11
Other pension and postretirement	546	49	(16)
Gain on sale of equity method investment	(275)	0	0
Interest expense	452	436	284
Interest income	(82)	(53)	(15)
Foreign exchange	34	41	16
Income before income taxes and equity in net earnings of affiliates	743	795	1,056
Provision for income taxes	183	222	243
Equity in net earnings of affiliates	0	14	42
Net income	560	587	855
Net income attributable to noncontrolling interests	136	137	128
Net income attributable to Crown Holdings	$ 424	$ 450	$ 727
Earnings per common share attributable to Crown Holdings:
Basic (in dollars per share)	$ 3.56	$ 3.77	$ 6.01
Diluted (in dollars per share)	$ 3.55	$ 3.76	$ 5.99

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 560	$ 587	$ 855
Other comprehensive income / (loss), net of tax
Foreign currency translation adjustments	(214)	176	(41)
Pension and other postretirement benefits	434	22	83
Derivatives qualifying as hedges	5	8	(40)
Total other comprehensive income	225	206	2
Total comprehensive income	785	793	857
Net income attributable to noncontrolling interests	136	137	128
Translation adjustments attributable to noncontrolling interests	0	1	(2)
Pension and other postretirement benefits attributable to noncontrolling interests	0	0	1
Derivatives qualifying as hedges attributable to noncontrolling interests	0	0	(3)
Comprehensive income attributable to Crown Holdings	$ 649	$ 655	$ 733

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 918	$ 1,310
Receivables, net	1,656	1,719
Inventories	1,440	1,613
Prepaid expenses and other current assets	197	191
Total current assets	4,211	4,833
Goodwill	2,954	3,117
Intangible assets, net	1,044	1,258
Property, plant and equipment, net	4,927	5,062
Operating lease right-of-use assets, net	201	211
Other non-current assets	511	553
Total assets	13,848	15,034
Current liabilities
Short-term debt	66	16
Current maturities of long-term debt	80	759
Current portion of operating lease liabilities	47	45
Accounts payable	2,425	2,459
Accrued liabilities	847	922
Total current liabilities	3,465	4,201
Long-term debt, excluding current maturities	6,058	6,699
Postretirement and pension liabilities	260	414
Non-current portion of operating lease liabilities	167	175
Other non-current liabilities	670	681
Commitments and contingent liabilities (Note Q)
Equity
Noncontrolling interests	472	454
Preferred stock, authorized: 30,000,000; none issued (Note U)	0	0
Common stock, par value: $5.00; 500,000,000 shares authorized; 185,744,072 shares issued; 118,503,631 and 120,644,313 shares outstanding in 2024 and 2023 (Note U)	594	604
Additional paid-in capital	0	17
Retained earnings	3,624	3,476
Accumulated other comprehensive loss	(1,462)	(1,687)
Crown Holdings shareholders’ equity	2,756	2,410
Total equity	3,228	2,864
Total liabilities and equity	$ 13,848	$ 15,034

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, shares authorized (in shares)	30,000,000	30,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 5	$ 5
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	185,744,072	185,744,072
Common stock, shares outstanding (in shares)	118,503,631	120,644,313

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities
Net income	$ 560	$ 587	$ 855
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	448	499	460
Restructuring and other, net	75	114	(52)
Pension and postretirement expense	568	70	12
Pension contributions	(122)	(19)	53
Gain on sale of equity method investment	(275)	0	0
Stock-based compensation	42	31	29
Deferred income taxes	(168)	(53)	28
Asbestos payments	(15)	(17)	(21)
Changes in assets and liabilities:
Receivables	65	98	29
Inventories	102	463	(299)
Accounts payable and accrued liabilities	(90)	(413)	(149)
Prepaids and other assets	13	31	(44)
Other, net	(11)	62	(98)
Net cash provided by operating activities	1,192	1,453	803
Cash flows from investing activities
Capital expenditures	(403)	(793)	(839)
Proceeds from sale of businesses, net of cash	0	0	182
Proceeds from sale of property, plant and equipment	28	17	15
Acquisitions of businesses, net of cash	0	(126)	(31)
Net investment hedges	25	25	26
Distribution from equity method investment	338	68	7
Other	0	5	(2)
Net cash used for investing activities	(12)	(804)	(642)
Cash flows from financing activities
Net change in revolving credit facility and short-term debt	0	(396)	268
Proceeds from short-term debt	222	129	45
Payments of short-term debt	(165)	(131)	(45)
Proceeds from long-term debt	675	1,096	2,953
Payments of long-term debt	(1,788)	(312)	(2,278)
Debt issuance costs	(10)	(16)	(25)
Dividends paid to noncontrolling interests	(119)	(126)	(100)
Dividends paid to shareholders	(119)	(115)	(106)
Common stock repurchased	(217)	(12)	(722)
Other	(5)	(1)	(15)
Net cash (used for) / provided by financing activities	(1,526)	116	(25)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(38)	(4)	(90)
Net change in cash, cash equivalents and restricted cash	(384)	761	46
Cash, cash equivalents and restricted cash at January 1	1,400	639	593
Cash, cash equivalents and restricted cash at December 31	$ 1,016	$ 1,400	$ 639

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Millions	Total	Total Crown Equity	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2021	$ 2,330	$ 1,912	$ 630	$ 0	$ 3,180	$ (1,898)	$ 418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	855	727			727		128
Other comprehensive income	2	6				6	(4)
Dividends declared	(210)	(106)			(106)		(104)
Restricted stock awarded	1	1	2	(1)
Stock-based compensation	29	29		29
Common stock issued	2	2		2
Common stock repurchased	(722)	(722)	(32)	(30)	(660)
Balance at end of period at Dec. 31, 2022	2,287	1,849	600	0	3,141	(1,892)	438
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	587	450			450		137
Other comprehensive income	206	205				205	1
Dividends declared	(237)	(115)			(115)		(122)
Restricted stock awarded	0	0	4	(4)
Stock-based compensation	31	31		31
Common stock issued	2	2		2
Common stock repurchased	(12)	(12)		(12)
Balance at end of period at Dec. 31, 2023	2,864	2,410	604	17	3,476	(1,687)	454
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	560	424			424		136
Other comprehensive income	225	225				225
Dividends declared	(238)	(119)			(119)		(119)
Restricted stock awarded	0	0	2	(2)
Stock-based compensation	42	42		42
Common stock issued	1	1		1
Common stock repurchased	(219)	(219)	(12)	(50)	(157)
Purchase of noncontrolling interests	(7)	(8)		(8)			1
Balance at end of period at Dec. 31, 2024	$ 3,228	$ 2,756	$ 594	$ 0	$ 3,624	$ (1,462)	$ 472

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business and Principles of Consolidation . The consolidated financial statements include the accounts of Crown Holdings, Inc. (the “Company”) and its consolidated subsidiary companies (where the context requires, the “Company” shall include reference to the Company and its consolidated subsidiary companies). The Company, through its subsidiaries, is a leading global, diversified packaging business that manufactures metal cans and ends (aluminum and steel) for the beverage, food and aerosol industries and a wide range of transit packaging products and solutions from multiple substrates including steel, paper, and plastic. The Company's transit packaging products include automation and equipment technologies, protective packaging solutions and steel and plastic consumables which are sold into the metals, food and beverage, construction, agricultural, corrugated, and general industries. The financial statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and reflect management’s estimates and assumptions. Actual results could differ from those estimates, impacting reported results of operations and financial position. All intercompany accounts and transactions are eliminated in consolidation. In deciding which entities should be reported on a consolidated basis, the Company first determines whether the entity is a variable interest entity (“VIE”). If an entity is a VIE, the Company determines whether it is the primary beneficiary and therefore, should consolidate the VIE. If an entity is not a VIE, the Company consolidates those entities in which it has control, including certain subsidiaries that are not majority-owned. Certain of the Company’s agreements with noncontrolling interests contain provisions in which the Company would surrender certain decision-making rights upon a change in control of the Company. Accordingly, consolidation of these operations may no longer be appropriate subsequent to a change in control of the Company, as defined in the agreements. Investments in companies over which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. The proportionate share of the net income resulting from these investments is reported in Equity in net earnings of affiliates in the Consolidated Statements of Operations. The carrying values of the Company's equity method investments are reported in Other non-current assets in the Consolidated Balance Sheets. Equity method investments are reported at cost and adjusted each period for the Company's share of the investee's income or loss and dividends paid, if any. The Company classifies distributions received from equity method investees using the cumulative earnings approach. The Company assesses investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Foreign Currency Translation . For non-U.S. subsidiaries which operate in a local currency environment, assets and liabilities are translated into U.S. dollars at year-end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the year. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired; all other assets and liabilities are translated at year-end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates; all other income and expense items are translated at average exchange rates prevailing during the year. Gains and losses which result from remeasurement are included in earnings. Revenue Recognition . The majority of the Company’s revenues from metal packaging products are derived from multi-year requirement contracts with leading manufacturers and marketers of packaged consumer products for can sets, comprising a can and an end. As requirement contracts do not typically include fixed volumes, customers often purchase products pursuant to purchase orders or other communications which are short-term in nature. The can and the end are considered separate performance obligations because they are distinct and separately identifiable. Revenues from Transit Packaging are generally derived from individual purchase orders which may include multiple goods and services which are separate performance obligations because they are distinct and separately identifiable. The Company manufactures certain products that have no alternative use to the Company once they are printed or manufactured to customer specifications. If the Company has an enforceable right to payment for custom products at all times in the manufacturing process, revenue is recognized over time. In each of the Company’s geographic markets, revenue from beverage cans is primarily recognized over time using the units produced output method as beverage cans are generally printed for a specific customer in a continuous production process. The timing of revenue recognition for the Company’s other products, including beverage ends and three-piece products, which includes food cans and ends and aerosol cans and ends, may vary as these products may be printed or customized depending upon customer preferences. Revenue that is recognized over time for the Company’s three-piece products and equipment business is generally recognized using the cost-to-cost input method as these products involve an intermediary step that results in customized work-in-process inventory. For products that follow a point in time model, revenue is generally recognized when title and risk of loss transfer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Standalone selling prices for each performance obligation are generally stated in the contract. When the Company offers variable consideration in the form of volume rebates to customers, it estimates the most likely amount of revenue to which it is expected to be entitled and includes the estimate in the transaction price, limited to the amount which is probable will not result in reversal of cumulative revenue recognized when the variable consideration is resolved. When the Company offers customers options to purchase additional product at discounted prices, judgment is required to determine if the discounted prices represent material rights. If so, the transaction price allocated to the discount is based on its relative standalone price and is recognized upon purchase of the additional product. Customer payment terms are typically less than one year and as such, the Company has applied the practical expedient to exclude consideration of significant financing components from the determination of transaction price. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Shipping and handling fees and costs from product sales are reported as cost of products sold and are accrued when the Company recognizes revenue over time before the shipping and handling activities occur. Costs to obtain a contract are generally immaterial but the Company has elected the practical expedient to expense these costs as incurred if the duration of the contract is one year or less. Unbilled receivables are recorded for revenue recognized over time when the Company has determined that control has passed to the customer but the customer has not yet been invoiced because the Company does not have present right to payment. The Company generally has a present right to payment when title of product transfers. Unbilled receivables are included in receivables, net in the Consolidated Balance Sheet with a corresponding decrease to inventory. Contract assets are recorded for revenue recognized over time when the Company has determined that control for a performance obligation has passed to the customer, but the right to invoice the customer is contingent upon the completion of the performance obligations included in the contract. Contract assets are classified as current as they are expected to be invoiced within one year and may not exceed their net realizable value. Contract assets are included in prepaid and other current assets in the Consolidated Balance Sheet. Contract liabilities are established if the Company must defer the recognition of a portion of consideration received because it has to satisfy a future obligation. Contract liabilities are classified as current or noncurrent based on when the Company expects to recognize revenue. Stock-Based Compensation . For awards with a service or market condition, compensation expense is recognized over the vesting period on a straight-line basis using the grant date fair value of the award and the estimated number of awards that are expected to vest. For awards with a performance condition, the Company assesses the probability of vesting at each reporting period and adjusts compensation cost based on its probability assessment. The Company’s plans provide for stock awards which may include accelerated vesting upon retirement, disability, or death of eligible employees. The Company considers a stock-based award to be vested when the service period is no longer contingent on the employee providing future service. Accordingly, the related compensation cost is recognized immediately for awards granted to retirement-eligible individuals, or over the period from the grant date to the date that retirement eligibility is achieved if less than the stated vesting period. Cash, Cash Equivalents and Restricted Cash . Cash equivalents represent highly liquid investments with maturities of three months or less from the time of purchase and are carried at cost, which approximates fair value because of the short maturity of those instruments. Outstanding checks in excess of funds on deposit are included in accounts payable. The Company generally classifies any cash that is legally restricted as to withdrawal or usage as restricted cash. Accounts Receivable and Allowance for Credit Losses. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The measurement of expected credit losses is based on past events, including historical experience, current conditions and forecasts that affect the collectability of accounts receivable. Inventory Valuation . Inventories are stated at the lower of cost or net realizable value, with cost principally determined under the first-in, first-out (“FIFO”) or average cost method. Property, Plant and Equipment . Property, plant and equipment (“PP&E”) is carried at cost less accumulated depreciation and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. Cost of constructed assets includes capitalized interest incurred during the construction and development period. Maintenance and repairs, including labor and material costs for planned major maintenance such as annual production line overhauls, are expensed as incurred. When PP&E is retired or otherwise disposed, the net carrying amount is eliminated with any gain or loss on disposition recognized in earnings at that time. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). During the first quarter of 2024, the Company completed a review of the useful lives of its beverage machinery and equipment and buildings based on the Company’s experience with the duration over which equipment and buildings of its aluminum beverage can business can be utilized. The Company engaged a third-party appraiser to assist in this review and, as a result, effective January 1, 2024, the Company revised the estimated useful lives of its buildings up to 50 years, and machinery and equipment up to 23 years. The change in useful lives resulted in a net reduction in depreciation expense of approximately $64 or $0.40 per diluted share for the year ended December 31, 2024, respectively, as compared to the amount of depreciation expense that would have been recorded by utilizing the prior depreciable lives. Land improvements 25 Buildings and building improvements 25 – 50 Machinery and equipment 3– 23 Goodwill and Intangible Assets . Assets and liabilities of acquired businesses are recorded under the acquisition method of accounting at their estimated fair values at the dates of acquisition. Goodwill represents costs in excess of fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is carried at cost and reviewed for impairment annually in the fourth quarter of each year or when facts and circumstances indicate goodwill may be impaired. Goodwill is allocated to the reporting units at the time of each acquisition based on the relative fair values of the reporting units. In assessing goodwill for impairment, the Company may first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Further quantitative assessment may then be required. The quantitative assessment involves a number of assumptions and judgments, including the calculation of fair value for the Company’s identified reporting units. The Company determines the estimated fair value of each reporting unit based on an average of the estimated fair values using an income and a market approach. The income approach utilizes significant assumptions, including revenue and Adjusted EBITDA (a non-GAAP item defined by the Company as net customer sales, less cost of products sold excluding depreciation and amortization, less selling and administrative expenses) margin growth rates and discount rate. If the carrying value of a reporting unit exceeds its fair value, any impairment loss is measured by comparing the carrying value of the reporting unit to its fair value, not to exceed the carrying amount of goodwill. Finite-lived intangible assets are carried at cost less accumulated amortization. Finite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Customer relationships 10 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Impairment or Disposal of Long-Lived Assets . In the event that facts and circumstances indicate that the carrying value of long-lived assets, primarily PP&E and finite-lived intangible assets, may be impaired, the Company performs a recoverability evaluation. If the evaluation indicates that the carrying value of an asset group is not recoverable from its undiscounted cash flows, an impairment loss is measured by comparing the carrying value of the asset to its fair value, based on discounted cash flows. Long-lived assets classified as held for sale are presented in the balance sheet at the lower of their carrying value or fair value less cost to sell. Leases. The Company has operating and finance leases for land and buildings related to certain manufacturing facilities, warehouses and corporate offices, vehicle fleets and certain office and manufacturing equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company's lease terms include options to extend the lease when it is reasonably certain that the Company will exercise the option. Variable lease payment amounts that cannot be determined at commencement of the lease, such as increases in index rates, are not included in the measurement of the lease liabilities and corresponding right-of-use assets and are recognized in the period those payments are incurred. The Company separates lease and non-lease components of lease arrangements and allocates contract consideration based on standalone selling prices. Variable consideration is allocated to the lease and non-lease components to which the variable payments specifically relate. The discount rate implicit within the Company's leases is often not determinable and therefore the Company generally uses its incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of the lease payments. The incremental borrowing rate is determined based on lease term and the currency in which lease payments are made. The Company's leases do not contain any material residual value guarantees or material restrictive covenants. Taxes on Income . The provision for income taxes is determined using the asset and liability approach. Deferred taxes represent the future expected tax consequences of differences between the financial reporting and tax bases of assets and liabilities based upon enacted tax rates and laws. The Company has made an accounting policy election to treat taxes due on future U.S. inclusions of certain intangible income of foreign subsidiaries as a current period expense when incurred. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Investment tax credits are accounted for using the deferral method. Income tax-related interest and penalties are reported as income tax expense. Derivatives and Hedging . All outstanding derivative financial instruments are recognized in the balance sheet at their fair values. The impact on earnings from recognizing the fair values of these instruments depends on their intended use, their hedge designation and their effectiveness in offsetting changes in the fair values of the exposures they are hedging. Changes in the fair values of instruments designated to reduce or eliminate adverse fluctuations in the fair values of recognized assets and liabilities are reported currently in earnings along with changes in the fair values of the hedged items. Changes in the effective portions of the fair values of instruments used to reduce or eliminate adverse fluctuations in cash flows of anticipated or forecasted transactions are reported in equity as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified to earnings when the related hedged items impact earnings or the forecasted transactions become probable of not occurring. Changes in the fair values of derivative instruments that are not designated as hedges or do not qualify for hedge accounting treatment are reported currently in earnings. Amounts reported in earnings are classified consistent with the item being hedged. The effectiveness of derivative instruments in reducing risks associated with the hedged exposures is assessed at inception and on an ongoing basis. Time value, a component of an instrument’s fair value, is excluded in assessing effectiveness for fair value hedges, except hedges of firm commitments, and included for cash flow hedges. Hedge accounting is discontinued prospectively when (i) the instrument is no longer effective in offsetting changes in fair value or cash flows of the underlying hedged item, (ii) the instrument expires, is sold, terminated or exercised, or (iii) designating the instrument as a hedge is no longer appropriate. The Company formally documents all relationships between its hedging instruments and hedged items at inception, including its risk management objective and strategy for establishing various hedge relationships. Cash flows from hedging instruments are classified in the Consolidated Statements of Cash Flows consistent with the items being hedged. Research and Development . Research, development and engineering costs of $32 in 2024, $33 in 2023 and $34 in 2022, were expensed as incurred and reported in selling and administrative expense in the Consolidated Statements of Operations. Substantially all engineering and development costs are related to developing new products or designing significant improvements to existing products or processes. Costs primarily include employee salaries and benefits and facility costs. Reclassifications and Revisions. Certain reclassifications of prior years’ data have been made to conform to the current year presentation. In the first quarter of 2024, the Company corrected its presentation of certain borrowings and repayments of short-term debt that did not qualify for net presentation in our previously issued Consolidated Statements of Cash Flows. The Company now presents these borrowings and repayments of short-term debt on a gross basis within cash flows from financing activities. The Company determined that the corrections, which had no impact to cash flows (used for) provided by financing activities, were not material to any prior annual or interim periods and therefore, amendments of previously filed reports are not required. The effects of the revisions on each of the impacted financial statement line items within the Company's Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022 were as follows: Year Ended December 31, 2023 As Previously Reported Adjustments As Revised Net change in revolving credit facility and short-term debt $ (398) $ 2 $ (396) Proceeds from short-term debt — 129 129 Payments of short-term debt — (131) (131) Net cash provided by financing activities 116 — 116 Year Ended December 31, 2022 As Previously Reported Adjustments As Revised Net change in revolving credit facility and short-term debt $ 268 $ — $ 268 Proceeds from short-term debt — 45 45 Payments of short-term debt — (45) $ (45) Net cash used for financing activities (25) — (25) Recent Accounting and Reporting Pronouncements. Recently Adopted Accounting Standards In November 2023, the Financial Accounting Standards Board issued new guidance that requires incremental disclosures related to reportable segments. That standard requires disclosure, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of profit or loss. The title and position of the CODM and how the reported measure of segment profit or loss is used by the CODM to assess segment performance and allocate resources is also required to be disclosed. The standard also permits disclosure of additional measures of segment profit. The Company adopted the new guidance for the year ended December 31, 2024. Refer to Note Z . Recently Issued Accounting Standards In November 2024, the Financial Accounting Standards Board issued a final standard on disaggregation of income statement expenses. The standard requires disclosure of more detailed information about certain costs and expenses in the notes to the financial statements. The standard is effective for fiscal years beginning after December 15, 2026 and for interim periods beginning after December 15, 2027. Early adoption is permitted. The standard is applied prospectively with an option for retrospective adoption. The Company is currently evaluating the impact of adopting this standard on its disclosures.

Acquisitions and Divestitures

Acquisitions and Divestitures	12 Months Ended
	Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Acquisitions and Divestitures	Acquisitions and Divestitures In December 2024 KPS Capital Partners LP completed the sale of Eviosys, including the Company's approximate 20% ownership share. The Company received pre-tax proceeds of $338 and recorded a gain of $275 in the fourth quarter of 2024. The Company's share of Eviosys net earnings was a loss of $3 for the year ended December 31, 2024 and income of $9 and $34 for years ended December 31, 2023 and 2022 and is reported in Equity in net earnings of affiliates in the Consolidated Statements of Operations. The Company received distributions of $83 and $26 in the years ended December 31, 2023 and 2022. In October 2023, the Company completed its acquisition of Helvetia Packaging AG ("Helvetia"), a beverage can and end manufacturing facility in Saarlouis, Germany f or $126. The addition of Helvetia expanded the Company's European Beverage segment into Germany, adding capacity to serve growing demand for beverage cans . Assets acquired primarily included property, plant and equipment of $70 and customer relationship intangible assets of $14, with goodwill acquired of $44. Restructuring and other, net

Cash, Cash Equivalents, and Res

Cash, Cash Equivalents, and Restricted Cash	12 Months Ended
	Dec. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statements of Cash Flows were as follows: 2024 2023 Cash and cash equivalents $ 918 $ 1,310 Restricted cash included in prepaid expenses and other current assets 98 90 Total cash, cash equivalents and restricted cash $ 1,016 $ 1,400 Amounts included in restricted cash primarily represent amounts required to be segregated by certain of the Company's receivables securitization agreements.

Receivables

Receivables	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Receivables	Receivables 2024 2023 Accounts receivable $ 1,060 $ 1,122 Less: allowance for credit losses (30) (29) Net trade receivables 1,030 1,093 Unbilled receivables 316 338 Miscellaneous receivables 310 288 $ 1,656 $ 1,719 The Company uses receivables securitization and factoring facilities in the normal course of business as part of managing its cash flows. The Company accounts for transfers under these facilities as either sales or secured borrowings based on whether it has transferred control over the factored receivables. The Company’s continuing involvement in factored receivables accounted for as sales is limited to servicing the receivables. The Company receives adequate compensation for servicing the receivables and no servicing asset or liability is recorded.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories 2024 2023 Raw materials and supplies $ 965 $ 1,031 Work in process 106 139 Finished goods 369 443 $ 1,440 $ 1,613

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2024 and 2023 were as follows: Americas Beverage European Beverage Transit Packaging Other Total Balance at January 1, 2023 $ 850 $ 491 $ 1,428 $ 182 $ 2,951 Goodwill acquired — 37 — — 37 Foreign currency translation 71 22 35 1 129 Balance at December 31, 2023 921 550 1,463 183 3,117 Transfers and adjustments — 8 (3) 3 8 Foreign currency translation (94) (22) (50) (5) (171) Balance at December 31, 2024 $ 827 $ 536 $ 1,410 $ 181 $ 2,954 During the year-ended December 31, 2023, goodwill acquired was from the acquisition of Helvetia Packaging AG. See Note B for more information. The carrying amount of goodwill at December 31, 2024 and 2023 was net of the following accumulated impairments: Americas Beverage European Beverage Other Total Accumulated impairments $ 29 $ 73 $ 11 $ 113

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2024 December 31, 2023 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,342 $ (734) $ 608 $ 1,423 $ (670) $ 753 Trade names 522 (148) 374 539 (130) 409 Technology 153 (140) 13 159 (133) 26 Long term supply contracts 139 (92) 47 167 (99) 68 Patents 12 (10) 2 12 (10) 2 $ 2,168 $ (1,124) $ 1,044 $ 2,300 $ (1,042) $ 1,258 $14 of customer relationship intangible assets were acquired from the 2023 acquisition of Helvetia Packaging AG. See Note B for more information. Amortization expense for the years ended December 31, 2024, 2023, and 2022 was $151, $163 and $159. Annual amortization expense is estimated to be $147 for 2025, $138 for 2026, $135 for 2027, $134 for 2028 and $122 for 2029.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment 2024 2023 Buildings and improvements $ 1,898 $ 1,888 Machinery and equipment 5,940 6,153 Land and improvements 265 269 Construction in progress 469 589 8,572 8,899 Less: accumulated depreciation and amortization (3,645) (3,837) $ 4,927 $ 5,062

Leases

Leases	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Leases	Leases The components of lease expense for the years ended December 31, 2024, 2023 and 2022 were as follows: 2024 2023 2022 Operating lease costs: Operating lease cost $ 56 $ 54 $ 58 Short-term lease cost 2 2 2 Total operating lease costs $ 58 $ 56 $ 60 Finance lease cost: Amortization of right-of-use assets $ — $ 1 $ 1 Total finance lease costs $ — $ 1 $ 1 Variable operating lease cost was $4, $5, and $4 for the years ended December 31, 2024, 2023, and 2022. Interest on finance lease liabilities was less than $1 for each of the years ended December 31, 2024, 2023, and 2022. Supplemental cash flow information related to leases was as follows: 2024 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 55 $ 54 $ 53 Financing cash flows from finance leases 2 2 1 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 52 $ 36 $ 87 Supplemental balance sheet information related to finance leases was as follows: 2024 2023 Finance leases: Property, plant and equipment $ 19 $ 21 Accumulated depreciation (3) (3) Property, plant and equipment, net $ 16 $ 18 Accrued liabilities $ 1 $ 1 Other non-current liabilities 3 5 Total finance lease liabilities $ 4 $ 6 The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2024 2023 Weighted average remaining lease term (years): Operating leases 9.4 9.5 Finance leases 3.1 4.1 Weighted average discount rate: Operating leases 4.7 % 4.5 % Finance leases 2.7 % 3.5 % Maturities of lease liabilities as of December 31, 2024 were as follows: Operating Leases Finance Leases 2025 $ 49 $ 2 2026 42 1 2027 33 1 2028 27 — 2029 23 — Thereafter 97 — Total lease payments 271 4 Less imputed interest (57) — $ 214 $ 4 At December 31, 2024, the Company did not have material lease commitments that had not commenced.
Leases	Leases The components of lease expense for the years ended December 31, 2024, 2023 and 2022 were as follows: 2024 2023 2022 Operating lease costs: Operating lease cost $ 56 $ 54 $ 58 Short-term lease cost 2 2 2 Total operating lease costs $ 58 $ 56 $ 60 Finance lease cost: Amortization of right-of-use assets $ — $ 1 $ 1 Total finance lease costs $ — $ 1 $ 1 Variable operating lease cost was $4, $5, and $4 for the years ended December 31, 2024, 2023, and 2022. Interest on finance lease liabilities was less than $1 for each of the years ended December 31, 2024, 2023, and 2022. Supplemental cash flow information related to leases was as follows: 2024 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 55 $ 54 $ 53 Financing cash flows from finance leases 2 2 1 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 52 $ 36 $ 87 Supplemental balance sheet information related to finance leases was as follows: 2024 2023 Finance leases: Property, plant and equipment $ 19 $ 21 Accumulated depreciation (3) (3) Property, plant and equipment, net $ 16 $ 18 Accrued liabilities $ 1 $ 1 Other non-current liabilities 3 5 Total finance lease liabilities $ 4 $ 6 The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2024 2023 Weighted average remaining lease term (years): Operating leases 9.4 9.5 Finance leases 3.1 4.1 Weighted average discount rate: Operating leases 4.7 % 4.5 % Finance leases 2.7 % 3.5 % Maturities of lease liabilities as of December 31, 2024 were as follows: Operating Leases Finance Leases 2025 $ 49 $ 2 2026 42 1 2027 33 1 2028 27 — 2029 23 — Thereafter 97 — Total lease payments 271 4 Less imputed interest (57) — $ 214 $ 4 At December 31, 2024, the Company did not have material lease commitments that had not commenced.

Other Non-Current Assets

Other Non-Current Assets	12 Months Ended
	Dec. 31, 2024
Investments, All Other Investments [Abstract]
Other Non-Current Assets	Other Non-Current Assets 2024 2023 Deferred taxes $ 134 $ 132 Pension assets 88 94 Fair value of derivatives 86 47 Investments 22 87 Other 181 193 $ 511 $ 553 In March

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Accrued Liabilities	Accrued Liabilities 2024 2023 Salaries and employee benefits $ 170 $ 173 Income taxes 116 119 Accrued taxes, other than on income 76 85 Accrued interest 65 59 Pension and postretirement liabilities 32 25 Asbestos liabilities 20 20 Fair value of derivatives 14 20 Restructuring 13 22 Other 341 399 $ 847 $ 922

Supplier Finance Program Obliga

Supplier Finance Program Obligations	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Supplier Finance Program Obligations	Supplier Finance Program Obligations The Company has various supplier finance programs under which the Company agrees to pay banks the stated amount of confirmed invoices from its designated suppliers on the original maturity dates of the invoices. Suppliers, at their sole discretion, have the opportunity to sell their receivables due from the Company earlier than contracted payment terms. The Company or the banks may terminate the agreements upon at least 30 days' notice. The Company does not have assets pledged as collateral for supplier finance programs. The supplier invoices that have been confirmed as valid under the programs typically have payment terms of 150 days or less, consistent with the commercial terms and conditions as agreed upon with suppliers. Changes in the confirmed obligations outstanding under these supplier finance programs, included in Accounts Payable Balance at January 1, 2024 $ 862 Additions 2,107 Settlements (2,032) Foreign currency translation (10) Balance at December 31, 2024 $ 927

Restructuring and Other

Restructuring and Other	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other	Restructuring and Other The Company recorded restructuring and other items as follows: 2024 2023 2022 Restructuring $ 49 $ 23 $ 35 Asset impairments and sales 19 72 (106) Other costs 11 19 14 Asbestos (4) — 5 $ 75 $ 114 $ (52) 2024 Activity Restructuring charges of $49 primarily relates to other exit costs related to previously announced plant closures in the U.S, including the Batesville, Mississippi beverage can facility and the Decatur, Illinois aerosol plant and line consolidations and business reorganization activities in European Beverage. During the third quarter of 2024, the Company closed its food can plant in La Villa, Mexico and entered into an agreement to sell equipment for $30 to be paid in three annual installments, the first of which was received in 2024. The Company recognized a gain of $22 from sale of the equipment, included in asset impairments and sales above and recorded severance and other exit costs of $6 related to the plant closure, included in restructuring above. Asset impairments and sales also includes $20 for the planned closure of the Sihanoukville, Cambodia beverage can plant and $11 related to line consolidations at the Dong Nai, Vietnam beverage can plant. See Note P for more information on the Company's provision for asbestos. 2023 Activity During the fourth quarter of 2023, the Company made the decision to close various production facilities across various segments. Asset impairments and sales primarily includes, $19 for the planned closure of the Batesville, Mississippi beverage can plant, $8 related to a shift in capacity from beverage can plants in Ho Chi Minh City, Vietnam and Singapore to Vung Tau, Vietnam and $5 for the planned closure of the Decatur, Illinois aerosol plant. Asset impairments and sales also includes $19 related to line consolidation and modernization at the Dong Nai, Vietnam beverage can plant. Restructuring included termination benefits and other exit costs of $11 related to the actions described above. In addition, termination and other exit costs of $9 and $3 were recorded in the European Beverage and Other segments, respectively, related to line consolidation and business reorganization activities, including headcount reductions in the beverage can making equipment business. O ther costs includes $11 related to disputes, including a fine fro m the French Competition Authority, and $4 of tax indemnity charges related to the European Tinplate business sold in 2021. See Note Q for more information on the French Competition Authority matter. 2022 Activity Asset sales and impairments primarily relates to the $113 gain on sale of the Kiwiplan business. See Note B for more information on the sale. Restructuring included charges of $29 related to an overhead cost reduction program initiated by the Company's Transit Packaging segment that reduced headcount by approximately 600 employees. Restructuring charges by segment were as follows: 2024 2023 2022 Americas Beverage $ 11 $ 4 $ — European Beverage 17 9 — Asia Pacific 4 7 — Transit Packaging 4 (1) 35 Other 13 4 — $ 49 $ 23 $ 35 Restructuring charges by type were as follows: 2024 2023 2022 Termination benefits $ 15 $ 15 $ 29 Other exit costs 34 8 6 $ 49 $ 23 $ 35 At December 31, 2023, the Company had a restructuring accrual of $22, related to restructuring actions discussed above. During 2024, the Company made severance p ayments of $27 and had a restructuring accrual of $13 related to the actions referenced above. These amounts include payments of $6 related to the overhead cost reduction program initiated in 2022 in the Transit Packaging segment. The Company expects to pay the remaining

Debt

Debt	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Debt	Debt 2024 2023 Principal Carrying Principal Carrying outstanding amount outstanding amount Short-term debt $ 66 $ 66 $ 16 $ 16 Long-term debt Senior secured borrowings: Revolving credit facilities — — — — Term loan facilities U.S. dollar due 2027 1,175 1,171 1,575 1,569 Euro due 2027 1 538 538 589 589 Senior notes and debentures: €600 at 2.625% due 2024 — — 663 662 €600 at 3.375% due 2025 — — 663 662 U.S. dollar at 4.25% due 2026 400 399 400 398 U.S. dollar at 4.75% due 2026 875 873 875 871 U.S. dollar at 7.375% due 2026 350 350 350 350 €500 at 2.875% due 2026 518 517 552 550 €500 at 5.00% due 2028 518 513 552 544 €500 at 4.75% due 2029 518 513 552 544 €600 at 4.50% due 2030 621 611 — — U.S. dollar at 5.25% due 2030 500 495 500 494 U.S. dollar at 7.50% due 2096 40 40 40 40 Other indebtedness in various currencies: Fixed rate with rates in 2024 from 2.8% to 7.6% due through 2027 108 108 169 169 Variable rate with an average rate in 2024 of 3.6% due 2026 10 10 16 16 Total long-term debt 6,171 6,138 7,496 7,458 Less: current maturities (80) (80) (759) (759) Total long-term debt, less current maturities $ 6,091 $ 6,058 $ 6,737 $ 6,699 (1) €520 at December 31, 2024 and €533 at December 31, 2023 The estimated fair value of the Company’s debt, using a market approach incorporating level 2 inputs such as quoted market prices for the same or similar issues, was $6,255 at December 31, 2024 and $7,484 at December 31, 2023. In August 2024, the Company issued €600 principal amount of 4.50% senior unsecured notes due 2030 issued at par by its subsidiary Crown European Holdings S.A and used the proceeds to repay the €600 principal amount of 2.625% senior unsecured notes due September 2024. Additionally, in December 2024, the Company redeemed the €600 principal amount of 3.375% senior unsecured notes due May 2025 and made an early payment of $400 towards the U.S. dollar term loan facility due 2027. The revolving credit facilities include provisions for letters of credit up to $335 that reduce the amount of borrowing capacity otherwise available. At December 31, 2024, the Company’s available borrowing capacity under the credit facilities was $1,614 equal to the facilities’ aggregate capacity of $1,650 less $36 of outstanding letters of credit. The interest rates on the facilities can vary from SOFR or EURIBOR, with a floor of zero, plus a margin of up to 1.60%, depending on the facility, based on the Company's leverage ratio. The revolving credit facilities and term loan facilities required the Company to maintain a leverage ratio of no greater than 4.50 times at December 31, 2024. The leverage ratio is calculated as total net debt divided by Consolidated EBITDA (as defined in the credit agreement). Total net debt is defined in the credit agreement as total debt less cash and cash equivalents. Consolidated EBITDA is calculated as the sum of, among other things, net income attributable to Crown Holdings, net income attributable to certain of the Company's subsidiaries, income taxes, interest expense, depreciation and amortization, and certain non-cash charges. The Company was in compliance with all covenants as of December 31, 2024. At December 31, 2024, the U.S. dollar term loan interest rate was SOFR plus 1.10% and the Euro term loan interest rate was EURIBOR plus 1.00%. The weighted average interest rates were as follows: 2024 2023 2022 Short-term debt 4.3 % 13.2 % 3.8 % Revolving credit facilities 4.7 % 4.5 % 2.5 % Aggregate maturities of long-term debt, excluding unamortized discounts and debt issuance costs, for the five years subsequent to 2024 are $80, $2,225, $1,669, $518 and $518. Cash payments for interest during 2024, 2023 and 2022 were $367, $390, and $270.

Derivative and Other Financial

Derivative and Other Financial Instruments	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative and Other Financial Instruments	Derivative and Other Financial Instruments Fair Value Measurements Under U.S. GAAP a framework exists for measuring fair value, providing a three-tier hierarchy of pricing inputs used to report assets and liabilities that are adjusted to fair value. Level 1 includes inputs such as quoted prices which are available in active markets for identical assets or liabilities as of the report date. Level 2 includes inputs other than those available in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 includes unobservable pricing inputs that are not corroborated by market data or other objective sources. The Company has no recurring items valued using Level 3 inputs other than certain pension plan assets. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of assets and liabilities measured at fair value and their placement within the fair value hierarchy. The Company applies a market approach to value its commodity price hedge contracts. Prices from observable markets are used to develop the fair value of these financial instruments and they are reported under Level 2. The Company uses an income approach to value its foreign exchange forward contracts. These contracts are valued using a discounted cash flow model that calculates the present value of future cash flows under the terms of the contracts using market information as of the reporting date, such as foreign exchange spot and forward rates, and are reported under Level 2 of the fair value hierarchy. Fair value disclosures for financial assets and liabilities that were accounted for at fair value on a recurring basis are provided below. In addition, see Note N for fair value disclosures related to debt. Derivative Financial Instruments In the normal course of business the Company is subject to risk from adverse fluctuations in currency exchange rates, interest rates and commodity prices. The Company manages these risks through a program that includes the use of derivative financial instruments, primarily swaps and forwards. Counterparties to these contracts are major financial institutions. The Company is exposed to credit loss in the event of nonperformance by these counterparties. The Company does not use derivative instruments for trading or speculative purposes. The Company’s objective in managing exposure to market and interest rate risk is to limit the impact on earnings and cash flow. The extent to which the Company uses such instruments is dependent upon its access to these contracts in the financial markets and its success using other methods, such as netting exposures in the same currencies to mitigate foreign exchange risk, using sales agreements that permit the pass-through of commodity price and foreign exchange rate risk to customers and borrowing both fixed and floating debt instruments to manage interest rate risk. For derivative financial instruments accounted for in hedging relationships, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the manner in which effectiveness will be assessed. The Company formally assesses, both at inception and at least quarterly thereafter, whether the hedging relationships are effective in offsetting changes in fair value or cash flows of the related underlying exposures. When a forecasted transaction is reasonably possible, but not probable of occurring, the hedge no longer qualifies for hedge accounting and the change in fair value from the date of the last effectiveness test is recognized in earnings. Any gain or loss which has accumulated in other comprehensive income at the date of the last effectiveness test is reclassified into earnings at the same time of the underlying exposure or when the forecasted transaction becomes probable of not occurring. Cash Flow Hedges The Company designates certain derivative financial instruments as cash flow hedges. No components of the hedging instruments are excluded from the assessment of hedge effectiveness. Changes in fair value of outstanding derivatives accounted for as cash flow hedges are recorded in accumulated other comprehensive income until earnings are impacted by the hedged transaction. Classification of the gain or loss in the Consolidated Statements of Operations upon reclassification from accumulated other comprehensive income is the same as that of the underlying exposure. Contracts outstanding at December 31, 2024 mature between one The Company uses commodity forward contracts to hedge anticipated purchases of various commodities, primarily aluminum as well as natural gas and electricity, and these exposures are hedged by a central treasury unit. The Company also designates certain foreign exchange contracts as cash flow hedges of anticipated foreign currency denominated sales or purchases. The Company manages these risks at the operating unit level. Often, foreign currency risk is hedged together with the related commodity price risk. The Company may also use interest rate swaps to convert interest on floating rate debt to a fixed-rate. The following tables set forth financial information about the impact on other comprehensive income ("OCI"), accumulated other comprehensive income ("AOCI") and earnings from changes in the fair value related to derivative instruments designated as cash flow hedges. Amount of gain / (loss) recognized in AOCI Derivatives in cash flow hedges 2024 2023 Foreign exchange $ (1) $ (2) Commodities 6 (8) $ 5 $ (10) Amount of gain / (loss) reclassified from AOCI into income Derivatives in cash flow hedges 2024 2023 Affected line item in the Commodities $ (16) $ 9 Net sales Foreign exchange (1) — Cost of products sold, excluding depreciation and amortization Commodities 14 (38) Cost of products sold, excluding depreciation and amortization (3) (29) Income before income taxes and equity in net earnings of affiliates — 7 Provision for income taxes $ (3) $ (22) Net income For the year ending December 31, 2025, a net gain of $5 ($4, net of tax) is expected to be reclassified to earnings for commodity and foreign exchange contracts. No material amounts were reclassified during the years ended December 31, 2024 and 2023 in connection with anticipated transactions that were no longer considered probable. Fair Value Hedges and Contracts Not Designated as Hedges The Company may designate certain derivative financial instruments as fair value hedges of recognized foreign-denominated assets and liabilities, generally trade accounts receivable and payable and unrecognized firm commitments. The notional values and maturity dates of the derivative instruments coincide with those of the hedged items. Changes in fair value of the derivative financial instruments, excluding time value, are offset by changes in fair value of the related hedged items. For the years ended December 31, 2024, and December 31, 2023, the Company recorded a gain of $7 and loss of $12 from foreign exchange contracts designated as fair value hedges. These adjustments were reported within foreign exchange in the Consolidated Statements of Operations. Certain derivative financial instruments, including foreign exchange contracts related to intercompany debt, were not designated or did not qualify for hedge accounting; however, they are effective economic hedges as the changes in their fair value, except for time value, are offset by changes from re-measurement of the related hedged items. The Company’s primary use of these derivative instruments is to offset the earnings impact that fluctuations in foreign exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. Changes in fair value of these derivative instruments are immediately recognized in earnings as foreign exchange adjustments. The following table sets forth the impact on earnings from derivatives not designated as hedges. Pre-tax amount of gain / (loss) recognized in earnings Derivatives not designated as hedges 2024 2023 Affected line item in the Foreign exchange — (4) Cost of products sold, excluding depreciation and amortization Foreign exchange 15 (4) Foreign exchange $ 15 $ (8) Net Investment Hedges The Company designates certain debt and derivative instruments as net investment hedges to manage foreign currency risk relating to net investments in subsidiaries denominated in foreign currencies and reduce the variability in the functional currency equivalent cash flows. For the years ended December 31, 2024 and 2023, the Company recorded a gain of $84 ($63, net of tax) and a loss of $52 ($43, net of tax) in other comprehensive income for certain debt instruments that are designated as hedges of its net investment in a euro-based subsidiary. As of December 31, 2024 and December 31, 2023, cumulative gains of $133 ($131, net of tax) and $49 ($68, net of tax) were recognized in accumulated other comprehensive income related to these net investment hedges and the carrying amount of the hedging instrument was approximately €1,246 ($1,291) at December 31, 2024. The Company also has cross-currency swaps with an aggregate notional values of $875 designated as hedges of the Company's net investment in a euro-based subsidiary. These swaps mature in 2026 and reduced interest expense by $25 for the years ended December 31, 2024, 2023 and 2022. The following table sets forth financial information about the impact on accumulated other comprehensive income from changes in the fair value of these derivative instruments designated as net investment hedges. Amount of gain / (loss) recognized in AOCI Derivatives designated as net investment hedges 2024 2023 Foreign exchange $ 29 $ (33) Gains and losses representing components excluded from the assessment of effectiveness on derivatives designated as net investment hedges are recognized in accumulated other comprehensive income. Gains or losses on net investment hedges remain in accumulated other comprehensive income until disposal of the underlying assets. Fair Values of Derivative Financial Instruments and Valuation Hierarchy The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2024 and December 31, 2023, respectively. The fair value of these financial instruments were reported under Level 2 of the fair value hierarchy. Balance Sheet classification December 31, December 31, Balance Sheet classification December 31, December 31, Derivatives designated as hedging instruments Foreign exchange contracts cash flow Prepaid expenses and other current assets $ 2 $ 1 Accrued liabilities $ 4 $ 2 Foreign exchange contracts fair value Prepaid expenses and other current assets — — Accrued liabilities — 2 Commodities contracts cash flow Prepaid expenses and other current assets 10 13 Accrued liabilities 3 13 Net investment hedge Other non-current assets 86 47 Other non-current liabilities — — $ 98 $ 61 $ 7 $ 17 Derivatives not designated as hedging instruments Foreign exchange contracts Prepaid expenses and other current assets $ 4 $ 3 Accrued liabilities $ 7 $ 3 Total derivatives $ 102 $ 64 $ 14 $ 20 Fair Value Hedge Carrying Amounts Carrying amount of the hedged assets and liabilities Line item in the Balance Sheet in which the hedged item is included December 31, 2024 December 31, 2023 Cash and cash equivalents — 2 Receivables, net — 12 Accrued liabilities — 120 As of December 31, 2023, the cumulative amount of fair value hedging adjustments included in the carrying amount of the hedged assets and liabilities was a net gain of $2. Offsetting of Derivative Assets and Liabilities Certain derivative financial instruments are subject to agreements with counterparties similar to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments. In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2024 Derivative assets $ 102 $ 3 $ 99 Derivative liabilities 14 3 11 Balance at December 31, 2023 Derivative assets $ 64 $ 7 $ 57 Derivative liabilities 20 7 13 Notional Values of Outstanding Derivative Instruments The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets at December 31, 2024 and December 31, 2023 were: December 31, 2024 December 31, 2023 Derivatives designated as cash flow hedges: Foreign exchange $ 380 $ 75 Commodities 73 160 Derivatives designated as fair value hedges: Foreign exchange — 202 Derivatives designated as net investment hedges: Foreign exchange 875 875 Derivatives not designated as hedges: Foreign exchange 305 302

Asbestos-Related Liabilities

Asbestos-Related Liabilities	12 Months Ended
	Dec. 31, 2024
Movement in Liability for Asbestos and Environmental Claims [Abstract]
Asbestos-Related Liabilities	Asbestos-Related Liabilities Crown Cork & Seal Company, Inc. (“Crown Cork”) is one of many defendants in a substantial number of lawsuits filed throughout the U.S. by persons alleging bodily injury as a result of exposure to asbestos. These claims arose from the insulation operations of a U.S. company, the majority of whose stock Crown Cork purchased in 1963. Approximately ninety days after the stock purchase, this U.S. company sold its insulation assets and was later merged into Crown Cork. Prior to 1998, amounts paid to asbestos claimants were covered by a fund made available to Crown Cork under a 1985 settlement with carriers insuring Crown Cork through 1976, when Crown Cork became self-insured. The fund was depleted in 1998 and the Company has no remaining coverage for asbestos-related costs. The states of Alabama, Arizona, Arkansas, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Michigan, Mississippi, Nebraska, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, West Virginia, Wisconsin and Wyoming have enacted legislation that limits asbestos-related liabilities under state law of companies such as Crown Cork that allegedly incurred these liabilities because they are successors by corporate merger to companies that had been involved with asbestos. The legislation, which applies to future and, with the exception of Arkansas, Georgia, South Carolina, South Dakota, West Virginia and Wyoming, pending claims at the time of enactment, caps asbestos-related liabilities at the fair market value of the predecessor's total gross assets adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the total value of its predecessor's assets adjusted for inflation. Crown Cork has integrated the legislation into its claims defense strategy. The Company cautions, however, that the legislation may be challenged and there can be no assurance regarding the ultimate effect of the legislation on Crown Cork. In June 2003, the State of Texas enacted legislation that limits the asbestos-related liabilities in Texas courts of companies such as Crown Cork that allegedly incurred these liabilities because they are successors by corporate merger to companies that had been involved with asbestos. The Texas legislation, which applies to future and pending claims, caps asbestos-related liabilities at the total gross value of the predecessor’s assets adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the total adjusted value of its predecessor’s assets. In October 2010, the Texas Supreme Court reversed a lower court decision, Barbara Robinson v. Crown Cork & Seal Company, Inc., No. 14-04-00658-CV, Fourteenth Court of Appeals, Texas, which had upheld the dismissal of an asbestos-related case against Crown Cork. The Texas Supreme Court held that the Texas legislation was unconstitutional under the Texas Constitution when applied to asbestos-related claims pending against Crown Cork when the legislation was enacted in June of 2003. The Company believes that the decision of the Texas Supreme Court is limited to retroactive application of the Texas legislation to asbestos-related cases that were pending against Crown Cork in Texas on June 11, 2003 and therefore, in its accrual, continues to assign no value to claims filed after June 11, 2003. In December 2001, the Commonwealth of Pennsylvania enacted legislation that limits the asbestos-related liabilities of Pennsylvania corporations that are successors by corporate merger to companies involved with asbestos. The legislation limits the successor’s liability for asbestos to the acquired company’s asset value adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the acquired company’s adjusted asset value. In November 2004, the legislation was amended to address a Pennsylvania Supreme Court decision (Ieropoli v. AC&S Corporation, et. al., No. 117 EM 2002) which held that the statute violated the Pennsylvania Constitution due to retroactive application. The Company cautions that the limitations of the statute, as amended, are subject to litigation and may not be upheld. The Company further cautions that an adverse ruling in any litigation relating to the constitutionality or applicability to Crown Cork of one or more statutes that limits the asbestos-related liability of alleged defendants like Crown Cork could have a material impact on the Company. The Company's approximate claims activity for the years ended 2024, 2023 and 2022 was as follows: 2024 2023 2022 Beginning claims 58,500 57,500 57,000 New claims 1,400 1,500 1,500 Settlements or dismissals (600) (500) (1,000) Ending claims 59,300 58,500 57,500 For the years ended December 31, 2024, 2023, and 2022, the Company made cash payments of $15, $17, and $21 to settle asbestos claims and pay related legal and defense costs. In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes by year of exposure and state filed. As of December 31, 2024 and December 31, 2023, the Company's outstanding claims were: 2024 2023 Claimants alleging first exposure after 1964 18,000 18,000 Claimants alleging first exposure before or during 1964 filed in: Texas 13,000 13,000 Pennsylvania 1,300 1,500 Other states that have enacted asbestos legislation 6,000 6,000 Other states 21,000 20,000 Total claims outstanding 59,300 58,500 The outstanding claims in each period exclude approximately 19,000 inactive claims. Due to the passage of time, the Company considers it unlikely that the plaintiffs in these cases will pursue further action against the Company. The exclusion of these inactive claims had no effect on the calculation of the Company’s accrual as the claims were filed in states, as described above, where the Company’s liability is limited by statute. With respect to claimants alleging first exposure to asbestos before or during 1964, the Company does not include in its accrual any amounts for settlements in states where the Company’s liability is limited by statute except for certain pending claims in Texas as described earlier. With respect to post-1964 claims, regardless of the existence of asbestos legislation, the Company does not include in its accrual any amounts for settlement of these claims because of increased difficulty of establishing identification of relevant insulation products as the cause of injury. Given its settlement experience with post-1964 claims, the Company does not believe that an adverse ruling in the Texas or Pennsylvania asbestos litigation cases, or in any other state that has enacted asbestos legislation, would have a material impact on the Company with respect to such claims. As of December 31, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows: 2024 2023 2022 Total claims 27 % 25 % 24 % Pre-1965 claims in states without asbestos legislation 43 % 44 % 43 % Crown Cork has entered into arrangements with plaintiffs’ counsel in certain jurisdictions with respect to claims which are not yet filed, or asserted, against it. However, Crown Cork expects claims under these arrangements to be filed or asserted against Crown Cork in the future. The projected value of these claims is included in the Company’s estimated liability as of December 31, 2024. Approximately 82% of the claims outstanding at the end of 2024 were filed by plaintiffs who do not claim a specific amount of damages or claim a minimum amount as established by court rules relating to jurisdiction; approximately 15% were filed by plaintiffs who claim damages of less than $5; approximately 3% were filed by plaintiffs who claim damages from $5 to less than $100 (29% of whom claim damages less than $25) and 14 claims were filed by plaintiffs who claim damages in excess of $100. As of December 31, 2024, the Company’s accrual for pending and future asbestos-related claims and related legal costs was $185, including $141 for unasserted claims. The Company determines its accrual without limitation to a specified time period. It is reasonably possible that the actual loss could be in excess of the Company’s accrual. However, the Company is unable to estimate the reasonably possible loss in excess of its accrual due to uncertainty in the following assumptions that underlie the Company’s accrual and the possibility of losses in excess of such accrual: the amount of damages sought by the claimant, the Company and claimant’s willingness to negotiate a settlement, the terms of settlements of other defendants with asbestos-related liabilities, the bankruptcy filings of other defendants (which may result in additional claims and higher settlements for non-bankrupt defendants), the nature of pending and future claims (including the seriousness of alleged disease, whether claimants allege first exposure to asbestos before or during 1964 and the claimant’s ability to demonstrate the alleged link to Crown Cork), the volatility of the litigation environment, the defense strategies available to the Company, the level of future claims, the rate of receipt of claims, the jurisdiction in which claims are filed, and the effect of state asbestos legislation (including the validity and applicability of the Pennsylvania legislation to non-Pennsylvania jurisdictions, where the substantial majority of the Company’s asbestos cases are filed).

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	Commitments and Contingent Liabilities The Company, along with others in most cases, has been identified by the EPA or a comparable state environmental agency as a Potentially Responsible Party (“PRP”) at a number of sites and has recorded aggregate accruals of $12 for its share of estimated future remediation costs at these sites. The Company has been identified as having either directly or indirectly disposed of commercial or industrial waste at the sites subject to the accrual, and where appropriate and supported by available information, generally has agreed to be responsible for a percentage of future remediation costs based on an estimated volume of materials disposed in proportion to the total materials disposed at each site. The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites. The Company has also recorded aggregate accruals of $8 for remediation activities at various worldwide locations that are owned by the Company and for which the Company is not a member of a PRP group. Although the Company believes its accruals are adequate to cover its portion of future remediation costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flow. Any possible loss or range of potential loss that may be incurred in excess of the recorded accruals cannot be estimated. In March 2015, the Bundeskartellamt, or German Federal Cartel Office (“FCO”), conducted unannounced inspections of the premises of several metal packaging manufacturers, including a German subsidiary of the Company. The local court order authorizing the inspection cited FCO suspicions of anti-competitive agreements in the German market for the supply of metal packaging products. The Company conducted an internal investigation into the matter and discovered instances of inappropriate conduct by certain employees of German subsidiaries of the Company. The Company cooperated with the FCO and submitted a leniency application with the FCO which disclosed the findings of its internal investigation to date. In April 2018, the FCO discontinued its national investigation and referred the matter to the European Commission (the “Commission”). Following the referral, Commission officials conducted unannounced inspections of the premises of several metal packaging manufacturers, including Company subsidiaries in Germany, France and the U.K. The Company cooperated with the Commission and submitted a leniency application with the Commission with respect to the findings of its internal investigation in Germany. In July 2022, the Company reached a settlement with the Commission relating to the Commission’s investigation, pursuant to which the Company agreed to pay a fine in the amount of $8. Fining decisions based on settlements can be appealed under EU law and the Company sought annulment of the Commission’s fining decision on the basis that the referral of the case from the FCO to the Commission was unjustified. In October 2024, the General Court of the EU issued a judgment dismissing the Company’s appeal. In December 2024, the Company appealed the General Court’s judgment to the European Court of Justice. There can be no assurance regarding the outcome of such appeal. In March 2017, U.S. Customs and Border Protection (“CBP”) at the Port of Milwaukee issued a penalty notification alleging that certain of the Company’s subsidiaries intentionally misclassified the importation of certain goods into the U.S. during the period 2004 - 2009. CBP initially assessed a penalty of $18. The Company has acknowledged to CBP that the goods were misclassified and has paid all related duties, which CBP does not dispute. The Company has asserted that the misclassification was unintentional and disputes the penalty assessment by CBP. CBP has brought suit in the U.S. Court of International Trade seeking enforcement of the initial penalty against the Company. At the present time, based on the information available, the Company does not believe that a loss for the alleged intentional misclassification is probable. However, there can be no assurance that the Company will be successful in contesting the assessed penalty. On October 7, 2021, the French Autorité de la concurrence (the French Competition Authority or “FCA”) issued a statement of objections to 14 trade associations, one public entity and 101 legal entities from 28 corporate groups, including the Company, certain of its subsidiaries, other leading metal can manufacturers, certain can fillers and certain retailers in France. The FCA alleged violations of Articles 101 of the Treaty on the Functioning of the EU and L.420-1 of the French Commercial Code. The statement of objections alleges, among other things, anti-competitive behavior in connection with the removal of bisphenol-A from metal packaging in France. The removal of bisphenol-A was mandated by French legislation that went into effect in 2015. On December 29, 2023, the FCA issued a decision imposing a fine of €4 million on the Company. The Company intends to appeal the decision of the FCA and there can be no assurance regarding the outcome of such appeal. In June 2024, the Brazilian Federal Tax Authorities issued an assessment against the Company's Brazilian subsidiary in relation to the use of PIS and COFINS indirect tax credits arising from a favorable judicial decision received by the Company in 2019. The assessment disallowed credits of $42 taken by the Company for the years 2004 through 2015 when the PIS and COFINS indirect taxes were calculated by fixed rates and assessed interest and penalties. During the fourth quarter, the Company received an unfavorable ruling to their challenge filed at the admini strative level. The Company does not believe that a loss for this assessment is probable and plans to challenge the assessment at the judicial level. There can be no assurances that the Company will be successful in contesting the assessment. The Company and its subsidiaries are also subject to various other lawsuits and claims with respect to labor, environmental, securities, vendor and other matters arising out of the Company’s normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes that the ultimate liabilities resulting from such lawsuits and claims will not materially affect the Company’s consolidated earnings, financial position or cash flow. The Company has various commitments to purchase materials, supplies and utilities as part of the ordinary conduct of business. At times, the Company guarantees the obligations of subsidiaries under certain of these contracts and is liable for such arrangements only if the subsidiary fails to perform its obligations under the contract. The Company’s basic raw materials for its products are aluminum and steel, both of which are purchased from multiple sources. The Company is subject to fluctuations in the cost of these raw materials and has periodically adjusted its selling prices to reflect these movements. There can be no assurance, however, that the Company will be able to fully recover any increases or fluctuations in raw material costs from its customers. The Company also has commitments for standby letters of credit and for purchases of capital assets.

Other Non-Current Liabilities

Other Non-Current Liabilities	12 Months Ended
	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Other Non-Current Liabilities	Other Non-Current Liabilities 2024 2023 Deferred taxes $ 338 $ 338 Asbestos liabilities 165 184 Postemployment benefits 23 22 Income taxes payable 18 27 Environmental 12 12 Other 114 98 $ 670 $ 681 Income taxes payable includes unrecognized tax benefits as discussed in Note T .

Pension and Other Postretiremen

Pension and Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits Pensions. The Company sponsors various pension plans covering certain U.S. and non-U.S. employees, and participates in certain multi-employer pension plans. The benefits under the Company plans are based primarily on years of service and either the employees’ remuneration near retirement or a fixed dollar multiple. A measurement date of December 31 was used for all plans presented below. The components of pension expense were as follows: U.S. Plans 2024 2023 2022 Service cost $ 15 $ 13 $ 19 Interest cost 40 54 31 Expected return on plan assets (46) (60) (75) Settlements and curtailments 469 — 1 Amortization of actuarial loss 32 43 44 Amortization of prior service cost 1 1 1 Net periodic cost $ 511 $ 51 $ 21 Non-U.S. Plans 2024 2023 2022 Service cost $ 7 $ 7 $ 9 Interest cost 16 19 13 Expected return on plan assets (18) (22) (22) Settlements 44 — — Special termination benefits — 6 — Amortization of actuarial loss 2 3 5 Amortization of prior service credit — — (1) Net periodic cost $ 51 $ 13 $ 4 In the third quarter of 2024, the Company's Canadian and primary U.S. defined benefit pension plans (the "Canadian Plan" and the "U.S. Plans", respectively) entered into transactions to transfer a significant portion of their pension liabilities through the purchase of group annuity insurance contracts for the benefit of nearly all their respective retiree and deferred vested participants. The issuers of the group annuity insurance contracts fully guarantee and are solely responsible for paying each participant's future benefits in full. The Company used plan assets to settle $119 of Canadian Plan obligations and $740 of U.S. Plans obligations and recorded settlement charges of $47 and $469, respectively, for the Canadian and U.S. Plans. As part of the transaction, the Company also made a cash contribution of approximately $100 to the U.S. Plans. In addition in 2024, $35 of U.S. plan obligations were settled as a result of certain retiree and deferred vested participants electing lump-sum distributions. Additional pension expense of $6 in 2024 and 2023 and $5 for 2022 was recognized for multi-employer plans. The projected benefit obligations, accumulated benefit obligations, plan assets and funded status of the Company's U.S. and non-U.S. plans were as follows: U.S. Plans Non-U.S. Plans 2024 2023 2024 2023 Projected Benefit Obligations Benefit obligations at January 1 $ 1,109 $ 1,094 $ 415 $ 387 Service cost 15 13 7 7 Interest cost 40 54 16 19 Plan participants' contributions — — 2 2 Amendments — 1 — (2) Settlements (775) — (122) (8) Special termination benefits — — — 6 Actuarial (gain) / loss (15) 36 (7) 18 Benefits paid (75) (89) (22) (38) Foreign currency translation — — (31) 24 Benefit obligations at December 31 $ 299 $ 1,109 $ 258 $ 415 Plan Assets Fair value of plan assets at January 1 $ 880 $ 886 $ 412 $ 381 Actual gain on plan assets 40 81 27 33 Employer contributions / (withdrawals) 125 2 (12) 17 Plan participants' contributions — — 1 2 Settlements (775) — (122) (7) Benefits paid (75) (89) (22) (38) Foreign currency translation — — (30) 24 Fair value of plan assets at December 31 $ 195 $ 880 $ 254 $ 412 Funded status $ (104) $ (229) $ (4) $ (3) Accumulated benefit obligations at December 31 $ 257 $ 1,065 $ 229 $ 389 During 2024, actuarial gains for the Company’s U.S. and non-U.S. pension plans total ed $25. Actua rial gains and losses arise each year primarily due to changes in discount rates, differences in actual plan asset returns compared to expected returns, and changes in actuarial assumptions such as mortality. The gain in 2024 was primarily due to higher discount rates at the end of 2024 compared to 2023. U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 93 $ 1,109 Accumulated benefit obligations 88 1,065 Fair value of plan assets — 880 U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 296 $ 1,109 Accumulated benefit obligations 255 1,065 Fair value of plan assets 192 880 Non-U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 199 $ 213 Accumulated benefit obligations 179 195 Fair value of plan assets 114 117 The Company’s investment strategy in its U.S. plan is designed to generate returns that are consistent with providing benefits to plan participants within the risk tolerance of the plan. Asset allocation is the primary determinant of return levels and investment risk exposure. The strategic ranges for asset allocation in the U.S. plans are as follows: U.S. equities 45 % to 55 % International equities 7.5 % to 12.5 % Fixed income 15 % to 25 % Balanced funds 7.5 % to 12.5 % Real estate 7.5 % to 12.5 % Subsequent to the annuitization of a portion of the U.S Plans liabilities discussed above, the U.S. Plans’ asset allocation will be migrating to the above target ranges. That migration will be staged over time and allow Crown to manage liquidity requirements and minimize transaction fees. Pension assets are classified into three levels. Level 1 asset values are derived from quoted prices which are available in active markets as of the report date. Level 2 asset values are derived from other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the report date. Level 3 asset values are derived from unobservable pricing inputs that are not corroborated by market data or other objective sources. Level 1 Investments Equity securities are valued at the latest quoted prices taken from the primary exchange on which the security trades. Mutual funds are valued at the net asset value ("NAV") of shares held at year-end. Level 2 Investments Fixed income securities, including government issued debt, corporate debt, asset-backed and structured debt securities are valued using the latest bid prices or valuations based on a matrix system (which considers such factors as benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and other reference data including market research publications). Derivatives, which consist mainly of interest rate swaps, are valued using a discounted cash flow pricing model based on observable market data. Level 3 Investments Hedge funds and private equity funds are valued at the NAV at year-end. The values assigned to private equity funds are based upon assessments of each underlying investment, incorporating valuations that consider the evaluation of financing and sale transactions with third parties, expected cash flows and market-based information, including comparable transactions, and performance multiples among other factors. Real estate investments are based on third party appraisals. Investments Measured Using NAV per Share Practical Expedient Investments measured using NAV per share as a practical expedient include investment funds that invest in global equity, emerging markets and fixed income. The global equity funds invest in equity securities of various market sectors including industrial materials, consumer discretionary goods and services, financial infrastructure, technology, and health care. The emerging markets funds invest in equity markets within financial services, consumer goods and services, energy, and technology. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair value. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in different fair value measurements at the reporting date. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and their placement within the fair value hierarchy. The levels assigned to the defined benefit plan assets as of December 31, 2024 and 2023 are summarized in the tables below: 2024 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 8 $ 28 $ 36 Global large cap equity — 8 8 U.S. large cap equity — 10 10 Mutual funds – U.S. equity 51 — 51 59 46 105 Level 2 Government issued debt securities — 18 18 Corporate debt securities — 6 6 Insurance contracts — 102 102 Investment funds – fixed income — 1 1 — 127 127 Level 3 Investment funds – real estate 106 28 134 Private equity 2 — 2 Real estate – direct 28 8 36 136 36 172 Total assets in fair value hierarchy 195 209 404 Investments measured at NAV Practical Expedient (a) Investment funds - fixed income — 25 25 Investment funds - global equity — 20 20 — 45 45 Total investments at fair value $ 195 $ 254 $ 449 2023 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 15 $ 23 $ 38 Global large cap equity — 3 3 U.S. large cap equity 173 4 177 U.S. mid/small cap equity 276 21 297 Mutual funds – global equity 59 — 59 Mutual funds – U.S. equity 49 — 49 Mutual funds – fixed income 18 — 18 590 51 641 Level 2 Government issued debt securities — 18 18 Corporate debt securities 41 8 49 Insurance contracts — 110 110 Investment funds – fixed income — 1 1 41 137 178 Level 3 Investment funds – real estate 127 60 187 Private equity 3 — 3 Real estate – direct 27 17 44 157 77 234 Total assets in fair value hierarchy 788 265 1,053 Investments measured at NAV Practical Expedient (a) Investment funds - fixed income 86 22 108 Investment funds - global equity — 118 118 Investment funds - emerging markets 5 — 5 Investments funds - real estate — 7 7 91 147 238 Total investments at fair value $ 879 $ 412 $ 1,291 (a) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Accrued income excluded from the tables above was as follows: 2024 2023 U.S. plan assets $ — $ 1 Plan assets as of December 31, 2023, include $297 of the Company’s common stock. The following tables reconcile the beginning and ending balances of plan assets measured using significant unobservable inputs (Level 3). Private Real Total Balance at January 1, 2023 $ 5 $ 247 $ 252 Foreign currency translation — 2 2 Asset returns – assets held at reporting date 18 (24) (6) Asset returns – assets sold during the period (18) 11 (7) Purchases, sales and settlements, net (2) (5) (7) Balance at December 31, 2023 3 231 234 Foreign currency translation — (4) (4) Asset returns – assets held at reporting date 3 (6) (3) Asset returns – assets sold during the period (4) 2 (2) Purchases, sales and settlements, net — (53) (53) Balance at December 31, 2024 $ 2 $ 170 $ 172 The following table presents additional information about the pension plan assets valued using NAV as a practical expedient: Fair Value Redemption Frequency Redemption Notice Period Balance at December 31, 2024 Investment funds – fixed income $ 25 Daily 10 days Investment funds – global equity 20 Daily 10 days Balance at December 31, 2023 Investment funds – fixed income $ 108 Semi-monthly 1- 5 days Investment funds – global equity 118 Daily 10 days Investment funds – emerging markets 5 Daily 30 days Investment funds – real estate 7 Daily 10 days The pension plan assets valued using NAV as a practical expedient do not have any unfunded commitments. Pension assets and liabilities included in the Consolidated Balance Sheets were: 2024 2023 Non-current assets $ 88 $ 94 Current liabilities 22 12 Non-current liabilities 174 314 The Company’s current liability at December 31, 2024, represents the expected required payments to be made for unfunded plans over the next twelve months. Total estimated 2025 employer contributions are $20 for the Company’s pension plans. Changes in the net loss and prior service credit for the Company’s pension plans were: 2024 2023 2022 Net loss Prior Net loss Prior Net loss Prior Balance at January 1 $ 686 $ (1) $ 712 $ — $ 814 $ 2 Reclassification to net periodic benefit cost (551) (1) (46) (1) (49) (1) Current year (gain) / loss (25) — 22 — (45) (1) Amendments — — (1) — — — Foreign currency translation (1) — (1) — (8) — Balance at December 31 $ 109 $ (2) $ 686 $ (1) $ 712 $ — Expected future benefit payments as of December 31, 2024 are: U.S. Non-U.S. 2025 $ 17 $ 20 2026 16 17 2027 33 16 2028 11 19 2029 13 19 2030 - 2034 90 102 The weighted average actuarial assumptions used to calculate the benefit obligations at December 31 were: U.S. Plans 2024 2023 2022 Discount rate 5.9 % 5.0 % 5.2 % Compensation increase 5.0 % 5.0 % 5.0 % Non-U.S. Plans 2024 2023 2022 Discount rate 5.1 % 4.8 % 4.9 % Compensation increase 2.8 % 2.9 % 2.7 % The weighted average actuarial assumptions used to calculate pension expense for each year were: U.S. Plans 2024 2023 2022 Discount rate - service cost 5.2 % 5.4 % 3.3 % Discount rate - interest cost 4.9 % 5.1 % 2.2 % Compensation increase 5.0 % 5.0 % 4.7 % Long-term rate of return 7.2 % 7.2 % 6.6 % Non-U.S. Plans 2024 2023 2022 Discount rate - service cost 4.7 % 5.0 % 2.9 % Discount rate - interest cost 4.7 % 5.1 % 2.6 % Compensation increase 2.9 % 2.9 % 2.7 % Long-term rate of return 4.2 % 5.1 % 4.3 % The expected long-term rate of return on plan assets is determined by taking into consideration expected long-term returns associated with each major asset class based on long-term historical ranges, inflation assumptions and the expected net value from active management of the assets based on actual results. Other Postretirement Benefit Plans. The Company sponsors unfunded plans to provide health care and life insurance benefits to certain retirees and survivors. Generally, the medical plans pay a stated percentage of medical expenses reduced by deductibles and other coverages. Life insurance benefits are generally provided by insurance contracts. The Company reserves the right, subject to existing agreements, to change, modify or discontinue the plans. A measurement date of December 31 was used for the plans presented below. The components of net postretirement benefits cost were as follows: Other Postretirement Benefits 2024 2023 2022 Service cost $ — $ — $ 1 Interest cost 6 6 4 Amortization of prior service credit — — (20) Amortization of actuarial loss — — 2 Net periodic benefit cost / (credit) $ 6 $ 6 $ (13) Changes in the benefit obligations were: 2024 2023 Benefit obligations at January 1 $ 107 $ 108 Interest cost 6 6 Actuarial (gain) / loss (2) — Benefits paid (9) (11) Foreign currency translation (6) 4 Benefit obligations at December 31 $ 96 $ 107 Changes in the net (gain) / loss and prior service credit for the Company’s postretirement benefit plans were: 2024 2023 2022 Net gain Prior Net gain Prior Net Prior Balance at January 1 $ (3) $ — $ (2) $ — $ 21 $ (20) Reclassification to net periodic benefit cost — — — — (2) 20 Current year (gain) / loss (3) — — — (22) — Foreign currency translation 1 — (1) — 1 — Balance at December 31 $ (5) $ — $ (3) $ — $ (2) $ — Expected future benefit payments are as follows: Benefit Payments 2025 $ 12 2026 10 2027 10 2028 9 2029 9 2030 - 2034 39 The assumed health care cost trend rates at December 31, 2024 were as follows: Health care cost trend rate assumed for 2024 5.9 % Rate that the cost trend rate gradually declines to 4.1 % Year that the rate reaches the rate it is assumed to remain 2032 Weighted average discount rates used to calculate the benefit obligations at the end of each year and the cost for each year are presented below: 2024 2023 2022 Benefit obligations 6.5 % 5.0 % 5.8 % Service cost 8.1 % 5.3 % 7.8 % Interest cost 5.8 % 4.9 % 5.7 % Defined Contribution Benefit Plans.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of income before income taxes were as follows: 2024 2023 2022 U.S. $ (448) $ (1) $ 295 Foreign 1,191 796 761 $ 743 $ 795 $ 1,056 The provision for income taxes consisted of the following: 2024 2023 2022 Current tax: U.S. federal $ 89 $ 31 $ 18 State and foreign 262 244 190 $ 351 $ 275 $ 208 Deferred tax: U.S. federal $ (109) $ (27) $ 46 State and foreign (59) (26) (11) (168) (53) 35 Total $ 183 $ 222 $ 243 The provision for income taxes differs from the amount of income tax determined by applying the U.S. statutory federal income tax rate to pre-tax income as a result of the following items: 2024 2023 2022 U.S. statutory rate at 21% $ 156 $ 167 $ 222 Statutory tax rate differences (17) 6 9 Taxes on foreign income (30) 1 (39) Foreign withholding taxes 19 23 5 U.S. taxes on foreign income, net of credits 67 5 1 State taxes (12) 2 (2) Valuation allowance changes (17) 5 33 Tax contingencies 6 2 7 Tax law changes 5 8 2 Other items, net 6 3 5 Income tax provision $ 183 $ 222 $ 243 The Company benefits from certain incentives in Brazil which allow it to pay reduced income taxes. The incentives expire at various dates beginning in December 2026. These incentives increased net income attributable to the Company by $22 in 2024,$20 in 2023 and $21 in 2022. In the fourth quarter of 2024, the Company recorded a gain of $275 related to the $338 distribution from the sale of the Eviosys equity method investment by KPS Capital Partners. The tax charge of $64 is included in U.S. taxes on foreign income, net of credits, as a portion of the distribution was taxable in the U.S. The distribution was non-taxable in Switzerland, and is shown as a reduction of taxes on foreign income above. In 2022, taxes on foreign income includes income tax charges of $11 for the sale of the Company's Transit Packaging segment's Kiwiplan business in 2022. During the year-ended December 31, 2022, the Company recorded a deferred tax asset of $21 for goodwill amortization and net operating loss carryforwards in Switzerland and established a full valuation allowance for these deferred tax assets as it was more likely than not that the deferred tax assets would not be utilized prior to their expiration. During the year-ended December 31, 2024, the Company recognized a deferred tax benefit of $17 resulting from the release of this valuation allowance due to improved profitability and continued forecasted income in Switzerland. On July 8, 2022, Pennsylvania enacted a corporate net income tax rate reduction over a nine year period. The income tax rate for the 2022 and 2023 tax years were 9.99% and 8.99%, respectively. Starting with the 2024 tax year, the income tax rate is reduced by 0.50% annually until it reaches 4.99% for the 2031 tax year. The remeasurement of the Company's deferred taxes in 2022 had a $78 impact on the Company's state net operating loss carryforward and corresponding valuation allowance. As of December 31, 2024, the Company had not provided deferred taxes on approximately $1,100 of earnings in certain non-U.S. subsidiaries because such earnings are indefinitely reinvested in its international operations. Upon distribution of such earnings in the form of dividends or otherwise, the Company may be subject to incremental foreign tax. It is not practicable to estimate the amount of foreign tax that might be payable. The Company paid tax es of $398 , $262 and $223, respectively, in 2024, 2023 and 2022. The components of deferred taxes at December 31 were: 2024 2023 Assets Liabilities Assets Liabilities Tax carryforwards $ 251 $ — $ 274 $ — Disallowed interest carryforwards 105 — 54 — Intangible assets — 260 — 292 Property, plant and equipment 14 257 16 253 Accruals and other 126 129 123 94 Pensions 48 21 90 20 Asbestos 46 — 50 — Postretirement and postemployment benefits 23 — 23 — Lease liabilities 32 — 32 — Right of use assets — 30 — 31 Valuation allowances (152) — (178) — Total $ 493 $ 697 $ 484 $ 690 Tax carryforwards expire as follows: Year Amount 2025 $ 13 2026 12 2027 7 2028 2 2029 10 Thereafter 77 Unlimited 130 Tax carryforwards expiring after 2029 include $48 of U.S. state tax loss carryforwards. The unlimited category includes $76 of French tax loss carryforwards and $25 of Luxembourg tax loss carryforwards. In addition, the Company has disallowed interest in the U.S. which can be carried forward indefinitely. The Company’s valuation allowances at December 31, 2024 include $72 related to the portion of U.S. state tax loss carryforwards that the Company does not believe are more likely than not to be utilized prior to their expiration. The Company’s ability to utilize state tax loss carryforwards is impacted by several factors including taxable income, expiration dates, limitations imposed by certain states on the amount of loss carryforwards that can be used in a given year to offset taxable income and whether the state permits the Company to file a combined return. In addition, the Company's valuation allowances at December 31, 2024 includes $62 related to tax loss carryforwards in France. Management’s estimate of the appropriate valuation allowance in any jurisdiction involves a number of assumptions and judgments, including the amount and timing of future taxable income. Should future results differ from management’s estimates, it is possible there could be future adjustments to the valuation allowances that would result in an increase or decrease in tax expense in the period such changes in estimates are made. A reconciliation of unrecognized tax benefits follows: 2024 2023 2022 Balance at January 1 $ 46 $ 46 $ 48 Additions for prior year tax positions 10 6 7 Reductions to prior period tax positions (4) — — Lapse of statute of limitations (4) (4) (1) Settlements (2) (2) (6) Foreign currency translation — — (2) Balance at December 31 $ 46 $ 46 $ 46 The Company’s unrecognized tax benefits include potential liabilities related to transfer pricing, foreign withholding taxes, and non-deductibility of expenses. The total interest and penalties recorded in income tax expense was $2 in 2024 and 2023 and less than $1 in 2022. As of December 31, 2024, unrecognized tax benefits of $46, if recognized, would affect the Company's effective tax rate. The Company’s unrecognized tax benefits are not expected to increase over the next twelve months and are expected to decrease as open tax years lapse or claims are settled. The Company is unable to estimate a range of reasonably possible changes in its unrecognized tax benefits in the next twelve months as it is unable to predict when, or if, the tax authorities will commence their audits, the time needed for the audits, and the audit findings that will require settlement with the applicable tax authorities, if any. The tax years that remained subject to examination by major tax jurisdictions as of December 31, 2024 were, 2010 and subsequent years for Germany; 2013 and subsequent years for India and Cambodia; 2015 and subsequent years for Thailand; 2016 and subsequent years for Vietnam; 2018 and subsequent years for Italy; 2019 and subsequent years for Mexico, Greece, Luxembourg and Netherlands; 2020 and subsequent years for Canada, Spain, Turkey, Brazil and Singapore; 2021 and subsequent years for the U.S., U.K. and France.; 2022 and subsequent years for Switzerland and Belgium. The U.S. also remains subject to exam for 2018, specifically as it relates to the transition tax incurred related to the 2017 Tax Act. In addition, tax authorities in certain jurisdictions , including France

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Capital Stock	Capital Stock A summary of common share activity for the years ended December 31 follows (in shares): 2024 2023 2022 Common shares outstanding at January 1 120,644,313 119,945,302 126,131,799 Shares repurchased (2,470,604) (143,736) (6,574,610) Restricted stock issued to employees, net of forfeitures 313,136 820,343 370,178 Shares issued to non-employee directors 16,786 22,404 17,935 Common shares outstanding at December 31 118,503,631 120,644,313 119,945,302 The Company declared and paid dividends of $1.00, $0.96 and $0.88 per share in 2024, 2023 and 2022, respectively. Additionally, on February 27, 2025, the Company's Board of Directors declared a dividend of $0.26 per share payable on April 1, 2025, to shareholders of record as of March 18, 2025. On July 25, 2024, the Company's Board of Directors authorized the repurchase of an aggregate amount of $2,000 of the Company's common stock through the end of 2027. The new authorization supersedes the previous authorization announced in December 2021, which authorized the repurchase of an aggregate amount of $3,000 of Company common stock through the end of 2024. Share repurchases under the Company's program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The Company uses the par value method of accounting for its stock repurchases. The excess of the fair value over par value is first charged to paid-in capital, if any, and then to retained earnings. The Company repurchased $217 of its shares during 2024. The Company is not obligated to acquire any shares of its common stock and the share repurchase program may be suspended or terminated at any time at the Company's discretion. Share repurchases are subject to the terms of the Company's debt agreements, market conditions and other factors. The Board of Directors has the authority to issue, at any time or from time to time, up to 30 million shares of preferred stock and has authority to fix the designations, number and voting rights, preferences, privileges, limitations, restrictions, conversion rights and other special or relative rights, if any, of any class or series of any class of preferred stock that may be desired, provided the shares of any such class or series of preferred stock shall not be entitled to more than one vote per share when voting as a class with holders of the Company's common stock. Dividends are payable when declared by the Company's Board of Directors and in accordance with the restrictions set forth in the Company's debt agreements. While the Company's debt agreements impose restrictions on the Company's ability to pay dividends and repurchase common stock, the debt agreements generally permit dividends and common stock repurchases provided that the Company is in compliance with applicable financial and other covenants and meets certain liquidity requirements.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss Attributable to Crown Holdings	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss Attributable to Crown Holdings	Accumulated Other Comprehensive Loss Attributable to Crown Holdings The following table provides information about the changes in each component of accumulated other comprehensive loss for the years ended December 31, 2024 and 2023. Defined benefit plans Foreign currency translation Cash flow hedges Total Balance at January 1, 2023 $ (686) $ (1,197) $ (9) $ (1,892) Other comprehensive income / (loss) before reclassifications (14) 175 (14) 147 Amounts reclassified from accumulated other comprehensive income 36 — 22 58 Other comprehensive income 22 175 8 205 Balance at December 31, 2023 (664) (1,022) (1) (1,687) Other comprehensive income / (loss) before reclassifications 21 (213) 5 (187) Amounts reclassified from accumulated other comprehensive income 413 (1) — 412 Other comprehensive income / (loss) 434 (214) 5 225 Balance at December 31, 2024 $ (230) $ (1,236) $ 4 $ (1,462) See Note O and Note S

Revenue

Revenue	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Revenue For the years ended December 31, 2024, 2023 and 2022, the Company recognized revenue as follows: 2024 2023 2022 Revenue recognized over time $ 6,632 $ 6,472 $ 6,937 Revenue recognized at a point in time 5,169 5,538 6,006 Total $ 11,801 $ 12,010 $ 12,943 See Note Z for further disaggregation of the Company's revenue. The Company has applied the practical expedient to exclude disclosure of remaining performance obligations as its binding orders typically have a term of one year or less. Contract assets are typically recognized for work in process related to the Company's three-piece printed products and equipment business. Contract assets and liabilities are reported in a net position on a contract-by-contract basis. The Company had net contract assets of $9 and $8, respectively, as of December 31, 2024 and 2023 included in prepaid and other current assets. For the year ended December 31, 2024, the Company satisfied performance obligations related to contract assets at December 31, 2023 and also recorded new contract assets primarily related to work in process for the equipment business.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company’s shareholder-approved stock-based incentive compensation plans provide for the granting of awards in the form of stock options, deferred stock, restricted stock or stock appreciation rights (“SARs”). The awards may be subject to the achievement of certain performance goals as determined by the Compensation Committee designated by the Company’s Board of Directors. There have been no awards of SARs. In April 2022, the Company's shareholders approved the 2022 Stock-Based Incentive Plan which allowed for a total of 2.8 million shares to be issued under future awards. At December 31, 2024, there were 3.4 million authorized shares available for future awards under the 2013 and 2022 Stock-Based Incentive Plan. Restricted and Deferred Stock Annually, the Company awards shares of restricted stock to certain senior executives in the form of time-vesting restricted stock and performance-based shares. The time-vesting restricted stock vests ratably over three years. The performance-based share awards are subject to either a market condition or a performance condition. For awards subject to a market condition, the metric is the Company’s Total Shareholder Return (“TSR”), which includes share price appreciation and dividends paid, during the three-year term of the award measured against the TSR of a peer group of companies. For awards subject to a performance condition, the metric is the Company's average return on invested capital over the three-year term. The performance-based shares cliff vest at the end of three years. The number of performance-based shares that will ultimately vest is based on the level of performance achieved, ranging between 0% and 200% of the shares originally awarded, and is settled in shares of common stock. Participants who terminate employment because of disability, death or, subject to Company approval, retirement, receive accelerated vesting of their service condition to the date of termination and, if approved, performance restrictions laps on the original vesting date. The Company also issues shares of time-vesting restricted stock to U.S. employees and deferred stock to non-U.S. employees which vest ratably over three A summary of restricted and deferred stock activity follows: Number of shares Non-vested shares outstanding at January 1, 2024 1,444,712 Awarded: Time-vesting 240,680 Performance-based 166,380 Released: Time-vesting (284,127) Performance-based (103,993) Forfeitures: Time-vesting (112,020) Performance-based (21,355) Non-vested shares outstanding at December 31, 2024 1,330,277 The average grant-date fair value of restricted stock awarded in 2024, 2023 and 2022 follows: 2024 2023 2022 Time-vesting $ 80.21 $ 87.66 $ 96.29 Performance-based 89.57 86.10 111.84 The fair values of the performance-based awards that include a market condition were calculated using a Monte Carlo valuation model and the following weighted average assumptions: 2024 2023 2022 Risk-free interest rate 4.0 % 4.1 % 1.0 % Expected term (years) 3 3 3 Expected stock price volatility 31.4 % 39.8 % 34.8 % At December 31, 2024, unrecognized compensation cost related to outstanding restricted and deferred stock was $76. The weighted average period over which the expense is expected to be recognized is 2.7 years. The aggregate market value of the shares released on the vesting dates was $33 in 2024.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table summarizes basic and diluted earnings per share ("EPS"). Basic EPS excludes all potentially dilutive securities and is computed by dividing net income attributable to Crown Holdings by the weighted average number of common shares outstanding during the period. Diluted EPS includes the effect of restricted stock, when dilutive, as calculated under the treasury stock method. 2024 2023 2022 Net income attributable to Crown Holdings $ 424 $ 450 $ 727 Weighted average shares outstanding: Basic 119.20 119.41 120.86 Add: dilutive restricted stock 0.23 0.26 0.52 Diluted 119.43 119.67 121.38 Basic earnings per share $ 3.56 $ 3.77 $ 6.01 Diluted earnings per share $ 3.55 $ 3.76 $ 5.99 Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive 0.8 0.2 0.7

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information The Company’s business is generally organized by product line and geography. The Company has determined that it has the following reportable segments: Americas Beverage, European Beverage, Asia Pacific and Transit Packaging. Other includes the Company's food can, aerosol can and closures businesses in North America, and beverage tooling and equipment operations in the U.S. and U.K. The Company's chief operating decision maker ("CODM") is the Chairman of the Board, President and Chief Executive Officer. Segment income is used by the CODM to allocate resources, including capital expenditures, and to evaluate operating performance against budgets and forecasts. Segment income, which is not a defined term under GAAP, is defined by the Company as income from operations adjusted to exclude intangi bles amortization charges, restructuring and other and the impact of fair value adjustments related to inventory acquired in an acquisition. Segment income includes cost of products sold, depreciation and general selling and administrative expenses. Segment income should not be considered in isolation or as a substitute for net income data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies. The tables below present information about operating segments for the three years ended December 31, 2024, 2023 and 2022: 2024 Inter- External segment Capital Segment sales sales Depreciation expenditures income Americas Beverage $ 5,240 $ — $ 128 $ 164 $ 987 European Beverage 2,071 — 55 133 276 Asia Pacific 1,161 — 46 21 195 Transit Packaging 2,107 15 43 22 270 Total reportable segments 10,579 15 272 340 $ 1,728 Other 1,222 67 23 42 Corporate and unallocated items — — 2 21 Total $ 11,801 $ 82 $ 297 $ 403 2023 Inter- External segment Capital Segment sales sales Depreciation expenditures income Americas Beverage $ 5,147 $ — $ 149 $ 296 $ 876 European Beverage 1,939 — 56 291 199 Asia Pacific 1,297 — 63 66 154 Transit Packaging 2,256 49 44 26 331 Total reportable segments 10,639 49 312 679 $ 1,560 Other 1,371 144 22 76 Corporate and unallocated items — — 2 38 Total $ 12,010 $ 193 $ 336 $ 793 2022 Inter- External segment Capital Segment sales sales Depreciation expenditures income Americas Beverage $ 5,126 $ 7 $ 128 $ 380 $ 742 European Beverage 2,114 89 49 283 123 Asia Pacific 1,615 — 62 51 172 Transit Packaging 2,545 36 41 64 281 Total reportable segments 11,400 132 280 778 $ 1,318 Other 1,543 103 18 61 Corporate and unallocated items — — 3 — Total $ 12,943 $ 235 $ 301 $ 839 The company does not disclose total assets by segment as it is not provided to the chief operating decision maker. Intersegment sales primarily include sales of cans, ends and parts and equipment used in the manufacturing process. Corporate and unallocated items include corporate and administrative costs, research and development, and unallocated items such as stock-based compensation and insurance costs. A reconciliation of segment income of reportable segments to income before income taxes for the three years ended December 31, 2024, 2023 and 2022 follows: 2024 2023 2022 Segment income of reportable segments $ 1,728 $ 1,560 $ 1,318 Other 82 117 240 Corporate and unallocated items (165) (131) (115) Restructuring and other (75) (114) 52 Amortization of intangibles (151) (163) (159) Loss from early extinguishments of debt (1) (1) (11) Other pension and postretirement (546) (49) 16 Gain on sale of equity method investment 275 — — Interest expense (452) (436) (284) Interest income 82 53 15 Foreign exchange (34) (41) (16) Income before income taxes and equity in net earnings of affiliates $ 743 $ 795 $ 1,056 For the years ended December 31, 2023 and 2022, intercompany profit of $13 and $19 was eliminated within segment income of other. For the year ended December 31, 2024, two customers each accounted for 12% of the Company's consolidated net sales. For the years ended December 31, 2023 and 2022, the same two customers each accounted for 12% and 11%, of the Company's consolidated net sales. These customers are global beverage companies served by the Company's beverage operations in the Americas, Europe and Asia. Sales by major product were: 2024 2023 2022 Metal beverage cans and ends $ 7,899 $ 7,514 $ 8,096 Transit packaging 2,107 2,256 2,545 Metal food cans and ends 887 1,013 1,099 Other products 461 701 598 Other metal packaging 447 526 605 Total $ 11,801 $ 12,010 $ 12,943 The following table provides sales and long-lived asset information for the major countries in which the Company operates. Long-lived assets comprises property, plant and equipment. Net Sales Long-Lived Assets 2024 2023 2022 2024 2023 United States $ 4,419 $ 4,482 $ 4,740 $ 1,667 $ 1,694 Mexico 1,053 1,129 1,080 534 560 Brazil 1,061 991 1,011 478 500 Canada 744 823 893 98 99 United Kingdom 398 494 521 502 466 Vietnam 387 423 547 293 317 Other 3,739 3,668 4,151 1,355 1,426 Total $ 11,801 $ 12,010 $ 12,943 $ 4,927 $ 5,062

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts and Reserves	12 Months Ended
	Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts and Reserves	SCHEDULE II – Valuation and Qualifying Accounts and Reserves (In millions) COLUMN A COLUMN B COLUMN C COLUMN D COLUMN E COLUMN F Additions Description Balance at Charged to costs and expense Charged to Acquisitions Deductions Balance at For the year ended December 31, 2024 Allowances deducted from assets to which they apply: Deferred tax assets 178 (16) (5) — (5) 152 For the year ended December 31, 2023 Allowances deducted from assets to which they apply: Deferred tax assets 173 7 (1) 7 (8) 178 For the year ended December 31, 2022 Allowances deducted from assets to which they apply: Deferred tax assets 227 (49) (3) — (2) 173

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 424	$ 450	$ 727

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Cybersecurity Risk Management a

Cybersecurity Risk Management and Strategy Disclosure	12 Months Ended
	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Cybersecurity is integrated into the Company’s overall risk management program. The Company has established a cyber risk management program that identifies and manages risks to our information assets that could be affected by a cyberattack. The Company leverages both internal and external threat detection and response capabilities, combined with a people-centric approach to employee awareness and engagement. The Company considers risks related to people, processes, and technology including those associated with our third-party service providers and allocates resources to maintain and enhance our cybersecurity measures. The Company engages external third-party security assessment vendors, both on a recurring basis and as needed, to perform realistic adversarial threat attacks (penetration testing) on our internal and external environments leveraging the International Organization for Standardization (ISO) cybersecurity frameworks. These third-party experts provide impartial, objective, and strategic evaluations of our cybersecurity posture, identifying critical vulnerabilities and recommending improvements. Although, through the date of this filing, we are not aware of any cybersecurity incidents that have materially impacted the Company, we cannot eliminate all risks from cybersecurity threats. We describe whether and how risks related to cybersecurity threats are reasonably likely to materially affect us, including our business strategy, results of operations, or financial condition, in Item 1A of this Annual Report on Form 10-K.
Cybersecurity Risk Management Processes Integrated [Flag]	true
Cybersecurity Risk Management Processes Integrated [Text Block]	Cybersecurity is integrated into the Company’s overall risk management program. The Company has established a cyber risk management program that identifies and manages risks to our information assets that could be affected by a cyberattack. The Company leverages both internal and external threat detection and response capabilities, combined with a people-centric approach to employee awareness and engagement. The Company considers risks related to people, processes, and technology including those associated with our third-party service providers and allocates resources to maintain and enhance our cybersecurity measures.
Cybersecurity Risk Management Third Party Engaged [Flag]	true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Company senior leadership has top-level responsibility for management of information security risk. The Company has established a dedicated, globally focused cybersecurity team led by its Chief Information Security Officer (CISO), who brings over 20 years of experience in the field of cybersecurity and IT operations. The CISO is responsible for overseeing the entire global cybersecurity program, which encompasses cyber risk management, operations, strategic planning, and compliance with cybersecurity policies and regulations. Crown's cybersecurity team maintains collaboration with other cross functional teams to assess and manage cybersecurity risks. This approach enables the Company to align cybersecurity efforts with broader business objectives and respond to emerging threats. Additionally, Crown’s Board of Directors, along with the Crown Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, and General Counsel oversee the identification, assessment, and management of cybersecurity risks. In case of a cyber incident with significant or material impact, the CISO would escalate to senior leadership and depending upon the severity and scope of any cyber incident, the Company will invoke its Corporate Crisis management plan.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Additionally, Crown’s Board of Directors, along with the Crown Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, and General Counsel oversee the identification, assessment, and management of cybersecurity risks.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Crown's cybersecurity team maintains collaboration with other cross functional teams to assess and manage cybersecurity risks. This approach enables the Company to align cybersecurity efforts with broader business objectives and respond to emerging threats. Additionally, Crown’s Board of Directors, along with the Crown Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, and General Counsel oversee the identification, assessment, and management of cybersecurity risks. In case of a cyber incident with significant or material impact, the CISO would escalate to senior leadership and depending upon the severity and scope of any cyber incident, the Company will invoke its Corporate Crisis management plan.
Cybersecurity Risk Role of Management [Text Block]	Company senior leadership has top-level responsibility for management of information security risk. The Company has established a dedicated, globally focused cybersecurity team led by its Chief Information Security Officer (CISO), who brings over 20 years of experience in the field of cybersecurity and IT operations. The CISO is responsible for overseeing the entire global cybersecurity program, which encompasses cyber risk management, operations, strategic planning, and compliance with cybersecurity policies and regulations. Crown's cybersecurity team maintains collaboration with other cross functional teams to assess and manage cybersecurity risks. This approach enables the Company to align cybersecurity efforts with broader business objectives and respond to emerging threats. Additionally, Crown’s Board of Directors, along with the Crown Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, and General Counsel oversee the identification, assessment, and management of cybersecurity risks. In case of a cyber incident with significant or material impact, the CISO would escalate to senior leadership and depending upon the severity and scope of any cyber incident, the Company will invoke its Corporate Crisis management plan.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	The Company has established a dedicated, globally focused cybersecurity team led by its Chief Information Security Officer (CISO), who brings over 20 years of experience in the field of cybersecurity and IT operations. The CISO is responsible for overseeing the entire global cybersecurity program, which encompasses cyber risk management, operations, strategic planning, and compliance with cybersecurity policies and regulations. Crown's cybersecurity team maintains collaboration with other cross functional teams to assess and manage cybersecurity risks. This approach enables the Company to align cybersecurity efforts with broader business objectives and respond to emerging threats. Additionally, Crown’s Board of Directors, along with the Crown Chief Executive Officer, Chief Operating Officer, Chief Financial Officer, and General Counsel oversee the identification, assessment, and management of cybersecurity risks.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	The Company has established a dedicated, globally focused cybersecurity team led by its Chief Information Security Officer (CISO), who brings over 20 years of experience in the field of cybersecurity and IT operations.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	In case of a cyber incident with significant or material impact, the CISO would escalate to senior leadership and depending upon the severity and scope of any cyber incident, the Company will invoke its Corporate Crisis management plan.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Business and Principles of Consolidation	Business and Principles of Consolidation . The consolidated financial statements include the accounts of Crown Holdings, Inc. (the “Company”) and its consolidated subsidiary companies (where the context requires, the “Company” shall include reference to the Company and its consolidated subsidiary companies). The Company, through its subsidiaries, is a leading global, diversified packaging business that manufactures metal cans and ends (aluminum and steel) for the beverage, food and aerosol industries and a wide range of transit packaging products and solutions from multiple substrates including steel, paper, and plastic. The Company's transit packaging products include automation and equipment technologies, protective packaging solutions and steel and plastic consumables which are sold into the metals, food and beverage, construction, agricultural, corrugated, and general industries. The financial statements were prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and reflect management’s estimates and assumptions. Actual results could differ from those estimates, impacting reported results of operations and financial position. All intercompany accounts and transactions are eliminated in consolidation. In deciding which entities should be reported on a consolidated basis, the Company first determines whether the entity is a variable interest entity (“VIE”). If an entity is a VIE, the Company determines whether it is the primary beneficiary and therefore, should consolidate the VIE. If an entity is not a VIE, the Company consolidates those entities in which it has control, including certain subsidiaries that are not majority-owned. Certain of the Company’s agreements with noncontrolling interests contain provisions in which the Company would surrender certain decision-making rights upon a change in control of the Company. Accordingly, consolidation of these operations may no longer be appropriate subsequent to a change in control of the Company, as defined in the agreements.
Foreign Currency Translation	Foreign Currency Translation . For non-U.S. subsidiaries which operate in a local currency environment, assets and liabilities are translated into U.S. dollars at year-end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the year. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired; all other assets and liabilities are translated at year-end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates; all other income and expense items are translated at average exchange rates prevailing during the year. Gains and losses which result from remeasurement are included in earnings.
Revenue Recognition	Revenue Recognition . The majority of the Company’s revenues from metal packaging products are derived from multi-year requirement contracts with leading manufacturers and marketers of packaged consumer products for can sets, comprising a can and an end. As requirement contracts do not typically include fixed volumes, customers often purchase products pursuant to purchase orders or other communications which are short-term in nature. The can and the end are considered separate performance obligations because they are distinct and separately identifiable. Revenues from Transit Packaging are generally derived from individual purchase orders which may include multiple goods and services which are separate performance obligations because they are distinct and separately identifiable. The Company manufactures certain products that have no alternative use to the Company once they are printed or manufactured to customer specifications. If the Company has an enforceable right to payment for custom products at all times in the manufacturing process, revenue is recognized over time. In each of the Company’s geographic markets, revenue from beverage cans is primarily recognized over time using the units produced output method as beverage cans are generally printed for a specific customer in a continuous production process. The timing of revenue recognition for the Company’s other products, including beverage ends and three-piece products, which includes food cans and ends and aerosol cans and ends, may vary as these products may be printed or customized depending upon customer preferences. Revenue that is recognized over time for the Company’s three-piece products and equipment business is generally recognized using the cost-to-cost input method as these products involve an intermediary step that results in customized work-in-process inventory. For products that follow a point in time model, revenue is generally recognized when title and risk of loss transfer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Standalone selling prices for each performance obligation are generally stated in the contract. When the Company offers variable consideration in the form of volume rebates to customers, it estimates the most likely amount of revenue to which it is expected to be entitled and includes the estimate in the transaction price, limited to the amount which is probable will not result in reversal of cumulative revenue recognized when the variable consideration is resolved. When the Company offers customers options to purchase additional product at discounted prices, judgment is required to determine if the discounted prices represent material rights. If so, the transaction price allocated to the discount is based on its relative standalone price and is recognized upon purchase of the additional product. Customer payment terms are typically less than one year and as such, the Company has applied the practical expedient to exclude consideration of significant financing components from the determination of transaction price. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Shipping and handling fees and costs from product sales are reported as cost of products sold and are accrued when the Company recognizes revenue over time before the shipping and handling activities occur. Costs to obtain a contract are generally immaterial but the Company has elected the practical expedient to expense these costs as incurred if the duration of the contract is one year or less. Unbilled receivables are recorded for revenue recognized over time when the Company has determined that control has passed to the customer but the customer has not yet been invoiced because the Company does not have present right to payment. The Company generally has a present right to payment when title of product transfers. Unbilled receivables are included in receivables, net in the Consolidated Balance Sheet with a corresponding decrease to inventory. Contract assets are recorded for revenue recognized over time when the Company has determined that control for a performance obligation has passed to the customer, but the right to invoice the customer is contingent upon the completion of the performance obligations included in the contract. Contract assets are classified as current as they are expected to be invoiced within one year and may not exceed their net realizable value. Contract assets are included in prepaid and other current assets in the Consolidated Balance Sheet. Contract liabilities are established if the Company must defer the recognition of a portion of consideration received because it has to satisfy a future obligation. Contract liabilities are classified as current or noncurrent based on when the Company expects to recognize revenue.
Stock-Based Compensation	Stock-Based Compensation . For awards with a service or market condition, compensation expense is recognized over the vesting period on a straight-line basis using the grant date fair value of the award and the estimated number of awards that are expected to vest. For awards with a performance condition, the Company assesses the probability of vesting at each reporting period and adjusts compensation cost based on its probability assessment. The Company’s plans provide for stock awards which may include accelerated vesting upon retirement, disability, or death of eligible employees. The Company considers a stock-based award to be vested when the service period is no longer contingent on the employee providing future service. Accordingly, the related compensation cost is recognized immediately for awards granted to retirement-eligible individuals, or over the period from the grant date to the date that retirement eligibility is achieved if less than the stated vesting period.
Cash and Cash Equivalents	Cash, Cash Equivalents and Restricted Cash
Restricted Cash	The Company generally classifies any cash that is legally restricted as to withdrawal or usage as restricted cash.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses.
Inventory Valuation	Inventory Valuation . Inventories are stated at the lower of cost or net realizable value, with cost principally determined under the first-in, first-out (“FIFO”) or average cost method.
Property, Plant And Equipment	Property, Plant and Equipment . Property, plant and equipment (“PP&E”) is carried at cost less accumulated depreciation and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. Cost of constructed assets includes capitalized interest incurred during the construction and development period. Maintenance and repairs, including labor and material costs for planned major maintenance such as annual production line overhauls, are expensed as incurred. When PP&E is retired or otherwise disposed, the net carrying amount is eliminated with any gain or loss on disposition recognized in earnings at that time. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). During the first quarter of 2024, the Company completed a review of the useful lives of its beverage machinery and equipment and buildings based on the Company’s experience with the duration over which equipment and buildings of its aluminum beverage can business can be utilized. The Company engaged a third-party appraiser to assist in this review and, as a result, effective January 1, 2024, the Company revised the estimated useful lives of its buildings up to 50 years, and machinery and equipment up to 23 years. The change in useful lives resulted in a net reduction in depreciation expense of approximately $64 or $0.40 per diluted share for the year ended December 31, 2024, respectively, as compared to the amount of depreciation expense that would have been recorded by utilizing the prior depreciable lives. Land improvements 25 Buildings and building improvements 25 – 50 Machinery and equipment 3– 23
Goodwill and Intangible Assets	Goodwill and Intangible Assets . Assets and liabilities of acquired businesses are recorded under the acquisition method of accounting at their estimated fair values at the dates of acquisition. Goodwill represents costs in excess of fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is carried at cost and reviewed for impairment annually in the fourth quarter of each year or when facts and circumstances indicate goodwill may be impaired. Goodwill is allocated to the reporting units at the time of each acquisition based on the relative fair values of the reporting units. In assessing goodwill for impairment, the Company may first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Further quantitative assessment may then be required. The quantitative assessment involves a number of assumptions and judgments, including the calculation of fair value for the Company’s identified reporting units. The Company determines the estimated fair value of each reporting unit based on an average of the estimated fair values using an income and a market approach. The income approach utilizes significant assumptions, including revenue and Adjusted EBITDA (a non-GAAP item defined by the Company as net customer sales, less cost of products sold excluding depreciation and amortization, less selling and administrative expenses) margin growth rates and discount rate. If the carrying value of a reporting unit exceeds its fair value, any impairment loss is measured by comparing the carrying value of the reporting unit to its fair value, not to exceed the carrying amount of goodwill. Finite-lived intangible assets are carried at cost less accumulated amortization. Finite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Customer relationships 10 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8
Impairment or Disposal of Long-Lived Assets	Impairment or Disposal of Long-Lived Assets . In the event that facts and circumstances indicate that the carrying value of long-lived assets, primarily PP&E and finite-lived intangible assets, may be impaired, the Company performs a recoverability evaluation. If the evaluation indicates that the carrying value of an asset group is not recoverable from its undiscounted cash flows, an impairment loss is measured by comparing the carrying value of the asset to its fair value, based on discounted cash flows. Long-lived assets classified as held for sale are presented in the balance sheet at the lower of their carrying value or fair value less cost to sell.
Leases	Leases. The Company has operating and finance leases for land and buildings related to certain manufacturing facilities, warehouses and corporate offices, vehicle fleets and certain office and manufacturing equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company's lease terms include options to extend the lease when it is reasonably certain that the Company will exercise the option. Variable lease payment amounts that cannot be determined at commencement of the lease, such as increases in index rates, are not included in the measurement of the lease liabilities and corresponding right-of-use assets and are recognized in the period those payments are incurred. The Company separates lease and non-lease components of lease arrangements and allocates contract consideration based on standalone selling prices. Variable consideration is allocated to the lease and non-lease components to which the variable payments specifically relate. The discount rate implicit within the Company's leases is often not determinable and therefore the Company generally uses its incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of the lease payments. The incremental borrowing rate is determined based on lease term and the currency in which lease payments are made. The Company's leases do not contain any material residual value guarantees or material restrictive covenants.
Taxes on Income	Taxes on Income . The provision for income taxes is determined using the asset and liability approach. Deferred taxes represent the future expected tax consequences of differences between the financial reporting and tax bases of assets and liabilities based upon enacted tax rates and laws. The Company has made an accounting policy election to treat taxes due on future U.S. inclusions of certain intangible income of foreign subsidiaries as a current period expense when incurred. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Investment tax credits are accounted for using the deferral method. Income tax-related interest and penalties are reported as income tax expense.
Derivatives and Hedging	Derivatives and Hedging . All outstanding derivative financial instruments are recognized in the balance sheet at their fair values. The impact on earnings from recognizing the fair values of these instruments depends on their intended use, their hedge designation and their effectiveness in offsetting changes in the fair values of the exposures they are hedging. Changes in the fair values of instruments designated to reduce or eliminate adverse fluctuations in the fair values of recognized assets and liabilities are reported currently in earnings along with changes in the fair values of the hedged items. Changes in the effective portions of the fair values of instruments used to reduce or eliminate adverse fluctuations in cash flows of anticipated or forecasted transactions are reported in equity as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified to earnings when the related hedged items impact earnings or the forecasted transactions become probable of not occurring. Changes in the fair values of derivative instruments that are not designated as hedges or do not qualify for hedge accounting treatment are reported currently in earnings. Amounts reported in earnings are classified consistent with the item being hedged. The effectiveness of derivative instruments in reducing risks associated with the hedged exposures is assessed at inception and on an ongoing basis. Time value, a component of an instrument’s fair value, is excluded in assessing effectiveness for fair value hedges, except hedges of firm commitments, and included for cash flow hedges. Hedge accounting is discontinued prospectively when (i) the instrument is no longer effective in offsetting changes in fair value or cash flows of the underlying hedged item, (ii) the instrument expires, is sold, terminated or exercised, or (iii) designating the instrument as a hedge is no longer appropriate. The Company formally documents all relationships between its hedging instruments and hedged items at inception, including its risk management objective and strategy for establishing various hedge relationships. Cash flows from hedging instruments are classified in the Consolidated Statements of Cash Flows consistent with the items being hedged.
Research and Development	Research and Development . Research, development and engineering costs of $32 in 2024, $33 in 2023 and $34 in 2022, were expensed as incurred and reported in selling and administrative expense in the Consolidated Statements of Operations. Substantially all engineering and development costs are related to developing new products or designing significant improvements to existing products or processes. Costs primarily include employee salaries and benefits and facility costs.
Reclassifications and Revisions	Reclassifications and Revisions. Certain reclassifications of prior years’ data have been made to conform to the current year presentation. In the first quarter of 2024, the Company corrected its presentation of certain borrowings and repayments of short-term debt that did not qualify for net presentation in our previously issued Consolidated Statements of Cash Flows. The Company now presents these borrowings and repayments of short-term debt on a gross basis within cash flows from financing activities. The Company determined that the corrections, which had no impact to cash flows (used for) provided by financing activities, were not material to any prior annual or interim periods and therefore, amendments of previously filed reports are not required.
Recent Accounting and Reporting Pronouncements	Recent Accounting and Reporting Pronouncements. Recently Adopted Accounting Standards In November 2023, the Financial Accounting Standards Board issued new guidance that requires incremental disclosures related to reportable segments. That standard requires disclosure, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of profit or loss. The title and position of the CODM and how the reported measure of segment profit or loss is used by the CODM to assess segment performance and allocate resources is also required to be disclosed. The standard also permits disclosure of additional measures of segment profit. The Company adopted the new guidance for the year ended December 31, 2024. Refer to Note Z . Recently Issued Accounting Standards In November 2024, the Financial Accounting Standards Board issued a final standard on disaggregation of income statement expenses. The standard requires disclosure of more detailed information about certain costs and expenses in the notes to the financial statements. The standard is effective for fiscal years beginning after December 15, 2026 and for interim periods beginning after December 15, 2027. Early adoption is permitted. The standard is applied prospectively with an option for retrospective adoption. The Company is currently evaluating the impact of adopting this standard on its disclosures.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Estimated Useful Lives of PP&E	Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). During the first quarter of 2024, the Company completed a review of the useful lives of its beverage machinery and equipment and buildings based on the Company’s experience with the duration over which equipment and buildings of its aluminum beverage can business can be utilized. The Company engaged a third-party appraiser to assist in this review and, as a result, effective January 1, 2024, the Company revised the estimated useful lives of its buildings up to 50 years, and machinery and equipment up to 23 years. The change in useful lives resulted in a net reduction in depreciation expense of approximately $64 or $0.40 per diluted share for the year ended December 31, 2024, respectively, as compared to the amount of depreciation expense that would have been recorded by utilizing the prior depreciable lives. Land improvements 25 Buildings and building improvements 25 – 50 Machinery and equipment 3– 23 2024 2023 Buildings and improvements $ 1,898 $ 1,888 Machinery and equipment 5,940 6,153 Land and improvements 265 269 Construction in progress 469 589 8,572 8,899 Less: accumulated depreciation and amortization (3,645) (3,837) $ 4,927 $ 5,062
Schedule of Gross Carrying Amounts and Accumulated Amortization of Finite-Lived Intangible Assets	Finite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Customer relationships 10 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2024 December 31, 2023 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,342 $ (734) $ 608 $ 1,423 $ (670) $ 753 Trade names 522 (148) 374 539 (130) 409 Technology 153 (140) 13 159 (133) 26 Long term supply contracts 139 (92) 47 167 (99) 68 Patents 12 (10) 2 12 (10) 2 $ 2,168 $ (1,124) $ 1,044 $ 2,300 $ (1,042) $ 1,258
Schedule of Change in Accounting Estimate	The effects of the revisions on each of the impacted financial statement line items within the Company's Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022 were as follows: Year Ended December 31, 2023 As Previously Reported Adjustments As Revised Net change in revolving credit facility and short-term debt $ (398) $ 2 $ (396) Proceeds from short-term debt — 129 129 Payments of short-term debt — (131) (131) Net cash provided by financing activities 116 — 116 Year Ended December 31, 2022 As Previously Reported Adjustments As Revised Net change in revolving credit facility and short-term debt $ 268 $ — $ 268 Proceeds from short-term debt — 45 45 Payments of short-term debt — (45) $ (45) Net cash used for financing activities (25) — (25)

Cash, Cash Equivalents, and R_2

Cash, Cash Equivalents, and Restricted Cash (Tables)	12 Months Ended
	Dec. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash, Cash Equivalents and Restricted Cash	Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statements of Cash Flows were as follows: 2024 2023 Cash and cash equivalents $ 918 $ 1,310 Restricted cash included in prepaid expenses and other current assets 98 90 Total cash, cash equivalents and restricted cash $ 1,016 $ 1,400
Schedule of Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statements of Cash Flows were as follows: 2024 2023 Cash and cash equivalents $ 918 $ 1,310 Restricted cash included in prepaid expenses and other current assets 98 90 Total cash, cash equivalents and restricted cash $ 1,016 $ 1,400

Receivables (Tables)

Receivables (Tables)	12 Months Ended
	Dec. 31, 2024
Receivables [Abstract]
Schedule of Receivables	2024 2023 Accounts receivable $ 1,060 $ 1,122 Less: allowance for credit losses (30) (29) Net trade receivables 1,030 1,093 Unbilled receivables 316 338 Miscellaneous receivables 310 288 $ 1,656 $ 1,719

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Components of Inventories	2024 2023 Raw materials and supplies $ 965 $ 1,031 Work in process 106 139 Finished goods 369 443 $ 1,440 $ 1,613

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2024 and 2023 were as follows: Americas Beverage European Beverage Transit Packaging Other Total Balance at January 1, 2023 $ 850 $ 491 $ 1,428 $ 182 $ 2,951 Goodwill acquired — 37 — — 37 Foreign currency translation 71 22 35 1 129 Balance at December 31, 2023 921 550 1,463 183 3,117 Transfers and adjustments — 8 (3) 3 8 Foreign currency translation (94) (22) (50) (5) (171) Balance at December 31, 2024 $ 827 $ 536 $ 1,410 $ 181 $ 2,954 During the year-ended December 31, 2023, goodwill acquired was from the acquisition of Helvetia Packaging AG. See Note B for more information. The carrying amount of goodwill at December 31, 2024 and 2023 was net of the following accumulated impairments: Americas Beverage European Beverage Other Total Accumulated impairments $ 29 $ 73 $ 11 $ 113

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Gross Carrying Amounts and Accumulated Amortization of Finite-Lived Intangible Assets	Finite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Customer relationships 10 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2024 December 31, 2023 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,342 $ (734) $ 608 $ 1,423 $ (670) $ 753 Trade names 522 (148) 374 539 (130) 409 Technology 153 (140) 13 159 (133) 26 Long term supply contracts 139 (92) 47 167 (99) 68 Patents 12 (10) 2 12 (10) 2 $ 2,168 $ (1,124) $ 1,044 $ 2,300 $ (1,042) $ 1,258

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). During the first quarter of 2024, the Company completed a review of the useful lives of its beverage machinery and equipment and buildings based on the Company’s experience with the duration over which equipment and buildings of its aluminum beverage can business can be utilized. The Company engaged a third-party appraiser to assist in this review and, as a result, effective January 1, 2024, the Company revised the estimated useful lives of its buildings up to 50 years, and machinery and equipment up to 23 years. The change in useful lives resulted in a net reduction in depreciation expense of approximately $64 or $0.40 per diluted share for the year ended December 31, 2024, respectively, as compared to the amount of depreciation expense that would have been recorded by utilizing the prior depreciable lives. Land improvements 25 Buildings and building improvements 25 – 50 Machinery and equipment 3– 23 2024 2023 Buildings and improvements $ 1,898 $ 1,888 Machinery and equipment 5,940 6,153 Land and improvements 265 269 Construction in progress 469 589 8,572 8,899 Less: accumulated depreciation and amortization (3,645) (3,837) $ 4,927 $ 5,062

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2024
Leases [Abstract]
Schedule of Components of Lease Cost	The components of lease expense for the years ended December 31, 2024, 2023 and 2022 were as follows: 2024 2023 2022 Operating lease costs: Operating lease cost $ 56 $ 54 $ 58 Short-term lease cost 2 2 2 Total operating lease costs $ 58 $ 56 $ 60 Finance lease cost: Amortization of right-of-use assets $ — $ 1 $ 1 Total finance lease costs $ — $ 1 $ 1
Schedule of Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows: 2024 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 55 $ 54 $ 53 Financing cash flows from finance leases 2 2 1 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 52 $ 36 $ 87
Schedule of Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to finance leases was as follows: 2024 2023 Finance leases: Property, plant and equipment $ 19 $ 21 Accumulated depreciation (3) (3) Property, plant and equipment, net $ 16 $ 18 Accrued liabilities $ 1 $ 1 Other non-current liabilities 3 5 Total finance lease liabilities $ 4 $ 6
Schedule of Weighted Average Remaining Lease Term and Discount Schedule	The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2024 2023 Weighted average remaining lease term (years): Operating leases 9.4 9.5 Finance leases 3.1 4.1 Weighted average discount rate: Operating leases 4.7 % 4.5 % Finance leases 2.7 % 3.5 %
Schedule of Maturities of Operating Lease Liabilities	Maturities of lease liabilities as of December 31, 2024 were as follows: Operating Leases Finance Leases 2025 $ 49 $ 2 2026 42 1 2027 33 1 2028 27 — 2029 23 — Thereafter 97 — Total lease payments 271 4 Less imputed interest (57) — $ 214 $ 4
Schedule of Maturities of Finance Lease Liabilities	Maturities of lease liabilities as of December 31, 2024 were as follows: Operating Leases Finance Leases 2025 $ 49 $ 2 2026 42 1 2027 33 1 2028 27 — 2029 23 — Thereafter 97 — Total lease payments 271 4 Less imputed interest (57) — $ 214 $ 4

Other Non-Current Assets (Table

Other Non-Current Assets (Tables)	12 Months Ended
	Dec. 31, 2024
Investments, All Other Investments [Abstract]
Schedule of Components of Other Non-Current Assets	2024 2023 Deferred taxes $ 134 $ 132 Pension assets 88 94 Fair value of derivatives 86 47 Investments 22 87 Other 181 193 $ 511 $ 553

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities	2024 2023 Salaries and employee benefits $ 170 $ 173 Income taxes 116 119 Accrued taxes, other than on income 76 85 Accrued interest 65 59 Pension and postretirement liabilities 32 25 Asbestos liabilities 20 20 Fair value of derivatives 14 20 Restructuring 13 22 Other 341 399 $ 847 $ 922

Supplier Finance Program Obli_2

Supplier Finance Program Obligations (Tables)	12 Months Ended
	Dec. 31, 2024
Payables and Accruals [Abstract]
Schedule of Supplier Finance Program	Changes in the confirmed obligations outstanding under these supplier finance programs, included in Accounts Payable Balance at January 1, 2024 $ 862 Additions 2,107 Settlements (2,032) Foreign currency translation (10) Balance at December 31, 2024 $ 927

Restructuring and Other (Tables

Restructuring and Other (Tables)	12 Months Ended
	Dec. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Charges by Segment and Type	The Company recorded restructuring and other items as follows: 2024 2023 2022 Restructuring $ 49 $ 23 $ 35 Asset impairments and sales 19 72 (106) Other costs 11 19 14 Asbestos (4) — 5 $ 75 $ 114 $ (52) Restructuring charges by segment were as follows: 2024 2023 2022 Americas Beverage $ 11 $ 4 $ — European Beverage 17 9 — Asia Pacific 4 7 — Transit Packaging 4 (1) 35 Other 13 4 — $ 49 $ 23 $ 35 Restructuring charges by type were as follows: 2024 2023 2022 Termination benefits $ 15 $ 15 $ 29 Other exit costs 34 8 6 $ 49 $ 23 $ 35

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2024
Debt Disclosure [Abstract]
Schedule of Outstanding Debt	2024 2023 Principal Carrying Principal Carrying outstanding amount outstanding amount Short-term debt $ 66 $ 66 $ 16 $ 16 Long-term debt Senior secured borrowings: Revolving credit facilities — — — — Term loan facilities U.S. dollar due 2027 1,175 1,171 1,575 1,569 Euro due 2027 1 538 538 589 589 Senior notes and debentures: €600 at 2.625% due 2024 — — 663 662 €600 at 3.375% due 2025 — — 663 662 U.S. dollar at 4.25% due 2026 400 399 400 398 U.S. dollar at 4.75% due 2026 875 873 875 871 U.S. dollar at 7.375% due 2026 350 350 350 350 €500 at 2.875% due 2026 518 517 552 550 €500 at 5.00% due 2028 518 513 552 544 €500 at 4.75% due 2029 518 513 552 544 €600 at 4.50% due 2030 621 611 — — U.S. dollar at 5.25% due 2030 500 495 500 494 U.S. dollar at 7.50% due 2096 40 40 40 40 Other indebtedness in various currencies: Fixed rate with rates in 2024 from 2.8% to 7.6% due through 2027 108 108 169 169 Variable rate with an average rate in 2024 of 3.6% due 2026 10 10 16 16 Total long-term debt 6,171 6,138 7,496 7,458 Less: current maturities (80) (80) (759) (759) Total long-term debt, less current maturities $ 6,091 $ 6,058 $ 6,737 $ 6,699 (1) €520 at December 31, 2024 and €533 at December 31, 2023
Schedule of Weighted Average Interest Rates	The weighted average interest rates were as follows: 2024 2023 2022 Short-term debt 4.3 % 13.2 % 3.8 % Revolving credit facilities 4.7 % 4.5 % 2.5 %

Derivative and Other Financia_2

Derivative and Other Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Impact on Accumulated Other Comprehensive Income and Earnings from Changes in Fair Value	The following tables set forth financial information about the impact on other comprehensive income ("OCI"), accumulated other comprehensive income ("AOCI") and earnings from changes in the fair value related to derivative instruments designated as cash flow hedges. Amount of gain / (loss) recognized in AOCI Derivatives in cash flow hedges 2024 2023 Foreign exchange $ (1) $ (2) Commodities 6 (8) $ 5 $ (10) Amount of gain / (loss) reclassified from AOCI into income Derivatives in cash flow hedges 2024 2023 Affected line item in the Commodities $ (16) $ 9 Net sales Foreign exchange (1) — Cost of products sold, excluding depreciation and amortization Commodities 14 (38) Cost of products sold, excluding depreciation and amortization (3) (29) Income before income taxes and equity in net earnings of affiliates — 7 Provision for income taxes $ (3) $ (22) Net income
Schedule of Impact on Earnings from Derivatives Not Designated as Hedges	The following table sets forth the impact on earnings from derivatives not designated as hedges. Pre-tax amount of gain / (loss) recognized in earnings Derivatives not designated as hedges 2024 2023 Affected line item in the Foreign exchange — (4) Cost of products sold, excluding depreciation and amortization Foreign exchange 15 (4) Foreign exchange $ 15 $ (8)
Schedule of Impact on Other Comprehensive Income from Changes in Fair Value	The following table sets forth financial information about the impact on accumulated other comprehensive income from changes in the fair value of these derivative instruments designated as net investment hedges. Amount of gain / (loss) recognized in AOCI Derivatives designated as net investment hedges 2024 2023 Foreign exchange $ 29 $ (33)
Schedule of Fair Value of Financial Assets and Liabilities on Recurring Basis	The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2024 and December 31, 2023, respectively. The fair value of these financial instruments were reported under Level 2 of the fair value hierarchy. Balance Sheet classification December 31, December 31, Balance Sheet classification December 31, December 31, Derivatives designated as hedging instruments Foreign exchange contracts cash flow Prepaid expenses and other current assets $ 2 $ 1 Accrued liabilities $ 4 $ 2 Foreign exchange contracts fair value Prepaid expenses and other current assets — — Accrued liabilities — 2 Commodities contracts cash flow Prepaid expenses and other current assets 10 13 Accrued liabilities 3 13 Net investment hedge Other non-current assets 86 47 Other non-current liabilities — — $ 98 $ 61 $ 7 $ 17 Derivatives not designated as hedging instruments Foreign exchange contracts Prepaid expenses and other current assets $ 4 $ 3 Accrued liabilities $ 7 $ 3 Total derivatives $ 102 $ 64 $ 14 $ 20 Fair Value Hedge Carrying Amounts Carrying amount of the hedged assets and liabilities Line item in the Balance Sheet in which the hedged item is included December 31, 2024 December 31, 2023 Cash and cash equivalents — 2 Receivables, net — 12 Accrued liabilities — 120
Schedule of Offsetting Assets	In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2024 Derivative assets $ 102 $ 3 $ 99 Derivative liabilities 14 3 11 Balance at December 31, 2023 Derivative assets $ 64 $ 7 $ 57 Derivative liabilities 20 7 13
Schedule of Offsetting Liabilities	In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2024 Derivative assets $ 102 $ 3 $ 99 Derivative liabilities 14 3 11 Balance at December 31, 2023 Derivative assets $ 64 $ 7 $ 57 Derivative liabilities 20 7 13
Schedule of Notional Values of Outstanding Derivative Instruments in the Consolidated Balance Sheets	The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets at December 31, 2024 and December 31, 2023 were: December 31, 2024 December 31, 2023 Derivatives designated as cash flow hedges: Foreign exchange $ 380 $ 75 Commodities 73 160 Derivatives designated as fair value hedges: Foreign exchange — 202 Derivatives designated as net investment hedges: Foreign exchange 875 875 Derivatives not designated as hedges: Foreign exchange 305 302

Asbestos-Related Liabilities (T

Asbestos-Related Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Movement in Liability for Asbestos and Environmental Claims [Abstract]
Schedule of Claims Activity	The Company's approximate claims activity for the years ended 2024, 2023 and 2022 was as follows: 2024 2023 2022 Beginning claims 58,500 57,500 57,000 New claims 1,400 1,500 1,500 Settlements or dismissals (600) (500) (1,000) Ending claims 59,300 58,500 57,500
Schedule of Outstanding Asbestos Claims by Years of Exposure and State Filed	In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes by year of exposure and state filed. As of December 31, 2024 and December 31, 2023, the Company's outstanding claims were: 2024 2023 Claimants alleging first exposure after 1964 18,000 18,000 Claimants alleging first exposure before or during 1964 filed in: Texas 13,000 13,000 Pennsylvania 1,300 1,500 Other states that have enacted asbestos legislation 6,000 6,000 Other states 21,000 20,000 Total claims outstanding 59,300 58,500
Schedule of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases	As of December 31, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows: 2024 2023 2022 Total claims 27 % 25 % 24 % Pre-1965 claims in states without asbestos legislation 43 % 44 % 43 %

Other Non-Current Liabilities (

Other Non-Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Schedule of Other Noncurrent Liabilities	2024 2023 Deferred taxes $ 338 $ 338 Asbestos liabilities 165 184 Postemployment benefits 23 22 Income taxes payable 18 27 Environmental 12 12 Other 114 98 $ 670 $ 681

Pension and Other Postretirem_2

Pension and Other Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2024
Retirement Benefits [Abstract]
Schedule of Components of Pension Expense and Benefits Cost	The components of pension expense were as follows: U.S. Plans 2024 2023 2022 Service cost $ 15 $ 13 $ 19 Interest cost 40 54 31 Expected return on plan assets (46) (60) (75) Settlements and curtailments 469 — 1 Amortization of actuarial loss 32 43 44 Amortization of prior service cost 1 1 1 Net periodic cost $ 511 $ 51 $ 21 Non-U.S. Plans 2024 2023 2022 Service cost $ 7 $ 7 $ 9 Interest cost 16 19 13 Expected return on plan assets (18) (22) (22) Settlements 44 — — Special termination benefits — 6 — Amortization of actuarial loss 2 3 5 Amortization of prior service credit — — (1) Net periodic cost $ 51 $ 13 $ 4 The components of net postretirement benefits cost were as follows: Other Postretirement Benefits 2024 2023 2022 Service cost $ — $ — $ 1 Interest cost 6 6 4 Amortization of prior service credit — — (20) Amortization of actuarial loss — — 2 Net periodic benefit cost / (credit) $ 6 $ 6 $ (13)
Schedule of Projected Benefit Obligations, Accumulated Benefit Obligations, Plan Assets and Funded Status	The projected benefit obligations, accumulated benefit obligations, plan assets and funded status of the Company's U.S. and non-U.S. plans were as follows: U.S. Plans Non-U.S. Plans 2024 2023 2024 2023 Projected Benefit Obligations Benefit obligations at January 1 $ 1,109 $ 1,094 $ 415 $ 387 Service cost 15 13 7 7 Interest cost 40 54 16 19 Plan participants' contributions — — 2 2 Amendments — 1 — (2) Settlements (775) — (122) (8) Special termination benefits — — — 6 Actuarial (gain) / loss (15) 36 (7) 18 Benefits paid (75) (89) (22) (38) Foreign currency translation — — (31) 24 Benefit obligations at December 31 $ 299 $ 1,109 $ 258 $ 415 Plan Assets Fair value of plan assets at January 1 $ 880 $ 886 $ 412 $ 381 Actual gain on plan assets 40 81 27 33 Employer contributions / (withdrawals) 125 2 (12) 17 Plan participants' contributions — — 1 2 Settlements (775) — (122) (7) Benefits paid (75) (89) (22) (38) Foreign currency translation — — (30) 24 Fair value of plan assets at December 31 $ 195 $ 880 $ 254 $ 412 Funded status $ (104) $ (229) $ (4) $ (3) Accumulated benefit obligations at December 31 $ 257 $ 1,065 $ 229 $ 389
Schedule of Information for Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 93 $ 1,109 Accumulated benefit obligations 88 1,065 Fair value of plan assets — 880 U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 296 $ 1,109 Accumulated benefit obligations 255 1,065 Fair value of plan assets 192 880 Non-U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 199 $ 213 Accumulated benefit obligations 179 195 Fair value of plan assets 114 117
Schedule of Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets	U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 93 $ 1,109 Accumulated benefit obligations 88 1,065 Fair value of plan assets — 880 U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 296 $ 1,109 Accumulated benefit obligations 255 1,065 Fair value of plan assets 192 880 Non-U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2024 2023 Projected benefit obligations $ 199 $ 213 Accumulated benefit obligations 179 195 Fair value of plan assets 114 117
Schedule of Ranges for Asset Allocation and Summary of Defined Benefit Plan Assets and Accrued Income	The strategic ranges for asset allocation in the U.S. plans are as follows: U.S. equities 45 % to 55 % International equities 7.5 % to 12.5 % Fixed income 15 % to 25 % Balanced funds 7.5 % to 12.5 % Real estate 7.5 % to 12.5 % 2024 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 8 $ 28 $ 36 Global large cap equity — 8 8 U.S. large cap equity — 10 10 Mutual funds – U.S. equity 51 — 51 59 46 105 Level 2 Government issued debt securities — 18 18 Corporate debt securities — 6 6 Insurance contracts — 102 102 Investment funds – fixed income — 1 1 — 127 127 Level 3 Investment funds – real estate 106 28 134 Private equity 2 — 2 Real estate – direct 28 8 36 136 36 172 Total assets in fair value hierarchy 195 209 404 Investments measured at NAV Practical Expedient (a) Investment funds - fixed income — 25 25 Investment funds - global equity — 20 20 — 45 45 Total investments at fair value $ 195 $ 254 $ 449 2023 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 15 $ 23 $ 38 Global large cap equity — 3 3 U.S. large cap equity 173 4 177 U.S. mid/small cap equity 276 21 297 Mutual funds – global equity 59 — 59 Mutual funds – U.S. equity 49 — 49 Mutual funds – fixed income 18 — 18 590 51 641 Level 2 Government issued debt securities — 18 18 Corporate debt securities 41 8 49 Insurance contracts — 110 110 Investment funds – fixed income — 1 1 41 137 178 Level 3 Investment funds – real estate 127 60 187 Private equity 3 — 3 Real estate – direct 27 17 44 157 77 234 Total assets in fair value hierarchy 788 265 1,053 Investments measured at NAV Practical Expedient (a) Investment funds - fixed income 86 22 108 Investment funds - global equity — 118 118 Investment funds - emerging markets 5 — 5 Investments funds - real estate — 7 7 91 147 238 Total investments at fair value $ 879 $ 412 $ 1,291 (a) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Accrued income excluded from the tables above was as follows: 2024 2023 U.S. plan assets $ — $ 1
Schedule of Reconciliation of Plan Assets Using Level 3	The following tables reconcile the beginning and ending balances of plan assets measured using significant unobservable inputs (Level 3). Private Real Total Balance at January 1, 2023 $ 5 $ 247 $ 252 Foreign currency translation — 2 2 Asset returns – assets held at reporting date 18 (24) (6) Asset returns – assets sold during the period (18) 11 (7) Purchases, sales and settlements, net (2) (5) (7) Balance at December 31, 2023 3 231 234 Foreign currency translation — (4) (4) Asset returns – assets held at reporting date 3 (6) (3) Asset returns – assets sold during the period (4) 2 (2) Purchases, sales and settlements, net — (53) (53) Balance at December 31, 2024 $ 2 $ 170 $ 172
Schedule of Additional Information About Pension Plan Assets Valued Using Net Asset Value	The following table presents additional information about the pension plan assets valued using NAV as a practical expedient: Fair Value Redemption Frequency Redemption Notice Period Balance at December 31, 2024 Investment funds – fixed income $ 25 Daily 10 days Investment funds – global equity 20 Daily 10 days Balance at December 31, 2023 Investment funds – fixed income $ 108 Semi-monthly 1- 5 days Investment funds – global equity 118 Daily 10 days Investment funds – emerging markets 5 Daily 30 days Investment funds – real estate 7 Daily 10 days
Schedule of Pension Assets and Liabilities	Pension assets and liabilities included in the Consolidated Balance Sheets were: 2024 2023 Non-current assets $ 88 $ 94 Current liabilities 22 12 Non-current liabilities 174 314
Schedule of Changes in Net (Gain)/ Loss and Prior Service Cost/(Credit)	Changes in the net loss and prior service credit for the Company’s pension plans were: 2024 2023 2022 Net loss Prior Net loss Prior Net loss Prior Balance at January 1 $ 686 $ (1) $ 712 $ — $ 814 $ 2 Reclassification to net periodic benefit cost (551) (1) (46) (1) (49) (1) Current year (gain) / loss (25) — 22 — (45) (1) Amendments — — (1) — — — Foreign currency translation (1) — (1) — (8) — Balance at December 31 $ 109 $ (2) $ 686 $ (1) $ 712 $ — Changes in the net (gain) / loss and prior service credit for the Company’s postretirement benefit plans were: 2024 2023 2022 Net gain Prior Net gain Prior Net Prior Balance at January 1 $ (3) $ — $ (2) $ — $ 21 $ (20) Reclassification to net periodic benefit cost — — — — (2) 20 Current year (gain) / loss (3) — — — (22) — Foreign currency translation 1 — (1) — 1 — Balance at December 31 $ (5) $ — $ (3) $ — $ (2) $ —
Schedule of Expected Future Benefit Payments	Expected future benefit payments as of December 31, 2024 are: U.S. Non-U.S. 2025 $ 17 $ 20 2026 16 17 2027 33 16 2028 11 19 2029 13 19 2030 - 2034 90 102 Expected future benefit payments are as follows: Benefit Payments 2025 $ 12 2026 10 2027 10 2028 9 2029 9 2030 - 2034 39
Schedule of Benefit Obligations Weighted Average Actuarial Assumptions	The weighted average actuarial assumptions used to calculate the benefit obligations at December 31 were: U.S. Plans 2024 2023 2022 Discount rate 5.9 % 5.0 % 5.2 % Compensation increase 5.0 % 5.0 % 5.0 % Non-U.S. Plans 2024 2023 2022 Discount rate 5.1 % 4.8 % 4.9 % Compensation increase 2.8 % 2.9 % 2.7 % The weighted average actuarial assumptions used to calculate pension expense for each year were: U.S. Plans 2024 2023 2022 Discount rate - service cost 5.2 % 5.4 % 3.3 % Discount rate - interest cost 4.9 % 5.1 % 2.2 % Compensation increase 5.0 % 5.0 % 4.7 % Long-term rate of return 7.2 % 7.2 % 6.6 % Non-U.S. Plans 2024 2023 2022 Discount rate - service cost 4.7 % 5.0 % 2.9 % Discount rate - interest cost 4.7 % 5.1 % 2.6 % Compensation increase 2.9 % 2.9 % 2.7 % Long-term rate of return 4.2 % 5.1 % 4.3 % Weighted average discount rates used to calculate the benefit obligations at the end of each year and the cost for each year are presented below: 2024 2023 2022 Benefit obligations 6.5 % 5.0 % 5.8 % Service cost 8.1 % 5.3 % 7.8 % Interest cost 5.8 % 4.9 % 5.7 %
Schedule of Changes in Benefit Obligations	Changes in the benefit obligations were: 2024 2023 Benefit obligations at January 1 $ 107 $ 108 Interest cost 6 6 Actuarial (gain) / loss (2) — Benefits paid (9) (11) Foreign currency translation (6) 4 Benefit obligations at December 31 $ 96 $ 107
Schedule of Assumed Health Care Cost Trend Rates	The assumed health care cost trend rates at December 31, 2024 were as follows: Health care cost trend rate assumed for 2024 5.9 % Rate that the cost trend rate gradually declines to 4.1 % Year that the rate reaches the rate it is assumed to remain 2032

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Income Before Income Taxes	The components of income before income taxes were as follows: 2024 2023 2022 U.S. $ (448) $ (1) $ 295 Foreign 1,191 796 761 $ 743 $ 795 $ 1,056
Schedule of Provision for Income Taxes	The provision for income taxes consisted of the following: 2024 2023 2022 Current tax: U.S. federal $ 89 $ 31 $ 18 State and foreign 262 244 190 $ 351 $ 275 $ 208 Deferred tax: U.S. federal $ (109) $ (27) $ 46 State and foreign (59) (26) (11) (168) (53) 35 Total $ 183 $ 222 $ 243
Schedule of U.S. Statutory Federal Income Tax Rate to Pre-tax Income	The provision for income taxes differs from the amount of income tax determined by applying the U.S. statutory federal income tax rate to pre-tax income as a result of the following items: 2024 2023 2022 U.S. statutory rate at 21% $ 156 $ 167 $ 222 Statutory tax rate differences (17) 6 9 Taxes on foreign income (30) 1 (39) Foreign withholding taxes 19 23 5 U.S. taxes on foreign income, net of credits 67 5 1 State taxes (12) 2 (2) Valuation allowance changes (17) 5 33 Tax contingencies 6 2 7 Tax law changes 5 8 2 Other items, net 6 3 5 Income tax provision $ 183 $ 222 $ 243
Schedule of Components of Deferred Taxes	The components of deferred taxes at December 31 were: 2024 2023 Assets Liabilities Assets Liabilities Tax carryforwards $ 251 $ — $ 274 $ — Disallowed interest carryforwards 105 — 54 — Intangible assets — 260 — 292 Property, plant and equipment 14 257 16 253 Accruals and other 126 129 123 94 Pensions 48 21 90 20 Asbestos 46 — 50 — Postretirement and postemployment benefits 23 — 23 — Lease liabilities 32 — 32 — Right of use assets — 30 — 31 Valuation allowances (152) — (178) — Total $ 493 $ 697 $ 484 $ 690
Schedule of Tax Carryforwards Expiration	Tax carryforwards expire as follows: Year Amount 2025 $ 13 2026 12 2027 7 2028 2 2029 10 Thereafter 77 Unlimited 130
Schedule of Unrecognized Tax Benefits Roll Forward	A reconciliation of unrecognized tax benefits follows: 2024 2023 2022 Balance at January 1 $ 46 $ 46 $ 48 Additions for prior year tax positions 10 6 7 Reductions to prior period tax positions (4) — — Lapse of statute of limitations (4) (4) (1) Settlements (2) (2) (6) Foreign currency translation — — (2) Balance at December 31 $ 46 $ 46 $ 46

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Common Share Activity	A summary of common share activity for the years ended December 31 follows (in shares): 2024 2023 2022 Common shares outstanding at January 1 120,644,313 119,945,302 126,131,799 Shares repurchased (2,470,604) (143,736) (6,574,610) Restricted stock issued to employees, net of forfeitures 313,136 820,343 370,178 Shares issued to non-employee directors 16,786 22,404 17,935 Common shares outstanding at December 31 118,503,631 120,644,313 119,945,302

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss Attributable to Crown Holdings (Tables)	12 Months Ended
	Dec. 31, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income/ (Loss)	The following table provides information about the changes in each component of accumulated other comprehensive loss for the years ended December 31, 2024 and 2023. Defined benefit plans Foreign currency translation Cash flow hedges Total Balance at January 1, 2023 $ (686) $ (1,197) $ (9) $ (1,892) Other comprehensive income / (loss) before reclassifications (14) 175 (14) 147 Amounts reclassified from accumulated other comprehensive income 36 — 22 58 Other comprehensive income 22 175 8 205 Balance at December 31, 2023 (664) (1,022) (1) (1,687) Other comprehensive income / (loss) before reclassifications 21 (213) 5 (187) Amounts reclassified from accumulated other comprehensive income 413 (1) — 412 Other comprehensive income / (loss) 434 (214) 5 225 Balance at December 31, 2024 $ (230) $ (1,236) $ 4 $ (1,462)

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	For the years ended December 31, 2024, 2023 and 2022, the Company recognized revenue as follows: 2024 2023 2022 Revenue recognized over time $ 6,632 $ 6,472 $ 6,937 Revenue recognized at a point in time 5,169 5,538 6,006 Total $ 11,801 $ 12,010 $ 12,943

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Restricted and Deferred Stock Activity	A summary of restricted and deferred stock activity follows: Number of shares Non-vested shares outstanding at January 1, 2024 1,444,712 Awarded: Time-vesting 240,680 Performance-based 166,380 Released: Time-vesting (284,127) Performance-based (103,993) Forfeitures: Time-vesting (112,020) Performance-based (21,355) Non-vested shares outstanding at December 31, 2024 1,330,277
Schedule of Average Grant-Date Fair Value of Restricted Stock	The average grant-date fair value of restricted stock awarded in 2024, 2023 and 2022 follows: 2024 2023 2022 Time-vesting $ 80.21 $ 87.66 $ 96.29 Performance-based 89.57 86.10 111.84
Schedule of Weighted Average Assumptions on Performance-Based Shares	The fair values of the performance-based awards that include a market condition were calculated using a Monte Carlo valuation model and the following weighted average assumptions: 2024 2023 2022 Risk-free interest rate 4.0 % 4.1 % 1.0 % Expected term (years) 3 3 3 Expected stock price volatility 31.4 % 39.8 % 34.8 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Earnings Per Share	The following table summarizes basic and diluted earnings per share ("EPS"). Basic EPS excludes all potentially dilutive securities and is computed by dividing net income attributable to Crown Holdings by the weighted average number of common shares outstanding during the period. Diluted EPS includes the effect of restricted stock, when dilutive, as calculated under the treasury stock method. 2024 2023 2022 Net income attributable to Crown Holdings $ 424 $ 450 $ 727 Weighted average shares outstanding: Basic 119.20 119.41 120.86 Add: dilutive restricted stock 0.23 0.26 0.52 Diluted 119.43 119.67 121.38 Basic earnings per share $ 3.56 $ 3.77 $ 6.01 Diluted earnings per share $ 3.55 $ 3.76 $ 5.99 Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive 0.8 0.2 0.7

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2024
Segment Reporting [Abstract]
Schedule of Information on Operating Segments	The tables below present information about operating segments for the three years ended December 31, 2024, 2023 and 2022: 2024 Inter- External segment Capital Segment sales sales Depreciation expenditures income Americas Beverage $ 5,240 $ — $ 128 $ 164 $ 987 European Beverage 2,071 — 55 133 276 Asia Pacific 1,161 — 46 21 195 Transit Packaging 2,107 15 43 22 270 Total reportable segments 10,579 15 272 340 $ 1,728 Other 1,222 67 23 42 Corporate and unallocated items — — 2 21 Total $ 11,801 $ 82 $ 297 $ 403 2023 Inter- External segment Capital Segment sales sales Depreciation expenditures income Americas Beverage $ 5,147 $ — $ 149 $ 296 $ 876 European Beverage 1,939 — 56 291 199 Asia Pacific 1,297 — 63 66 154 Transit Packaging 2,256 49 44 26 331 Total reportable segments 10,639 49 312 679 $ 1,560 Other 1,371 144 22 76 Corporate and unallocated items — — 2 38 Total $ 12,010 $ 193 $ 336 $ 793 2022 Inter- External segment Capital Segment sales sales Depreciation expenditures income Americas Beverage $ 5,126 $ 7 $ 128 $ 380 $ 742 European Beverage 2,114 89 49 283 123 Asia Pacific 1,615 — 62 51 172 Transit Packaging 2,545 36 41 64 281 Total reportable segments 11,400 132 280 778 $ 1,318 Other 1,543 103 18 61 Corporate and unallocated items — — 3 — Total $ 12,943 $ 235 $ 301 $ 839
Schedule of Reconciliation of Segment Income	A reconciliation of segment income of reportable segments to income before income taxes for the three years ended December 31, 2024, 2023 and 2022 follows: 2024 2023 2022 Segment income of reportable segments $ 1,728 $ 1,560 $ 1,318 Other 82 117 240 Corporate and unallocated items (165) (131) (115) Restructuring and other (75) (114) 52 Amortization of intangibles (151) (163) (159) Loss from early extinguishments of debt (1) (1) (11) Other pension and postretirement (546) (49) 16 Gain on sale of equity method investment 275 — — Interest expense (452) (436) (284) Interest income 82 53 15 Foreign exchange (34) (41) (16) Income before income taxes and equity in net earnings of affiliates $ 743 $ 795 $ 1,056
Schedule of Sales by Major Product	Sales by major product were: 2024 2023 2022 Metal beverage cans and ends $ 7,899 $ 7,514 $ 8,096 Transit packaging 2,107 2,256 2,545 Metal food cans and ends 887 1,013 1,099 Other products 461 701 598 Other metal packaging 447 526 605 Total $ 11,801 $ 12,010 $ 12,943
Schedule of Sales and Long-Lived Assets for the Major Countries	The following table provides sales and long-lived asset information for the major countries in which the Company operates. Long-lived assets comprises property, plant and equipment. Net Sales Long-Lived Assets 2024 2023 2022 2024 2023 United States $ 4,419 $ 4,482 $ 4,740 $ 1,667 $ 1,694 Mexico 1,053 1,129 1,080 534 560 Brazil 1,061 991 1,011 478 500 Canada 744 823 893 98 99 United Kingdom 398 494 521 502 466 Vietnam 387 423 547 293 317 Other 3,739 3,668 4,151 1,355 1,426 Total $ 11,801 $ 12,010 $ 12,943 $ 4,927 $ 5,062

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Property, Plant and Equipment (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jan. 01, 2024
Property, Plant and Equipment [Line Items]
Depreciation expense	$ 297	$ 336	$ 301
Diluted (in dollars per share)	$ 3.55	$ 3.76	$ 5.99
Service Life
Property, Plant and Equipment [Line Items]
Depreciation expense	$ (64)
Diluted (in dollars per share)	$ (0.40)
Building | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life				50 years
Land improvements
Property, Plant and Equipment [Line Items]
Estimated useful life	25 years
Buildings and building improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life	25 years
Buildings and building improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life	50 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful life	23 years			23 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Goodwill and Intangible Assets (Details)	Dec. 31, 2024
Long term supply contracts
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	15 years
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years
Minimum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	10 years
Minimum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years
Minimum | Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	6 years
Maximum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	18 years
Maximum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	27 years
Maximum | Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Research and Development (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Research, development and engineering costs	$ 32	$ 33	$ 34

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Effect of Change in Estimate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in Accounting Estimate [Line Items]
Net change in revolving credit facility and short-term debt	$ 0	$ (396)	$ 268
Proceeds from short-term debt	222	129	45
Payments of short-term debt	(165)	(131)	(45)
Net cash provided by financing activities	$ (1,526)	116	(25)
As Previously Reported
Change in Accounting Estimate [Line Items]
Net change in revolving credit facility and short-term debt		(398)	268
Proceeds from short-term debt		0	0
Payments of short-term debt		0	0
Net cash provided by financing activities		116	(25)
Adjustments
Change in Accounting Estimate [Line Items]
Net change in revolving credit facility and short-term debt		2	0
Proceeds from short-term debt		129	45
Payments of short-term debt		(131)	(45)
Net cash provided by financing activities		$ 0	$ 0

Acquisitions and Divestitures (

Acquisitions and Divestitures (Details) - USD ($) $ in Millions		1 Months Ended		3 Months Ended	12 Months Ended
	Oct. 03, 2023	Dec. 31, 2024	Apr. 30, 2022	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain on sale of equity method investment					$ 275	$ 0	$ 0
Income (loss) from equity in earnings of affiliates					0	14	42
Goodwill		$ 2,954		$ 2,954	2,954	3,117	2,951
Proceeds from sale of businesses, net of cash					0	0	182
Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]			Restructuring and other, net
Helvetia Packaging AG
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total consideration	$ 126
Property, plant, and equipment	70
Customer relationship intangible assets	14
Goodwill	$ 44
European Tinplate
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Income (loss) from equity in earnings of affiliates					$ (3)	9	34
Proceeds from dividend payment						$ 83	$ 26
Eviosys
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership share percentage		20%		20%	20%
Proceeds from sale of equity method investment		$ 338
Gain on sale of equity method investment				$ 275
Discontinued Operations, Disposed of by Sale | Transit Packaging
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of businesses, net of cash			$ 180
Pre-tax gain from disposal of business			$ 113

Cash, Cash Equivalents, and R_3

Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 918	$ 1,310
Restricted cash included in prepaid expenses and other current assets	98	90
Total cash, cash equivalents and restricted cash	$ 1,016	$ 1,400	$ 639	$ 593

Receivables - Schedule of Recei

Receivables - Schedule of Receivables (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Receivables [Abstract]
Accounts receivable	$ 1,060	$ 1,122
Less: allowance for credit losses	(30)	(29)
Net trade receivables	1,030	1,093
Unbilled receivables	316	338
Miscellaneous receivables	310	288
Receivables, net	$ 1,656	$ 1,719

Receivables - Narrative (Detail

Receivables - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Receivables [Abstract]
Transfer of financial assets accounted for as sales, amount derecognized	$ 1,119	$ 1,104
Factored receivables as secured borrowings	50
Expenses related to securitization and factoring facilities	$ 76	$ 82	$ 41

Inventories (Details)

Inventories (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 965	$ 1,031
Work in process	106	139
Finished goods	369	443
Total inventories	$ 1,440	$ 1,613

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Goodwill [Roll Forward]
Balance at beginning of period	$ 3,117	$ 2,951
Goodwill acquired		37
Foreign currency translation	(171)	129
Transfers and adjustments	8
Balance at end of period	2,954	3,117
Accumulated impairments	113	113
Americas Beverage
Goodwill [Roll Forward]
Balance at beginning of period	921	850
Goodwill acquired		0
Foreign currency translation	(94)	71
Transfers and adjustments	0
Balance at end of period	827	921
Accumulated impairments	29	29
European Beverage
Goodwill [Roll Forward]
Balance at beginning of period	550	491
Goodwill acquired		37
Foreign currency translation	(22)	22
Transfers and adjustments	8
Balance at end of period	536	550
Accumulated impairments	73	73
Transit Packaging
Goodwill [Roll Forward]
Balance at beginning of period	1,463	1,428
Goodwill acquired		0
Foreign currency translation	(50)	35
Transfers and adjustments	(3)
Balance at end of period	1,410	1,463
Other
Goodwill [Roll Forward]
Balance at beginning of period	183	182
Goodwill acquired		0
Foreign currency translation	(5)	1
Transfers and adjustments	3
Balance at end of period	181	183
Accumulated impairments	$ 11	$ 11

Intangible Assets - Schedule of

Intangible Assets - Schedule of Gross Carrying Amounts and Accumulated Amortization (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Gross	$ 2,168	$ 2,300
Accumulated amortization	(1,124)	(1,042)
Net	1,044	1,258
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	1,342	1,423
Accumulated amortization	(734)	(670)
Net	608	753
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross	522	539
Accumulated amortization	(148)	(130)
Net	374	409
Technology
Finite-Lived Intangible Assets [Line Items]
Gross	153	159
Accumulated amortization	(140)	(133)
Net	13	26
Long term supply contracts
Finite-Lived Intangible Assets [Line Items]
Gross	139	167
Accumulated amortization	(92)	(99)
Net	47	68
Patents
Finite-Lived Intangible Assets [Line Items]
Gross	12	12
Accumulated amortization	(10)	(10)
Net	$ 2	$ 2

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 151	$ 163	$ 159
Annual amortization expense:
2024	147
2025	138
2026	135
2027	134
2028	$ 122
Customer relationships | Helvetia Packaging AG
Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles acquired		$ 14

Property, Plant and Equipment -

Property, Plant and Equipment - Schedule of Components (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Buildings and improvements	$ 1,898	$ 1,888
Machinery and equipment	5,940	6,153
Land and improvements	265	269
Construction in progress	469	589
Property, plant and equipment, gross	8,572	8,899
Less: accumulated depreciation and amortization	(3,645)	(3,837)
Property, plant and equipment, net	$ 4,927	$ 5,062

Property, Plant, and Equipment

Property, Plant, and Equipment - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Capitalized interest related to construction in progress	$ 22	$ 39

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expense (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating lease costs:
Operating lease cost	$ 56	$ 54	$ 58
Short-term lease cost	2	2	2
Total operating lease costs	58	56	60
Finance lease cost:
Amortization of right-of-use assets	0	1	1
Total finance lease costs	$ 0	$ 1	$ 1

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Variable operating lease costs	$ 4	$ 5	$ 4
Interest on finance lease liabilities	$ 1	$ 1	$ 1

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 55	$ 54	$ 53
Financing cash flows from finance leases	2	2	1
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 52	$ 36	$ 87

Leases - Schedule of Suppleme_2

Leases - Schedule of Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Finance leases:
Property, plant and equipment	$ 19	$ 21
Accumulated depreciation	(3)	(3)
Property, plant and equipment, net	16	18
Accrued liabilities	1	1
Other non-current liabilities	3	5
Total finance lease liabilities	$ 4	$ 6
Weighted average remaining lease term (years):
Operating leases	9 years 4 months 24 days	9 years 6 months
Finance leases	3 years 1 month 6 days	4 years 1 month 6 days
Weighted average discount rate:
Operating leases	4.70%	4.50%
Finance leases	2.70%	3.50%
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment, net	Property, plant and equipment, net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities

Leases - Schedule of Operating

Leases - Schedule of Operating and Finance Lease Liability Maturity Schedule (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Operating Leases
2025	$ 49
2026	42
2027	33
2028	27
2029	23
Thereafter	97
Total lease payments	271
Less imputed interest	(57)
Total operating lease liabilities	214
Finance Leases
2025	2
2026	1
2027	1
2028	0
2029	0
Thereafter	0
Total lease payments	4
Less imputed interest	0
Total finance lease liabilities	$ 4	$ 6

Other Non-Current Assets - Sche

Other Non-Current Assets - Schedule of Components of Other Non-Current Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Investments, All Other Investments [Abstract]
Deferred taxes	$ 134	$ 132
Pension assets	88	94
Fair value of derivatives	86	47
Investments	22	87
Other	181	193
Other non-current assets	$ 511	$ 553

Other Non-Current Assets - Narr

Other Non-Current Assets - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Americas Beverage
Unusual or Infrequent Item, or Both [Line Items]
Accounts receivable noncurrent	$ 52	$ 66

Accrued Liabilities (Details)

Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Salaries and employee benefits	$ 170	$ 173
Income taxes	116	119
Accrued taxes, other than on income	76	85
Accrued interest	65	59
Pension and postretirement liabilities	32	25
Asbestos liabilities	20	20
Fair value of derivatives	14	20
Restructuring	13	22
Other	341	399
Accrued liabilities	$ 847	$ 922
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities

Supplier Finance Program Obli_3

Supplier Finance Program Obligations - Narrative (Details)	12 Months Ended
	Dec. 31, 2024
Supplier Finance Program [Line Items]
Supplier finance program, payment timing, period	150 days
Minimum
Supplier Finance Program [Line Items]
Supplier finance program, agreement notice, period	30 days

Supplier Finance Program Obli_4

Supplier Finance Program Obligations - Schedule of Obligations Outstanding Under Supplier Finance Programs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Supplier Finance Program, Obligation [Roll Forward]
Beginning balance	$ 862
Additions	2,107
Settlements	(2,032)
Foreign currency translation	(10)
Ending balance	$ 927
Supplier Finance Program, Obligation, Current, Statement of Financial Position [Extensible Enumeration]	Accounts payable	Accounts payable

Restructuring and Other - Sched

Restructuring and Other - Schedule of Restructuring and Other Charges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring	$ 49	$ 23	$ 35
Asset impairments and sales	19	72	(106)
Other costs	11	19	14
Asbestos	(4)	0	5
Restructuring and other	$ 75	$ 114	$ (52)

Restructuring and Other - Narra

Restructuring and Other - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended			12 Months Ended
	Apr. 30, 2022 USD ($)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($) installment	Dec. 31, 2023 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) employee
Restructuring Cost and Reserve [Line Items]
Restructuring					$ 49	$ 23	$ 35
Gain (loss) on restructuring					(19)	(72)	106
Other restructuring costs					11	19	14
Restructuring accrual		$ 13		$ 22	13	22
Severance payments					27
Food Can Plant, La Villa Mexico | Disposal Group, Disposed of by Sale, Not Discontinued Operations
Restructuring Cost and Reserve [Line Items]
Discontinued operations sale consideration			$ 30
Disposal group on sale consideration, number of annual installments | installment			3
Gain on sale of equipment			$ 22
Transit Packaging | Discontinued Operations, Disposed of by Sale
Restructuring Cost and Reserve [Line Items]
Pre-tax gain from disposal of business	$ 113
Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring					4	(1)	35
Severance and Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring			$ 6
Plant Closures | Batesville, Mississippi
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring		$ (19)
Plant Closures | Sihanoukville, Cambodia
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring					(20)
Plant Closures | Dong Nai, Vietnam
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring				(19)
Plant Closures | Ho Chi Minh City, Vietnam and Singapore
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring				(8)
Plant Closures | Decatur, Illinois
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring				$ (5)
Line Consolidation | Dong Nai, Vietnam
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring					(11)
Termination Benefits and Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring						11
Termination | European Beverage and Other
Restructuring Cost and Reserve [Line Items]
Restructuring						9
Other Exit Costs
Restructuring Cost and Reserve [Line Items]
Restructuring					34	8	6
Other Exit Costs | European Beverage and Other
Restructuring Cost and Reserve [Line Items]
Restructuring						3
Fines
Restructuring Cost and Reserve [Line Items]
Other restructuring costs						11
Tax Indemnity Charges | European Tinplate
Restructuring Cost and Reserve [Line Items]
Other restructuring costs						$ 4
Overhead Cost Reduction
Restructuring Cost and Reserve [Line Items]
Severance payments					$ 6
Overhead Cost Reduction | Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring							$ 29
Number of positions to be eliminated | employee							600

Restructuring and Other - Sch_2

Restructuring and Other - Schedule of Charges by Segment and Type (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 49	$ 23	$ 35
Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring	15	15	29
Other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring	34	8	6
Americas Beverage
Restructuring Cost and Reserve [Line Items]
Restructuring	11	4	0
European Beverage
Restructuring Cost and Reserve [Line Items]
Restructuring	17	9	0
Asia Pacific
Restructuring Cost and Reserve [Line Items]
Restructuring	4	7	0
Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring	4	(1)	35
Other
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 13	$ 4	$ 0

Debt - Schedule of Outstanding

Debt - Schedule of Outstanding Debt (Details) $ in Millions	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)	Aug. 31, 2024 EUR (€)	Dec. 31, 2023 USD ($)	Dec. 31, 2023 EUR (€)
Principal outstanding
Short-term debt	$ 66			$ 16
Total long-term debt	6,171			7,496
Less: current maturities	(80)			(759)
Total long-term debt, less current maturities	6,091			6,737
Carrying amount
Short-term debt	66			16
Total long-term debt	6,138			7,458
Less: current maturities	(80)			(759)
Total long-term debt, less current maturities	6,058			6,699
Secured Secured Borrowings | U.S. dollar due 2027
Principal outstanding
Total long-term debt	1,175			1,575
Carrying amount
Total long-term debt	1,171			1,569
Secured Secured Borrowings | Euro due 2027
Principal outstanding
Total long-term debt	538			589
Carrying amount
Total long-term debt	538			589
Debt instrument, face amount | €		€ 520,000,000			€ 533,000,000
Senior Notes and Debentures | €600 at 2.625% due 2024
Principal outstanding
Total long-term debt	0			663
Carrying amount
Total long-term debt	$ 0			662
Debt instrument, face amount | €		€ 600,000,000	€ 600,000,000
Debt instrument stated percentage	2.625%	2.625%	2.625%
Senior Notes and Debentures | €600 at 3.375% due 2025
Principal outstanding
Total long-term debt	$ 0			663
Carrying amount
Total long-term debt	$ 0			662
Debt instrument, face amount | €		€ 600,000,000
Debt instrument stated percentage	3.375%	3.375%
Senior Notes and Debentures | U.S. dollar at 4.25% due 2026
Principal outstanding
Total long-term debt	$ 400			400
Carrying amount
Total long-term debt	$ 399			398
Debt instrument stated percentage	4.25%	4.25%
Senior Notes and Debentures | U.S. dollar at 4.75% due 2026
Principal outstanding
Total long-term debt	$ 875			875
Carrying amount
Total long-term debt	$ 873			871
Debt instrument stated percentage	4.75%	4.75%
Senior Notes and Debentures | U.S. dollar at 7.375% due 2026
Principal outstanding
Total long-term debt	$ 350			350
Carrying amount
Total long-term debt	$ 350			350
Debt instrument stated percentage	7.375%	7.375%
Senior Notes and Debentures | €500 at 2.875% due 2026
Principal outstanding
Total long-term debt	$ 518			552
Carrying amount
Total long-term debt	$ 517			550
Debt instrument, face amount | €		€ 500,000,000
Debt instrument stated percentage	2.875%	2.875%
Senior Notes and Debentures | €500 at 5.00% due 2028
Principal outstanding
Total long-term debt	$ 518			552
Carrying amount
Total long-term debt	$ 513			544
Debt instrument, face amount | €		€ 500,000,000
Debt instrument stated percentage	5%	5%
Senior Notes and Debentures | €500 at 4.75% due 2029
Principal outstanding
Total long-term debt	$ 518			552
Carrying amount
Total long-term debt	$ 513			544
Debt instrument, face amount | €		€ 500,000,000
Debt instrument stated percentage	4.75%	4.75%
Senior Notes and Debentures | €600 at 4.50% due 2030
Principal outstanding
Total long-term debt	$ 621			0
Carrying amount
Total long-term debt	$ 611			0
Debt instrument, face amount | €		€ 600,000,000	€ 600,000,000
Debt instrument stated percentage	4.50%	4.50%	4.50%
Senior Notes and Debentures | U.S. dollar at 5.25% due 2030
Principal outstanding
Total long-term debt	$ 500			500
Carrying amount
Total long-term debt	$ 495			494
Debt instrument stated percentage	5.25%	5.25%
Senior Notes and Debentures | U.S. dollar at 7.50% due 2096
Principal outstanding
Total long-term debt	$ 40			40
Carrying amount
Total long-term debt	$ 40			40
Debt instrument stated percentage	7.50%	7.50%
Other Indebtedness, Fixed Rate
Principal outstanding
Total long-term debt	$ 108			169
Carrying amount
Total long-term debt	$ 108			169
Other Indebtedness, Fixed Rate | Minimum
Carrying amount
Debt instrument stated percentage	2.80%	2.80%
Other Indebtedness, Fixed Rate | Maximum
Carrying amount
Debt instrument stated percentage	7.60%	7.60%
Other Indebtedness, Variable Rate
Principal outstanding
Total long-term debt	$ 10			16
Carrying amount
Total long-term debt	$ 10			16
Average variable rates	3.60%	3.60%
Revolving credit facilities | Line of credit
Principal outstanding
Total long-term debt	$ 0			0
Carrying amount
Total long-term debt	$ 0			$ 0

Debt - Narrative (Details)

Debt - Narrative (Details) $ in Millions	1 Months Ended		12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2024 EUR (€)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 EUR (€)	Aug. 31, 2024 EUR (€)
Debt Instrument [Line Items]
Payments of long-term debt			$ 1,788	$ 312	$ 2,278
Letters of credit outstanding, amount	$ 36		36
Aggregate maturities of long term debt excluding unamortized discounts, year one	80		80
Aggregate maturities of long term debt excluding unamortized discounts, year two	2,225		2,225
Aggregate maturities of long term debt excluding unamortized discounts, year three	1,669		1,669
Aggregate maturities of long term debt excluding unamortized discounts, year four	518		518
Aggregate maturities of long term debt excluding unamortized discounts, year five	518		518
Cash payments for interest			367	390	$ 270
Revolving credit facilities
Debt Instrument [Line Items]
Credit facility, available borrowing capacity	1,614		1,614
Line of credit facility, maximum borrowing capacity	$ 1,650		$ 1,650
Debt covenant, leverage ratio	4.50		4.50			4.50
Maximum | Revolving credit facilities
Debt Instrument [Line Items]
Provisions for letters of credit	$ 335		$ 335
Basis spread on variable rate (as a percent)			1.60%
Minimum | Revolving credit facilities
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)			0%
Senior Notes and Debentures | €600 at 3.375% due 2025
Debt Instrument [Line Items]
Debt instrument stated percentage	3.375%		3.375%			3.375%
Payments of long-term debt | €		€ 600,000,000
Secured Secured Borrowings | U.S. dollar due 2027
Debt Instrument [Line Items]
Payments of long-term debt	$ 400
Senior Notes and Debentures | €600 at 4.50% due 2030
Debt Instrument [Line Items]
Debt instrument, face amount | €						€ 600,000,000	€ 600,000,000
Debt instrument stated percentage	4.50%		4.50%			4.50%	4.50%
Senior Notes and Debentures | €600 at 2.625% due 2024
Debt Instrument [Line Items]
Debt instrument, face amount | €						€ 600,000,000	€ 600,000,000
Debt instrument stated percentage	2.625%		2.625%			2.625%	2.625%
Senior Notes and Debentures | €600 at 3.375% due 2025
Debt Instrument [Line Items]
Debt instrument, face amount | €						€ 600,000,000
Debt instrument stated percentage	3.375%		3.375%			3.375%
Senior Notes and Debentures | €500 at 5.00% due 2028
Debt Instrument [Line Items]
Debt instrument, face amount | €						€ 500,000,000
Debt instrument stated percentage	5%		5%			5%
Senior Notes and Debentures | €500 at 4.75% due 2029
Debt Instrument [Line Items]
Debt instrument, face amount | €						€ 500,000,000
Debt instrument stated percentage	4.75%		4.75%			4.75%
Secured Secured Borrowings | SOFR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)			1.10%
Secured Secured Borrowings | EURIBOR
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)			1%
Level 2
Debt Instrument [Line Items]
Long-term debt, fair value	$ 6,255		$ 6,255	$ 7,484

Debt - Schedule of Weighted Ave

Debt - Schedule of Weighted Average Interest Rates (Details)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Short-term debt	4.30%	13.20%	3.80%
Revolving credit facilities	4.70%	4.50%	2.50%

Derivative and Other Financia_3

Derivative and Other Financial Instruments - Narrative (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2024 EUR (€)
Derivative Instruments, Gain (Loss) [Line Items]
Objectives for using derivative instruments	The Company’s objective in managing exposure to market and interest rate risk is to limit the impact on earnings and cash flow.
Net gain (loss) to be reclassified to earnings	$ 5
Loss, net of tax, expected to be reclassified to earnings	4
Reclassification of anticipated transactions that were no longer considered probable	0	$ 0
Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax	84	(52)
Gain (loss) on net investment hedge, net of tax	63	(43)
Gain on net investment hedge settlements, net of tax	(1,462)	(1,687)
Reduction in interest expense	25	25	$ 25
Cumulative amount of fair value hedging adjustment included in the carrying about of the hedged assets		2
Hedged liability, fair value hedge, cumulative increase (decrease)		2
Accumulated Other Comprehensive Gain
Derivative Instruments, Gain (Loss) [Line Items]
Gain on net investment hedge settlements	133	49
Gain on net investment hedge settlements, net of tax	131	68
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Carrying amount of hedging investment	1,291			€ 1,246
Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on foreign exchange contracts designated as fair value hedges	7	(12)
Other comprehensive income (loss), net investment hedge, gain (loss), before reclassification and tax	29	$ (33)
Cross currency swap
Derivative Instruments, Gain (Loss) [Line Items]
Aggregate notional amount	$ 875
Minimum
Derivative Instruments, Gain (Loss) [Line Items]
Contracts outstanding, maturity	1 month			1 month
Maximum
Derivative Instruments, Gain (Loss) [Line Items]
Contracts outstanding, maturity	24 months			24 months

Derivative and Other Financia_4

Derivative and Other Financial Instruments - Schedule of Cash Flow Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain / (loss) recognized in AOCI	$ 5	$ (10)
Net sales	11,801	12,010	$ 12,943
Cost of products sold, excluding depreciation and amortization	9,262	9,546	10,643
Income before income taxes and equity in net earnings of affiliates	743	795	1,056
Provision for income taxes	183	222	243
Net income	560	587	$ 855
Derivatives in Cash Flow Hedges | Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Provision for income taxes	0	7
Net income	(3)	(22)
Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain / (loss) recognized in AOCI	(1)	(2)
Foreign exchange | Cost of products sold, excluding depreciation and amortization | Derivatives in Cash Flow Hedges | Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Cost of products sold, excluding depreciation and amortization	(1)	0
Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain / (loss) recognized in AOCI	6	(8)
Commodities | Derivatives in Cash Flow Hedges | Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Income before income taxes and equity in net earnings of affiliates	(3)	(29)
Commodities | Net sales | Derivatives in Cash Flow Hedges | Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Net sales	(16)	9
Commodities | Cost of products sold, excluding depreciation and amortization | Derivatives in Cash Flow Hedges | Derivatives designated as hedging instruments | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Cost of products sold, excluding depreciation and amortization	$ 14	$ (38)

Derivative and Other Financia_5

Derivative and Other Financial Instruments - Schedule of Fair Value Hedges and Contracts Not Designated as Hedges (Details) - Derivatives not designated as hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	$ 15	$ (8)
Foreign exchange | Cost of products sold, excluding depreciation and amortization
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	0	(4)
Foreign exchange | Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	$ 15	$ (4)

Derivative and Other Financia_6

Derivative and Other Financial Instruments - Schedule of Net Investment Hedges (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Amount of gain / (loss) recognized in AOCI	$ 84	$ (52)
Foreign exchange
Derivative [Line Items]
Amount of gain / (loss) recognized in AOCI	$ 29	$ (33)

Derivative and Other Financia_7

Derivative and Other Financial Instruments - Schedule of Fair Values of Derivative Instruments and Valuation Hierarchy (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivative assets
Total derivatives	$ 102	$ 64
Derivative liabilities
Total derivatives	14	20
Level 2
Derivative assets
Derivatives designated as hedging instruments	98	61
Total derivatives	102	64
Derivative liabilities
Derivatives designated as hedging instruments	7	17
Total derivatives	14	20
Level 2 | Prepaid expenses and other current assets | Foreign exchange
Derivative assets
Derivatives not designated as hedging instruments	4	3
Level 2 | Prepaid expenses and other current assets | Foreign exchange | Cash flow hedges
Derivative assets
Derivatives designated as hedging instruments	2	1
Level 2 | Prepaid expenses and other current assets | Foreign exchange | Fair value hedges
Derivative assets
Derivatives designated as hedging instruments	0	0
Level 2 | Prepaid expenses and other current assets | Commodities contracts cash flow | Cash flow hedges
Derivative assets
Derivatives designated as hedging instruments	10	13
Level 2 | Other non-current assets | Net investment hedge
Derivative assets
Derivatives designated as hedging instruments	86	47
Level 2 | Accrued liabilities | Foreign exchange
Derivative liabilities
Derivatives not designated as hedging instruments	7	3
Level 2 | Accrued liabilities | Foreign exchange | Cash flow hedges
Derivative liabilities
Derivatives designated as hedging instruments	4	2
Level 2 | Accrued liabilities | Foreign exchange | Fair value hedges
Derivative liabilities
Derivatives designated as hedging instruments	0	2
Level 2 | Accrued liabilities | Commodities contracts cash flow | Cash flow hedges
Derivative liabilities
Derivatives designated as hedging instruments	3	13
Level 2 | Other non-current liabilities | Net investment hedge
Derivative liabilities
Derivatives designated as hedging instruments	$ 0	$ 0

Derivative and Other Financia_8

Derivative and Other Financial Instruments - Schedule of Fair Value Hedge Carrying Amounts (Details) - Derivatives in Fair Value Hedges - Derivative as Hedging Instrument - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Cash and cash equivalents
Derivative [Line Items]
Carrying amount of hedged assets	$ 0	$ 2
Receivables, net
Derivative [Line Items]
Carrying amount of hedged assets	0	12
Accrued liabilities
Derivative [Line Items]
Accrued liabilities	$ 0	$ 120

Derivative and Other Financia_9

Derivative and Other Financial Instruments - Schedule of Offsetting of Derivative Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Derivative assets
Gross amounts recognized in the Balance Sheet	$ 102	$ 64
Gross amounts not offset in the Balance Sheet	3	7
Net amount	99	57
Derivative liabilities
Gross amounts recognized in the Balance Sheet	14	20
Gross amounts not offset in the Balance Sheet	3	7
Net amount	$ 11	$ 13

Derivative and Other Financi_10

Derivative and Other Financial Instruments - Schedule of Notional Values of Outstanding Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Foreign exchange | Derivatives not designated as hedging instruments
Derivatives, Fair Value [Line Items]
Derivative, notional values	$ 305	$ 302
Foreign exchange | Derivatives in Cash Flow Hedges | Derivative as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative, notional values	380	75
Foreign exchange | Derivatives in Fair Value Hedges | Derivative as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative, notional values	0	202
Foreign exchange | Net Investment Hedging | Derivative as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative, notional values	875	875
Commodities | Derivatives in Cash Flow Hedges | Derivative as Hedging Instrument
Derivatives, Fair Value [Line Items]
Derivative, notional values	$ 73	$ 160

Asbestos-Related Liabilities -

Asbestos-Related Liabilities - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2024 USD ($) claim pendingClaim	Dec. 31, 2023 USD ($) claim	Dec. 31, 2022 USD ($) claim	Dec. 31, 2021 claim
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Holding period for insulation operations (in days)	90 days
Asbestos payments	$ 15	$ 17	$ 21
Number of inactive claims | claim	19,000
Claims that do not specify damages (as a percent)	82%
Claims outstanding | claim	59,300	58,500	57,500	57,000
Accrued asbestos claims and related legal costs	$ 185
Accrued asbestos unasserted claims	$ 141
Damage claims less than $5
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	15%
Damage claims less than $5 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 5
Damage claims from $5 to less than $100
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	3%
Damage claims from $5 to less than $100 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 100
Damage claims from $5 to less than $100 | Minimum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 5
Damage claims less than $25
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	29%
Damage claims less than $25 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 25
Damages claims in excess of $100
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 100
Claims outstanding | pendingClaim	14

Asbestos-Related Liabilities _2

Asbestos-Related Liabilities - Schedule of Claims Activity (Details) - claim	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Loss Contingency Accrual [Roll Forward]
Beginning claims	58,500	57,500	57,000
New claims	1,400	1,500	1,500
Settlements or dismissals	(600)	(500)	(1,000)
Ending claims	59,300	58,500	57,500

Asbestos-Related Liabilities _3

Asbestos-Related Liabilities - Schedule of Outstanding Claims by Year of Exposure and State Filed (Details) - claim	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	59,300	58,500	57,500	57,000
Claimants alleging first exposure after 1964
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	18,000	18,000
Asbestos Before Or During 1964 | Texas
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	13,000	13,000
Asbestos Before Or During 1964 | Pennsylvania
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	1,300	1,500
Asbestos Before Or During 1964 | Other states that have enacted asbestos legislation
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	6,000	6,000
Asbestos Before Or During 1964 | Other states
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	21,000	20,000

Asbestos-Related Liabilities _4

Asbestos-Related Liabilities - Schedule of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases (Details)	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Total claims
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims alleging serious diseases (as a percent)	27%	25%	24%
Pre-1965 claims in states without asbestos legislation
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims alleging serious diseases (as a percent)	43%	44%	43%

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) € in Millions, $ in Millions	1 Months Ended
	Jul. 31, 2022 USD ($)	Dec. 31, 2024 USD ($)	Jun. 30, 2024 USD ($)	Dec. 29, 2023 EUR (€)	Mar. 31, 2017 USD ($)
Violation of Articles 101 of the Treaty of the French Commercial Code by FCA
Commitments And Contingent Liabilities [Line Items]
Initial and subsequent penalty assessed | €				€ 4
Disallowance, Input Tax Credit | Brazil
Commitments And Contingent Liabilities [Line Items]
Initial and subsequent penalty assessed			$ 42
CCK vs. FCO
Commitments And Contingent Liabilities [Line Items]
Fine amount	$ 8
PRP Site
Commitments And Contingent Liabilities [Line Items]
Estimated future remediation costs		$ 12
Non- PRP Sites
Commitments And Contingent Liabilities [Line Items]
Estimated future remediation costs		$ 8
U.S. Customs and Border Protection | Penalty Notification Alleging Misclassification of Importation of Certain Goods into U.S. During 2004-2009
Commitments And Contingent Liabilities [Line Items]
Initial and subsequent penalty assessed					$ 18

Other Non-Current Liabilities_2

Other Non-Current Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Deferred taxes	$ 338	$ 338
Asbestos liabilities	165	184
Postemployment benefits	23	22
Income taxes payable	18	27
Environmental	12	12
Other	114	98
Other non-current liabilities	$ 670	$ 681

Pension and Other Postretirem_3

Pension and Other Postretirement Benefits - Schedule of Components of Pension Expense (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Postretirement Benefits
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost		$ 0	$ 0	$ 1
Interest cost		6	6	4
Amortization of actuarial loss		0	0	2
Amortization of prior service cost		0	0	(20)
Net periodic cost		6	6	(13)
U.S. Plans | Pension Plan
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost		15	13	19
Interest cost		40	54	31
Expected return on plan assets		(46)	(60)	(75)
Settlements	$ 469
Settlements and curtailments		469	0	1
Amortization of actuarial loss		32	43	44
Amortization of prior service cost		1	1	1
Net periodic cost		511	51	21
Non-U.S. Plans | Pension Plan
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost		7	7	9
Interest cost		16	19	13
Expected return on plan assets		(18)	(22)	(22)
Settlements	$ 47	44	0	0
Special termination benefits		0	6	0
Amortization of actuarial loss		2	3	5
Amortization of prior service cost		0	0	(1)
Net periodic cost		$ 51	$ 13	$ 4

Pension and Other Postretirem_4

Pension and Other Postretirement Benefits - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Multiemployer plans, additional expense		$ 6	$ 6	$ 5
Actuarial gain		25
Amounts of common stock included in plan assets			297
Total contributions		13	14	13
Pension Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Expected contributions		20
Pension Plan | Foreign Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Amount of irrevocable transfer	$ 119	122	8
Settlement charge	47	44	0	$ 0
Employer contributions			17
Actuarial gain		7	(18)
Pension Plan | U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Amount of irrevocable transfer	740	775	0
Settlement charge	469
Employer contributions	$ 100	125	2
Plan obligations settled		35
Actuarial gain		$ 15	$ (36)

Pension and Other Postretirem_5

Pension and Other Postretirement Benefits - Schedule of Projected and Changes in Benefit Obligations (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Projected Benefit Obligations
Actuarial (gain) / loss		$ (25)
Other Postretirement Benefits
Projected Benefit Obligations
Benefit obligations at beginning of period		107	$ 108
Service cost		0	0	$ 1
Interest cost		6	6	4
Actuarial (gain) / loss		(2)	0
Benefits paid		(9)	(11)
Foreign currency translation		(6)	4
Benefit obligations at end of period		96	107	108
U.S. Plans | Pension Plan
Projected Benefit Obligations
Benefit obligations at beginning of period		1,109	1,094
Service cost		15	13	19
Interest cost		40	54	31
Plan participants' contributions		0	0
Amendments		0	1
Settlements	$ (740)	(775)	0
Special termination benefits		0	0
Actuarial (gain) / loss		(15)	36
Benefits paid		(75)	(89)
Foreign currency translation		0	0
Benefit obligations at end of period		299	1,109	1,094
Plan Assets
Balance at beginning of period		880	886
Actual gain on plan assets		40	81
Employer contributions / (withdrawals)	100	125	2
Plan participants' contributions		0	0
Settlements		(775)	0
Benefits paid		(75)	(89)
Foreign currency translation		0	0
Balance at end of period		195	880	886
Funded status		(104)	(229)
Accumulated benefit obligations at end of period		257	1,065
Non-U.S. Plans | Pension Plan
Projected Benefit Obligations
Benefit obligations at beginning of period		415	387
Service cost		7	7	9
Interest cost		16	19	13
Plan participants' contributions		2	2
Amendments		0	(2)
Settlements	$ (119)	(122)	(8)
Special termination benefits		0	6
Actuarial (gain) / loss		(7)	18
Benefits paid		(22)	(38)
Foreign currency translation		(31)	24
Benefit obligations at end of period		258	415	387
Plan Assets
Balance at beginning of period		412	381
Actual gain on plan assets		27	33
Employer contributions / (withdrawals)			17
Employer contributions / (withdrawals)		(12)
Plan participants' contributions		1	2
Settlements		(122)	(7)
Benefits paid		(22)	(38)
Foreign currency translation		(30)	24
Balance at end of period		254	412	$ 381
Funded status		(4)	(3)
Accumulated benefit obligations at end of period		$ 229	$ 389

Pension and Other Postretirem_6

Pension and Other Postretirement Benefits - Schedule of Accumulated Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 93	$ 1,109
Accumulated benefit obligations	88	1,065
Fair value of plan assets	0	880
Non-U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	199	213
Accumulated benefit obligations	179	195
Fair value of plan assets	$ 114	$ 117

Pension and Other Postretirem_7

Pension and Other Postretirement Benefits - Schedule of Projected Benefit Obligations in Excess of Plan Assets (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 296	$ 1,109
Accumulated benefit obligations	255	1,065
Fair value of plan assets	192	880
Foreign Plan
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	199	213
Accumulated benefit obligations	179	195
Fair value of plan assets	$ 114	$ 117

Pension and Other Postretirem_8

Pension and Other Postretirement Benefits - Schedule of Strategic Ranges for Assets Allocation Plan (Details) - Pension Plan - U.S. Plans	Dec. 31, 2024
Minimum | U.S. equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	45%
Minimum | International equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.50%
Minimum | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	15%
Minimum | Balanced funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.50%
Minimum | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.50%
Maximum | U.S. equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	55%
Maximum | International equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	12.50%
Maximum | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	25%
Maximum | Balanced funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	12.50%
Maximum | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	12.50%

Pension and Other Postretirem_9

Pension and Other Postretirement Benefits - Schedule of Defined Benefit Plan Assets (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible Enumeration]	Fair Value Measured at Net Asset Value Per Share	Fair Value Measured at Net Asset Value Per Share
Investment funds - global equity
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible Enumeration]	Fair Value Measured at Net Asset Value Per Share	Fair Value Measured at Net Asset Value Per Share
Investment funds - emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible Enumeration]		Fair Value Measured at Net Asset Value Per Share
Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible Enumeration]		Fair Value Measured at Net Asset Value Per Share
Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	$ 172	$ 234	$ 252
Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	2	3	5
Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	170	231	247
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Total investments at fair value	449	1,291
Pension Plan | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	404	1,053
Pension Plan | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	105	641
Pension Plan | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	36	38
Pension Plan | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	8	3
Pension Plan | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	10	177
Pension Plan | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		297
Pension Plan | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		59
Pension Plan | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	51	49
Pension Plan | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		18
Pension Plan | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	127	178
Pension Plan | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	1	1
Pension Plan | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	18	18
Pension Plan | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	6	49
Pension Plan | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	102	110
Pension Plan | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	172	234
Pension Plan | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	134	187
Pension Plan | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	2	3
Pension Plan | Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	36	44
Pension Plan | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	45	238
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	25	108
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds - global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	20	118
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds - emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		5
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		7
Pension Plan | United States
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	195	880	886
Total investments at fair value	195	879
Accrued income	0	1
Pension Plan | United States | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	195	788
Pension Plan | United States | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	59	590
Pension Plan | United States | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	8	15
Pension Plan | United States | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | United States | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	173
Pension Plan | United States | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		276
Pension Plan | United States | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		59
Pension Plan | United States | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	51	49
Pension Plan | United States | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		18
Pension Plan | United States | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	41
Pension Plan | United States | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | United States | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | United States | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	41
Pension Plan | United States | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | United States | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	136	157
Pension Plan | United States | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	106	127
Pension Plan | United States | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	2	3
Pension Plan | United States | Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	28	27
Pension Plan | United States | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	91
Pension Plan | United States | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	86
Pension Plan | United States | Fair Value Measured at Net Asset Value Per Share | Investment funds - global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | United States | Fair Value Measured at Net Asset Value Per Share | Investment funds - emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		5
Pension Plan | United States | Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		0
Pension Plan | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	254	412	$ 381
Total investments at fair value	254	412
Pension Plan | Non-U.S. Plans | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	209	265
Pension Plan | Non-U.S. Plans | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	46	51
Pension Plan | Non-U.S. Plans | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	28	23
Pension Plan | Non-U.S. Plans | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	8	3
Pension Plan | Non-U.S. Plans | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	10	4
Pension Plan | Non-U.S. Plans | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		21
Pension Plan | Non-U.S. Plans | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		0
Pension Plan | Non-U.S. Plans | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | Non-U.S. Plans | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		0
Pension Plan | Non-U.S. Plans | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	127	137
Pension Plan | Non-U.S. Plans | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	1	1
Pension Plan | Non-U.S. Plans | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	18	18
Pension Plan | Non-U.S. Plans | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	6	8
Pension Plan | Non-U.S. Plans | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	102	110
Pension Plan | Non-U.S. Plans | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	36	77
Pension Plan | Non-U.S. Plans | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	28	60
Pension Plan | Non-U.S. Plans | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	0	0
Pension Plan | Non-U.S. Plans | Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	8	17
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	45	147
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	25	22
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds - global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets	$ 20	118
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds - emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		0
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets		$ 7

Pension and Other Postretire_10

Pension and Other Postretirement Benefits - Schedule of Reconciliation of Plan Assets Measured by Significant Unobservable Inputs (Details) - Level 3 - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Plan Assets
Balance at beginning of period	$ 234	$ 252
Foreign currency translation	(4)	2
Asset returns – assets held at reporting date	(3)	(6)
Asset returns – assets sold during the period	(2)	(7)
Purchases, sales and settlements, net	(53)	(7)
Balance at end of period	172	234
Private equity
Plan Assets
Balance at beginning of period	3	5
Foreign currency translation	0	0
Asset returns – assets held at reporting date	3	18
Asset returns – assets sold during the period	(4)	(18)
Purchases, sales and settlements, net	0	(2)
Balance at end of period	2	3
Real estate
Plan Assets
Balance at beginning of period	231	247
Foreign currency translation	(4)	2
Asset returns – assets held at reporting date	(6)	(24)
Asset returns – assets sold during the period	2	11
Purchases, sales and settlements, net	(53)	(5)
Balance at end of period	$ 170	$ 231

Pension and Other Postretire_11

Pension and Other Postretirement Benefits - Schedule of Additional Information About Pension Plan Assets Valued Using Net Asset Value (Details) - Fair Value Measured at Net Asset Value Per Share - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets	$ 45	$ 238
Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets	$ 25	108
Redemption Notice Period	10 days
Investment funds - global equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets	$ 20	$ 118
Redemption Notice Period	10 days	10 days
Investment funds - emerging markets
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets		$ 5
Redemption Notice Period		30 days
Investment funds – real estate
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets		$ 7
Redemption Notice Period		10 days
Minimum | Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period		1 day
Maximum | Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period		5 days

Pension and Other Postretire_12

Pension and Other Postretirement Benefits - Schedule of Pension Assets/(Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Retirement Benefits [Abstract]
Non-current assets	$ 88	$ 94
Current liabilities	22	12
Non-current liabilities	$ 174	$ 314

Pension and Other Postretire_13

Pension and Other Postretirement Benefits - Schedule of Changes in Net Loss and Prior Service Cost/(Credit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pension Plan
Net loss / (gain)
Balance at beginning of period	$ 686	$ 712	$ 814
Reclassification to net periodic benefit cost	(551)	(46)	(49)
Current year (gain) / loss	(25)	22	(45)
Amendments	0	(1)	0
Foreign currency translation	(1)	(1)	(8)
Balance at end of period	109	686	712
Prior service
Balance at beginning of period	(1)	0	2
Reclassification to net periodic benefit cost	(1)	(1)	(1)
Current year (gain) / loss	0	0	(1)
Amendments	0	0	0
Foreign currency translation	0	0	0
Balance at end of period	(2)	(1)	0
Other Postretirement Benefits
Net loss / (gain)
Balance at beginning of period	(3)	(2)	21
Reclassification to net periodic benefit cost	0	0	(2)
Current year (gain) / loss	(3)	0	(22)
Foreign currency translation	1	(1)	1
Balance at end of period	(5)	(3)	(2)
Prior service
Balance at beginning of period	0	0	(20)
Reclassification to net periodic benefit cost	0	0	20
Current year (gain) / loss	0	0	0
Foreign currency translation	0	0	0
Balance at end of period	$ 0	$ 0	$ 0

Pension and Other Postretire_14

Pension and Other Postretirement Benefits - Schedule of Expected Future Benefit Payments (Details) $ in Millions	Dec. 31, 2024 USD ($)
Other Postretirement Benefits
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2025	$ 12
2026	10
2027	10
2028	9
2029	9
2030 - 2034	39
Defined Benefit Plan, Expected Future Benefit Payment 2020
2025	12
2026	10
2027	10
2028	9
2029	9
2030 - 2034	39
U.S. Plans | Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2025	17
2026	16
2027	33
2028	11
2029	13
2030 - 2034	90
Defined Benefit Plan, Expected Future Benefit Payment 2020
2025	17
2026	16
2027	33
2028	11
2029	13
2030 - 2034	90
Non-U.S. Plans | Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2025	20
2026	17
2027	16
2028	19
2029	19
2030 - 2034	102
Defined Benefit Plan, Expected Future Benefit Payment 2020
2025	20
2026	17
2027	16
2028	19
2029	19
2030 - 2034	$ 102

Pension and Other Postretire_15

Pension and Other Postretirement Benefits - Schedule of Assumptions Used (Details) - Pension Plan	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	5.90%	5%	5.20%
Compensation increase	5%	5%	5%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - service cost	5.20%	5.40%	3.30%
Discount rate - interest cost	4.90%	5.10%	2.20%
Compensation increase	5%	5%	4.70%
Long-term rate of return	7.20%	7.20%	6.60%
Non-U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	5.10%	4.80%	4.90%
Compensation increase	2.80%	2.90%	2.70%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - service cost	4.70%	5%	2.90%
Discount rate - interest cost	4.70%	5.10%	2.60%
Compensation increase	2.90%	2.90%	2.70%
Long-term rate of return	4.20%	5.10%	4.30%

Pension and Other Postretire_16

Pension and Other Postretirement Benefits - Schedule of Assumed Health Care Cost Trend Rates (Details) - Other Postretirement Benefits	Dec. 31, 2024
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Health care cost trend rate assumed for 2024	5.90%
Rate that the cost trend rate gradually declines to	4.10%

Pension and Other Postretire_17

Pension and Other Postretirement Benefits - Schedule of Weighted Average Discount Rates used to Calculate the Benefit Obligations (Details) - Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Benefit obligations	6.50%	5%	5.80%
Service cost	8.10%	5.30%	7.80%
Interest cost	5.80%	4.90%	5.70%

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Income Before Income Taxes and Equity Earnings (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]
U.S.	$ (448)	$ (1)	$ 295
Foreign	1,191	796	761
Income before income taxes and equity in net earnings of affiliates	$ 743	$ 795	$ 1,056

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current tax:
U.S. federal	$ 89	$ 31	$ 18
State and foreign	262	244	190
Current tax, total	351	275	208
Deferred tax:
U.S. federal	(109)	(27)	46
State and foreign	(59)	(26)	(11)
Deferred tax, total	(168)	(53)	35
Total	$ 183	$ 222	$ 243

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Reconciliation (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Effective Income Tax Rate Reconciliation, Amount [Abstract]
U.S. statutory rate at 21%	$ 156	$ 167	$ 222
Statutory tax rate differences	(17)	6	9
Taxes on foreign income	(30)	1	(39)
Foreign withholding taxes	19	23	5
U.S. taxes on foreign income, net of credits	67	5	1
State taxes	(12)	2	(2)
Valuation allowance changes	(17)	5	33
Tax contingencies	6	2	7
Tax law changes	5	8	2
Other items, net	6	3	5
Total	$ 183	$ 222	$ 243

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jul. 08, 2022
Income Taxes [Line Items]
Gain on sale of equity method investment		$ 275	$ 0	$ 0
Distribution from equity method investment		338	68	7
Deferred tax benefit from release of valuation allowance		17	(5)	(33)
Undistributed earnings on non-U.S. subsidiaries	$ 1,100	1,100
Taxes paid		398	262	223
Valuation allowance	152	152	178		$ 78
Interest and penalties expense (less than in 2022 and 2021)		2	2	1
Unrecognized tax benefits that if recognized would affect ETR	46	46
Eviosys
Income Taxes [Line Items]
Gain on sale of equity method investment	275
Distribution from equity method investment	338
Tax charge from sale of equity method investment	64
France | Tax Loss Carryforwards
Income Taxes [Line Items]
Valuation allowance	62	62
Foreign | Transit Packaging | Discontinued Operations, Disposed of by Sale
Income Taxes [Line Items]
Income tax charges on sale of business				11
Foreign | Brazil
Income Taxes [Line Items]
Increase in net income attributable to the Company resulting from incentives		22	$ 20	21
Foreign | Switzerland
Income Taxes [Line Items]
Deferred tax assets, goodwill amortization				21
Net operating loss carryforward				$ 21
Foreign | France
Income Taxes [Line Items]
Tax loss carryforwards	76	76
Foreign | Luxembourg
Income Taxes [Line Items]
Tax loss carryforwards	25	25
State
Income Taxes [Line Items]
Net operating loss carryforward					$ 78
Tax loss carryforwards	48	48
Operating loss carryforwards impact on valuation allowance	$ 72	$ 72

Income Taxes - Schedule of Co_2

Income Taxes - Schedule of Components of Deferred Taxes (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Jul. 08, 2022
Assets
Tax carryforwards	$ 251	$ 274
Disallowed interest carryforwards	105	54
Property, plant and equipment	14	16
Accruals and other	126	123
Pensions	48	90
Asbestos	46	50
Postretirement and postemployment benefits	23	23
Lease liabilities	32	32
Valuation allowances	(152)	(178)	$ (78)
Total	493	484
Liabilities
Intangible assets	260	292
Property, plant and equipment	257	253
Accruals and other	129	94
Pensions	21	20
Right of use assets	30	31
Total	$ 697	$ 690

Income Taxes - Schedule of Tax

Income Taxes - Schedule of Tax Credit Carryforwards Expirations (Details) $ in Millions	Dec. 31, 2024 USD ($)
Income Tax Disclosure [Abstract]
2025	$ 13
2026	12
2027	7
2028	2
2029	10
Thereafter	77
Unlimited	$ 130

Income Taxes - Schedule of Reco

Income Taxes - Schedule of Reconciliation of Unrecognized Tax Benefits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at January 1	$ 46	$ 46	$ 48
Additions for prior year tax positions	10	6	7
Reductions to prior period tax positions	(4)	0	0
Lapse of statute of limitations	(4)	(4)	(1)
Settlements	(2)	(2)	(6)
Foreign currency translation	0	0	(2)
Balance at December 31	$ 46	$ 46	$ 46

Capital Stock - Schedule of Com

Capital Stock - Schedule of Common Stock Activity (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares outstanding at beginning of period (in shares)	120,644,313	119,945,302	126,131,799
Shares repurchased (in shares)	(2,470,604)	(143,736)	(6,574,610)
Common shares outstanding at end of period (in shares)	118,503,631	120,644,313	119,945,302
Restricted Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued to employees, net of forfeitures and Shares issued to non-employee directors (in shares)	313,136	820,343	370,178
Share-based Payment Arrangement | Share-based Payment Arrangement, Nonemployee
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued to employees, net of forfeitures and Shares issued to non-employee directors (in shares)	16,786	22,404	17,935

Capital Stock - Narrative (Deta

Capital Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Feb. 27, 2025	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Jul. 25, 2024	Dec. 09, 2021
Dividends Payable [Line Items]
Common stock, dividends, per share, declared (in dollars per share)		$ 1	$ 0.96	$ 0.88
Common stock, dividends, per share, paid (in dollars per share)		$ 1	$ 0.96	$ 0.88
Stock repurchase program, authorized amount					$ 2,000	$ 3,000
Stock repurchased, net of excise tax		$ 217
Preferred stock, shares authorized (in shares)		30,000,000	30,000,000
Subsequent Event
Dividends Payable [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.26

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss Attributable to Crown Holdings - Schedule of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
AOCI Attributable To Parent Net Of Tax [Roll Forward]
Balance at beginning of period	$ 3,228	$ 2,864	$ 2,287	$ 2,330
Total other comprehensive income	225	206	2
Balance at end of period	3,228	2,864	2,287
Total
AOCI Attributable To Parent Net Of Tax [Roll Forward]
Balance at beginning of period	(1,462)	(1,687)	(1,892)	$ (1,898)
Other comprehensive income / (loss) before reclassifications	(187)	147
Amounts reclassified from accumulated other comprehensive income	412	58
Total other comprehensive income	225	205	6
Balance at end of period	(1,462)	(1,687)	(1,892)
Defined benefit plans
AOCI Attributable To Parent Net Of Tax [Roll Forward]
Balance at beginning of period	(230)	(664)	(686)
Other comprehensive income / (loss) before reclassifications	21	(14)
Amounts reclassified from accumulated other comprehensive income	413	36
Total other comprehensive income	434	22
Balance at end of period	(230)	(664)	(686)
Foreign currency translation
AOCI Attributable To Parent Net Of Tax [Roll Forward]
Balance at beginning of period	(1,236)	(1,022)	(1,197)
Other comprehensive income / (loss) before reclassifications	(213)	175
Amounts reclassified from accumulated other comprehensive income	(1)	0
Total other comprehensive income	(214)	175
Balance at end of period	(1,236)	(1,022)	(1,197)
Cash flow hedges
AOCI Attributable To Parent Net Of Tax [Roll Forward]
Balance at beginning of period	4	(1)	(9)
Other comprehensive income / (loss) before reclassifications	5	(14)
Amounts reclassified from accumulated other comprehensive income	0	22
Total other comprehensive income	5	8
Balance at end of period	$ 4	$ (1)	$ (9)

Revenue - Schedule of Revenue R

Revenue - Schedule of Revenue Recognized (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue recognized	$ 11,801	$ 12,010	$ 12,943
Revenue recognized over time
Disaggregation of Revenue [Line Items]
Revenue recognized	6,632	6,472	6,937
Revenue recognized at a point in time
Disaggregation of Revenue [Line Items]
Revenue recognized	$ 5,169	$ 5,538	$ 6,006

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Net contract assets	$ 9	$ 8

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2024	Apr. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares)	3.4	2.8
Restricted Stock and Deferred Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 76
Weighted average recognition period (in years)	2 years 8 months 12 days
Aggregate market value of the shares released and issued on the vesting dates	$ 33
Time-Vested Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years) for shares awarded	3 years
Performance-Based Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years) for shares awarded	3 years
Award vesting period	3 years
Level of performance achieved based on shares awarded, minimum	0%
Level of performance achieved based on shares awarded, maximum	200%
Time-Vested Restricted Stock and Deferred Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Time-Vested Restricted Stock and Deferred Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Restricted Stock Transactions (Details)	12 Months Ended
	Dec. 31, 2024 shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested shares outstanding at beginning of period (in shares)	1,444,712
Non-vested shares outstanding at end of period (in shares)	1,330,277
Time-vesting
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	240,680
Released (in shares)	(284,127)
Forfeitures (in shares)	(112,020)
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	166,380
Released (in shares)	(103,993)
Forfeitures (in shares)	(21,355)

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Grant Date Fair Value of Restricted Stock (Details) - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Time-vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average grant-date fair value of restricted stock awarded (in dollars per share)	$ 80.21	$ 87.66	$ 96.29
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average grant-date fair value of restricted stock awarded (in dollars per share)	$ 89.57	$ 86.10	$ 111.84

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of Fair Value Assumptions (Details) - Performance-Based Shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	4%	4.10%	1%
Expected term (years)	3 years	3 years	3 years
Expected stock price volatility	31.40%	39.80%	34.80%

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share [Abstract]
Net income attributable to Crown Holdings	$ 424	$ 450	$ 727
Weighted average shares outstanding:
Basic (in shares)	119,200	119,410	120,860
Add: dilutive restricted stock (in shares)	230	260	520
Diluted (in shares)	119,430	119,670	121,380
Basic earnings per share (in dollars per share)	$ 3.56	$ 3.77	$ 6.01
Diluted earnings per share (in dollars per share)	$ 3.55	$ 3.76	$ 5.99
Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive (in shares)	800	200	700

Segment Information - Schedule

Segment Information - Schedule of Information About Operating Segments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Net sales	$ 11,801	$ 12,010	$ 12,943
Depreciation	297	336	301
Capital expenditures	403	793	839
Segment income	1,419	1,269	1,336
Operating segments
Segment Reporting Information [Line Items]
Segment income	1,728	1,560	1,318
Operating segments | Total reportable segments
Segment Reporting Information [Line Items]
Net sales	10,579	10,639	11,400
Depreciation	272	312	280
Capital expenditures	340	679	778
Segment income	1,728	1,560	1,318
Operating segments | Americas Beverage
Segment Reporting Information [Line Items]
Net sales	5,240	5,147	5,126
Depreciation	128	149	128
Capital expenditures	164	296	380
Segment income	987	876	742
Operating segments | European Beverage
Segment Reporting Information [Line Items]
Net sales	2,071	1,939	2,114
Depreciation	55	56	49
Capital expenditures	133	291	283
Segment income	276	199	123
Operating segments | Asia Pacific
Segment Reporting Information [Line Items]
Net sales	1,161	1,297	1,615
Depreciation	46	63	62
Capital expenditures	21	66	51
Segment income	195	154	172
Operating segments | Transit Packaging
Segment Reporting Information [Line Items]
Net sales	2,107	2,256	2,545
Depreciation	43	44	41
Capital expenditures	22	26	64
Segment income	270	331	281
Operating segments | Other
Segment Reporting Information [Line Items]
Net sales	1,222	1,371	1,543
Depreciation	23	22	18
Capital expenditures	42	76	61
Segment income	82	117	240
Intersegment sales
Segment Reporting Information [Line Items]
Net sales	(82)	(193)	(235)
Intersegment sales | Total reportable segments
Segment Reporting Information [Line Items]
Net sales	(15)	(49)	(132)
Intersegment sales | Americas Beverage
Segment Reporting Information [Line Items]
Net sales			(7)
Intersegment sales | European Beverage
Segment Reporting Information [Line Items]
Net sales			(89)
Intersegment sales | Transit Packaging
Segment Reporting Information [Line Items]
Net sales	(15)	(49)	(36)
Intersegment sales | Other
Segment Reporting Information [Line Items]
Net sales	(67)	(144)	(103)
Corporate and unallocated items
Segment Reporting Information [Line Items]
Depreciation	2	2	3
Capital expenditures	21	38	0
Segment income	$ (165)	$ (131)	$ (115)

Segment Information - Schedul_2

Segment Information - Schedule of Reconciliation of Segment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income from operations	$ 1,419	$ 1,269	$ 1,336
Restructuring and other	(75)	(114)	52
Amortization of intangibles	(151)	(163)	(159)
Loss from early extinguishments of debt	(1)	(1)	(11)
Other pension and postretirement	(546)	(49)	16
Gain on sale of equity method investment	275	0	0
Interest expense	(452)	(436)	(284)
Interest income	82	53	15
Foreign exchange	(34)	(41)	(16)
Income before income taxes and equity in net earnings of affiliates	743	795	1,056
Intercompany profit related to non-reportable segments		13	19
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income from operations	1,728	1,560	1,318
Operating segments | Total reportable segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income from operations	1,728	1,560	1,318
Operating segments | Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income from operations	82	117	240
Corporate and unallocated items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Income from operations	$ (165)	$ (131)	$ (115)

Segment Information - Concentra

Segment Information - Concentration Risk (Details) - Revenue Benchmark - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Customer A
Concentration Risk [Line Items]
Concentration risk, percentage	12%	12%	12%
Customer B
Concentration Risk [Line Items]
Concentration risk, percentage	12%	11%	11%

Segment Information - Schedul_3

Segment Information - Schedule of Sales by Major Product (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Revenue recognized	$ 11,801	$ 12,010	$ 12,943
Metal beverage cans and ends
Segment Reporting Information [Line Items]
Revenue recognized	7,899	7,514	8,096
Transit Packaging
Segment Reporting Information [Line Items]
Revenue recognized	2,107	2,256	2,545
Metal food cans and ends
Segment Reporting Information [Line Items]
Revenue recognized	887	1,013	1,099
Other products
Segment Reporting Information [Line Items]
Revenue recognized	461	701	598
Other metal packaging
Segment Reporting Information [Line Items]
Revenue recognized	$ 447	$ 526	$ 605

Segment Information - Schedul_4

Segment Information - Schedule of Sales and Long-Lived Assets for The Major Countries (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 11,801	$ 12,010	$ 12,943
Long-Lived Assets	4,927	5,062
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	4,419	4,482	4,740
Long-Lived Assets	1,667	1,694
Mexico
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,053	1,129	1,080
Long-Lived Assets	534	560
Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	1,061	991	1,011
Long-Lived Assets	478	500
Canada
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	744	823	893
Long-Lived Assets	98	99
United Kingdom
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	398	494	521
Long-Lived Assets	502	466
Vietnam
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	387	423	547
Long-Lived Assets	293	317
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	3,739	3,668	$ 4,151
Long-Lived Assets	$ 1,355	$ 1,426

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts and Reserves (Details) - Deferred tax assets - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 178	$ 173	$ 227
Charged to costs and expense	(16)	7	(49)
Charged to other  accounts	(5)	(1)	(3)
Acquisitions	0	7	0
Deductions – write-offs	(5)	(8)	(2)
Balance at end of period	$ 152	$ 178	$ 173